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Adaptations of the Supraspinatus Tendon and Muscle in a Rat Model of Exercise
Abstract
Rotator cuff tendon and muscle can beneficially adapt to exercise, but it is unknown how acute responses
following a single bout of exercise lead to chronic, beneficial adaptations. To develop new prevention and
treatment strategies for overuse injuries, we must first characterize how tissues adapt to non-injurious
loading. One feature that may distinguish beneficial and detrimental responses are pathways associated
with inflammation and tissue healing, including activation of the arachidonic acid cascade and matrix
turnover facilitated by matrix metalloproteinases (MMPs). The objective of this dissertation was to
characterize temporal, acute and chronic responses of the rat supraspinatus to non-injurious exercise and
examine the roles of cyclooxygenases-1 and -2 (arachidonic acid cascade components) and MMPs in
governing these responses by using pharmacologic inhibition. Using a rat model of non-injurious exercise,
we showed that tendon adapted chronically by enhancing its mechanical properties. Following a single
bout of exercise, tendon showed mild trends toward reduced mechanical properties, which may initiate
the beneficial adaptations detected chronically. Exercised tendon also had decreased MMP activity. We
administered ibuprofen, an inhibitor of cyclooxygenases-1 and -2, to understand how this commonly used
over-the-counter drug affects muscle and tendon responses to exercise. Ibuprofen did not detrimentally
affect tendon mechanical properties but did result in decreased muscle fiber cross-sectional area. Taken
together, these findings imply that the arachidonic acid cascade is not a primary modulator of tendon
adaptations to non-injurious exercise but is important for muscle growth. Finally, we studied the effects of
doxycycline, a broad-spectrum MMP inhibitor, on supraspinatus muscle and tendon adaptations to
exercise. Doxycycline enhanced tendon mechanical properties and collagen organization from sedentary
animals but not in exercised animals, which supports the increased MMP activity detected in sedentary
tendons. Doxycycline reduced muscle fiber cross-sectional area specific to exercised animals. We
conclude that the pathways responsible for muscle and tendon adaptations to exercise may be tissuedependent, and drugs such as ibuprofen and doxycycline also have activity-dependent effects. These
studies provide a foundation for future work to develop more efficient physical training regimens and new
prevention, treatment, and rehabilitation modalities for overuse injuries.
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ABSTRACT
ADAPTATIONS OF THE SUPRASPINATUS TENDON AND MUSCLE IN A RAT
MODEL OF EXERCISE

Sarah Ilkhanipour Rooney
Dr. Louis J. Soslowsky

Rotator cuff tendon and muscle can beneficially adapt to exercise, but it is
unknown how acute responses following a single bout of exercise lead to chronic,
beneficial adaptations. To develop new prevention and treatment strategies for overuse
injuries, we must first characterize how tissues adapt to non-injurious loading. One
feature that may distinguish beneficial and detrimental responses are pathways associated
with inflammation and tissue healing, including activation of the arachidonic acid
cascade and matrix turnover facilitated by matrix metalloproteinases (MMPs). The
objective of this dissertation was to characterize temporal, acute and chronic responses of
the rat supraspinatus to non-injurious exercise and examine the roles of cyclooxygenases1 and -2 (arachidonic acid cascade components) and MMPs in governing these responses
by using pharmacologic inhibition. Using a rat model of non-injurious exercise, we
showed that tendon adapted chronically by enhancing its mechanical properties.
Following a single bout of exercise, tendon showed mild trends toward reduced
mechanical properties, which may initiate the beneficial adaptations detected chronically.
Exercised tendon also had decreased MMP activity. We administered ibuprofen, an
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inhibitor of cyclooxygenases-1 and -2, to understand how this commonly used over-thecounter drug affects muscle and tendon responses to exercise. Ibuprofen did not
detrimentally affect tendon mechanical properties but did result in decreased muscle fiber
cross-sectional area. Taken together, these findings imply that the arachidonic acid
cascade is not a primary modulator of tendon adaptations to non-injurious exercise but is
important for muscle growth. Finally, we studied the effects of doxycycline, a broadspectrum MMP inhibitor, on supraspinatus muscle and tendon adaptations to exercise.
Doxycycline enhanced tendon mechanical properties and collagen organization from
sedentary animals but not in exercised animals, which supports the increased MMP
activity detected in sedentary tendons. Doxycycline reduced muscle fiber cross-sectional
area specific to exercised animals. We conclude that the pathways responsible for muscle
and tendon adaptations to exercise may be tissue-dependent, and drugs such as ibuprofen
and doxycycline also have activity-dependent effects. These studies provide a foundation
for future work to develop more efficient physical training regimens and new prevention,
treatment, and rehabilitation modalities for overuse injuries.
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Chapter 1: Introduction
A. Introduction
Rotator cuff tendinopathy, which primarily affects the supraspinatus tendon, is
estimated to affect 6.1% of women and 4.5% of men ages 25-64 years in the general
population.113 If left untreated, the tendon degeneration can progress to a rotator cuff tear,
which affects up to 50% of asymptomatic people over the age of 50 years.72,102,117 These
injuries are especially common in laborers and athletes that repeatedly use overhead
activity. The proposed etiology is accumulated microtrauma in which the tendon is
unable to properly adapt to the loading, resulting in a chronic overuse injury. These
injurious changes are in contrast to those found following non-injurious exercise, in
which the tissue is able to beneficially adapt to the loading. The fine line between
beneficial and detrimental loading conditions has not been elucidated.
One feature that may distinguish beneficial and detrimental adaptations to loading
is the role of pathways associated with inflammation. Acute inflammation is a series of
biologic events following injury. Two important processes related to inflammation are
activation of the arachidonic acid cascade and matrix turnover facilitated by a class of
enzymes called matrix metalloproteinases (MMPs). Previous studies suggest that
activation of these inflammatory pathways is important for enabling tendon and muscle
regeneration following acute injury; however, the mechanisms governing the role of these
inflammatory pathways in the adaptation of tendon and muscle to physiologically
relevant loading conditions is unknown.
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The use of pharmacologic inhibitors of these two inflammation-related pathways
(arachidonic acid cascade and MMPs) may help identify their roles in tissue adaptations
to load. Ibuprofen, one of the top three consumed drugs in the United States, is an
inhibitor of cyclooxygenases-1 and -2, components of the arachidonic acid cascade.
Current literature exploring the effects of ibuprofen on tissue adaptations to loading is
unclear, despite its prevalent use. Doxycycline, in addition to being an antibiotic, is an
MMP inhibitor that has been suggested as a treatment to improve tissue healing following
acute injury. The effect of doxycycline on muscle and tendon adaptions to load has not
been explored. Administration of ibuprofen and doxycycline, inhibitors of two pathways
associated with inflammation, may highlight the mechanisms that manage tissue
responses to loading.
The original objective of this dissertation was to investigate and compare an
overuse and non-injurious exercise model to distinguish pathologic from physiologic
adaptations to load; however, only the non-injurious exercise model was used here.
Therefore, the goal of this dissertation is to use an animal model to characterize how
supraspinatus tendon and muscle adapt to non-injurious exercise over time and the roles
of two inflammation-related pathways (arachidonic acid cascade and MMPs). Aim 1
characterizes the natural, temporal response of tendon to non-injurious loading. Aim 2
helps to answer the question “Will ibuprofen adversely affect muscle and tendon
adaptations to exercise?” Finally, Aim 3 explores the role of MMPs in sedentary and
exercised supraspinatus tendon and muscle by using doxycycline as a pharmacologic
agent to inhibit MMP activity.

2

Before addressing the role of inflammation in overuse injuries, we must first
understand its role in tissue adaptations to non-injurious exercise. This research is
innovative in that it directly investigates the supraspinatus tendon and muscle response to
non-injurious loading acutely and chronically using clinically relevant drugs. These
studies will identify the key processes associated with beneficial tissue responses to
exercise to inform physical training regimens. Importantly, results will reinforce or
challenge the regular use of anti-inflammatory drugs. Finally, these studies will also
provide a foundation to support development of new prevention, treatment, and
rehabilitation modalities for tendinopathy.
B. Background
1. Rotator Cuff Anatomy
The rotator cuff refers to the four muscles and associated tendons that stabilize the
shoulder: supraspinatus, infraspinatus, subscapularis, and teres minor. These muscles
originate on the scapula and insert (through their tendons) on the humerus. Of these four
tendons, the supraspinatus is most commonly injured with tendinopathy (tendon
degeneration) or tear. The supraspinatus passes underneath the coracoacromial arch, a
bony-ligamentous arch formed by the acromion and coracoid processes of the scapula
and the coracoacromial ligament that spans the two processes (Figure 1.1).
2. Supraspinatus Tendinopathy
a. Prevalence
Rotator cuff tendinopathy, which primarily affects the supraspinatus tendon, is a
common clinical condition. In the general population, the prevalence of this injury is
estimated at 6.1% for women and 4.5% for men ages 25-64 years.113 Of reported shoulder
3

complaints, 29% were due to rotator cuff tendinopathy.112 This injury is frequent in
overhead laborers and athletes. For example, 18% of industrial welders suffered from
rotator cuff tendinopathy.39 Degeneration precedes spontaneous tendon rupture in 97% of
patients,44 and if left untreated, chronic tendinopathy may progress to a full tendon tear.
Up to 50% of asymptomatic people over the age of 50 years suffer from a rotator cuff
tear.72,102,117 These tears can be difficult to treat, and tendinopathy can be painful and
debilitating; therefore, strategies to prevent the onset of supraspinatus tendinopathy are
needed.

Figure 1.1. Shoulder Anatomy
The supraspinatus passes underneath a bony-ligamentous arch
formed by the acromion, coracoid, and coracoacromial ligament.
(Image from http://www.edinburghosteopathy.co.uk)

b. Presentation
Tendinopathy is a clinical diagnosis characterized by focal tenderness, activityrelated pain, weakness, and increased size. Ultrasound shows hypoechoic regions, and
MRI shows increased signal due to fluid retention. “Tendinosis” is confirmed upon
4

histological evaluation of a tendon biopsy showing increased cellularity, rounding of
nuclei, increased mucoid ground substance (proteoglycans), loss of collagen organization,
and increased vascularity.43,46,61 These changes are generally heterogeneous and may be
present without clinical symptoms. Inflammation is not seen in the late stages of
degeneration when biopsies are taken, and early stages have not been studied since
patients typically present to the clinic only once tendon degeneration has progressed to a
chronic stage. Animal models would allow investigation of these early stages, but few
studies have yet been performed. Chronic tendinopathy is often described as a “failed
healing” response,35 with increases in both matrix synthesis and degradation that result in
net matrix catabolism. A summary of changes associated with chronic tendinopathy is
presented in Table 1.1.
Table 1.1. Chronic Tendinopathy Characteristics
Vascularity
Nerve fibers
↑
Cellularity
Synthesis
Total proteoglycan/glycosaminoglycans
Collagen type III : I ratio
Collagen disorganization
↑
Apoptotic cells
Degradation
Alterations in MMPs and their inhibitors (TIMPs)
Rounded cell shape
↑
Aggrecan
Cartilage
Collagen type II
phenotype
Sox9
Max stress
↓
Mechanical Modulus
properties Stiffness
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c. Proposed Etiology
The proposed etiology of supraspinatus tendinopathy is gradual accumulation of
microtrauma, resulting in an overuse injury. Overuse injuries account for approximately
29% of all injuries in college athletes.119 Over one-third of these overuse injuries could be
attributed to inflammation or tendinopathy.119 Highlighting the role of overuse in the
initiation and progression of tendon degeneration, supraspinatus tendinopathy in elite
swimmers correlated with the hours and kilometers swum per week.92 Overuse injuries
occur due to maladaptations to loading: while beneficial exercise results in matrix
turnover and net anabolism, overuse injuries result in unbalanced degeneration-repair
processes creating net catabolism. In order to understand the initiation and progression of
these injuries, we must first identify the physiologic adaptations to beneficial, noninjurious exercise.
d. Conservative Treatments
When a patient presents with tendinopathy, the first treatments prescribed are
conservative: e.g., administration of nonsteroidal anti-inflammatory drugs (NSAIDs)
such as ibuprofen, physical therapy, corticosteroid injections, extracorporeal shock wave
therapy, and/or sclerotherapy.6 NSAIDs and corticosteroid injections appear to provide
short-term pain relief but no long-term benefits.4,6 Other potential treatment mechanisms
targeting biologic pathways include modulating substance P,5,16,31 administration of
glyceryl trinitrate or L-NAME to alter nitric oxide,22,77,105 anti-TNF-α,85,1 NMDA
antagonist to target glutamate signaling pathways,85 and anakinra (IL-1 antagonist).1 The
efficacy of these treatments is debated and should be explored further. One promising
6

treatment strategy is use of MMP inhibitors. Several studies have shown alterations in
MMP expression with tendinopathy. It is believed that an imbalance in these enzymes
and their inhibitors leads to the advanced degeneration of the tendon. Aprotinin (MMP
inhibitor) injections to the Achilles tendon are promising in treatment of chronic
tendinopathy in humans,76 though another study has found no benefit over placebo.15
While changes in MMP expression are characteristic of chronic tendinopathy, nondamaging exercise may also produce changes in MMP expression indicative of matrix
turnover and beneficial adaptation. Exploring effects of potential “treatments” such as
NSAIDs and MMP inhibitors in sedentary and non-injurious exercise models would help
elucidate the differences between beneficial adaptations and maladaptations to loading.
3. Exercise
Exercise has both local and systemic effects on the body. Locally, exercise affects
the muscle, tendon, and bone of the region (among other tissues not discussed here).
Systemically, exercise affects the cardiac and metabolic systems (among other systems
not discussed here). The effects of exercise are both acute, wherein the
tissue/organ/system shows an immediate response to the altered loading or stress, and
chronic, wherein the tissue/organ/system shows adaptations with repeated exercise
sessions. These acute responses and chronic adaptations to exercise are tissue- and timedependent in addition to exercise protocol-dependent. Defining whether a tissue has been
“exercised” requires the analysis of a combination of features. Importantly, no single
metric can define exercise; therefore, a number of measurements must be made to
understand the entirety of the response. In the following sections, tendon- and musclespecific adaptations commonly found in response to exercise are discussed.
7

4. Tendon Properties
a. Biology
Tendons are tissues that connect muscle to bone, allowing transfer of loads. The
primary constituents are tenocytes (tendon fibroblasts), extracellular matrix, and water.
The extracellular matrix is composed of collagens (types I, II, III, V, IX, X), which are
the main structural proteins, with smaller amounts of proteoglycans, elastin, and
fibronectin.33 Type I collagen is the primary component, comprising approximately 60%
of the tendon dry weight and 95% of the total collagen.114 The collagen in healthy
tendons is arranged longitudinally along the axis of loading to facilitate efficient load
transfer. With injury, this collagen becomes more disorganized. The extracellular matrix
varies regionally along the tendon and is believed to be defined by the loading profile
experienced in that location. Healthy tendon is specifically adapted to its required
function. The biology and composition of tendon is influenced by age, loading
(unloading, exercise, overloading), gender, disease, and injury. These changes in
composition can lead to changes in tissue function, and alternately, changes in function
can lead to changes in composition. For example, eliminating compressive loading in a
rabbit flexor tendon led to changes in tendon thickness, nuclear density,
glycosaminoglycan content, collagen organization, and type II collagen.63 These biologic
and structural changes can lead to alterations in tendon mechanical properties.
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b. Mechanics
Tendons are characterized by having non-linear, strain-dependent viscoelastic
behavior. The unique crimping pattern of the tendon results in a toe region during which
the fibers straighten before entering the linear region of the stress-strain curve (Figure
1.2).114 Furthermore, tendons exhibit stress-relaxation, creep, and unique recovery
properties.28,27 The viscoelasticity of tendon has been attributed to accumulation of highly
polarized glycosaminoglycans that attract water.

Figure 1.2. Tendon Stress-Strain Curve
(Figure from Wang 200627)

c. Adaptations to Beneficial Exercise
As previously described, tendons alter their composition and structure to meet the
demands of their function, such as adaptations to non-injurious exercise. These changes
occur over time with chronic, non-injurious exercise. Compared to more metabolically
active tissues (such as muscle or bone), tendon adaptations to exercise may be mild and
difficult to detect, which results in unclear descriptions of exercise effects in the
literature. For example, tendon cross-sectional area is often unchanged32,51,57 with chronic
9

exercise but some studies find increases.21,93 Similarly, tendon stiffness and modulus may
increase21,32,51,93 or remain unchanged49,57,62 with chronic exercise. Importantly, the
mechanical properties do not decrease, as this would be indicative of injury. Increased
collagen content is likely the compositional change that supports these functional
adaptations.10,99 The temporal, chronic adaptations to exercise have not been welldefined, making it difficult to draw conclusions from studies that investigate a single time
point. In addition to chronic adaptations, tendons respond acutely to a change in loading,
as in response to a single bout of exercise.101 These changes include increased collagen
turnover,37,50,53,55,98 blood flow,14,89 and evidence of inflammation-related
components.52,54 Again, these changes are time-dependent, and it is unknown how acute
responses to exercise translate to chronic adaptations.
5. Skeletal Muscle Properties
a. Biology
Skeletal muscle is a voluntarily controlled, striated tissue. It has a hierarchical
structure composed of numerous muscle fibers. Muscle fibers (also called muscle cells or
myocytes) are cylindrical structures that have multiple nuclei. In mature, healthy tissue,
these nuclei are located on the periphery of the muscle fibers. During myogenesis or fiber
regeneration, myoblasts differentiate into myotubes, which contain centrally located
nuclei before maturing. Muscle fibers are composed of myofibrils which primarily
contain actin and myosin filaments in a repeating pattern, forming the contractile unit
(sarcomere). Muscle fibers come in a variety of “types” that result in different functional
capacities, summarized in Table 1.2. Myosin heavy chain (MHC) fiber type can be
determined through immunohistochemical staining for the different MHC isoforms.
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Depending on the function of the muscle, different muscles have different compositions
of fiber type.
Table 1.2. Properties of Skeletal Muscles
Type I
Type IIa
Slow oxidative
Fast oxidative
Also known as
(slow twitch)
(fast twitch A)
Red fibers
Red fibers
Color
Fatigue
Fatigue resistant
Fatigue
resistant
↑
↑
Myoglobin
↑
↑↑
Mitochondria
↑
↑
Oxidative capacity
Glycolytic capacity
↓
↑
and Glycogen levels
Creatine
Triglycerides
phosphate
Storage fuel
Glycogen
Aerobic
Middle-distance
activities
Functional Examples
aerobic activities
(long run)

Type IIb
Fast glycolytic
(fast twitch B)
White fibers
Fatigable
↓
↓
↓
↑↑
ATP
Creatine
phosphate
Sprinting

b. Adaptations to Beneficial Exercise
Skeletal muscle adapts to both resistance and endurance exercise. In response to
resistance training, the most notable adaptation is skeletal muscle hypertrophy which
leads to increased maximal force production. In response to endurance training, muscle
enhances its capacity to efficiently create energy by increasing the number of
mitochondria and their oxidative phosphorylation proteins. This response leads to
decreased fatigability of the trained muscle. These hypertrophic and aerobic metabolism
changes can be independent of each other. Furthermore, these adaptations may be fiber
type-specific.29 Whether fibers change type as a result of exercise training (e.g., type I
transitioning to type II fibers) is controversial, though if changes do occur they normally
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result in transition towards increased proportion of oxidative fiber types with endurance
training. Glycogen is the main energy storage form in muscle. With endurance training,
glycogen content within the resting muscle is increased compared to untrained
muscle.120,56 Additionally, the trained muscle is depleted of glycogen more slowly than
untrained.29 Gene expression and protein transcription is altered with exercise training.
PPARβ/δ transcription factor and PGC-1α and -1β transcriptional co-activators play a
major role in controlling the oxidative metabolism of skeletal muscle fibers.90 PGC-1α
overexpression in skeletal muscle is associated with resistance to fatigue and a shift to
oxidative phenotype.64 AMP-activated protein kinase (AMPK) activation can lead to
increased levels of mitochondrial oxidative enzymes.90 Exercise training induces a higher
basal AMPK activity level.34 It has been shown that AICAR, an AMPK agonist,
improves running endurance.73 AMPK and PPARδ regulate type I muscle fiber
specification and endurance adaptations during exercise.73 Finally, Myo1c is an actinbased motor protein that acts in GLUT4 translocation. GLUT4, the major glucose
transporter protein expressed in skeletal muscle, is increased in highly oxidative
muscle.106 Endurance training has been shown to significantly increase the GLUT4
expression and Myo1c abundance.106
Muscle also exhibits acute responses to a single bout of exercise, suggesting
matrix turnover and influences of growth factors.36-38,57 After an acute bout of exercise,
glycogen content is diminished. Although muscle responses to exercise are much better
defined than tendon, it is still debated what role inflammatory processes play in initiating
these adaptations.
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6. Rat Rotator Cuff Model
The rat has previously been identified as a model of the human rotator cuff.96
Apart from non-human primates, the rat was the only species to satisfy a checklist of
criteria important to model the human shoulder. Importantly, the rat supraspinatus passes
through a bony tunnel similar to that in humans. Furthermore, during normal walking, the
rat supraspinatus passes repeatedly underneath the coracoacromial arch, mimicking the
movements of the human supraspinatus during lateral arm raise and overhead activity.
The rat has also been used to develop a model of supraspinatus tendinopathy.97 In
this model, rats run on a 10º decline treadmill at a speed of 17 m/min, 5 days per week.
After as early as 4 weeks, the tendon shows degenerative changes consistent with injury,
including inferior mechanical properties, disorganized collagen matrix, hypercellularity,
and rounding of cell nuclei. The rat overuse model has since been used in several studies.
Similar to human tendinopathy, changes to the tendon matrix are evident in specific
alterations of MMPs,8 their inhibitors TIMPs,8,7 ADAM-10,7 proteoglycans (decorin,
biglycan, versican, aggrecan),7,9 and collagens (I, II, III, VI).9,7 Rounded cell shape and
increased aggrecan, type II collagen, and Sox9 are indicative of a shift toward a
fibrocartilaginous phenotype. Apoptosis may be present,69,91 and increased expression of
nitric oxide synthases100 and heat shock proteins69 are indicative of cellular stress.
Inflammatory regulators have also been identified in this model. Gene expression
quantified using PCR shows temporal changes in five-lipoxygenase activating protein
(FLAP), cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), and
von Willebrand factor (VWF) over the span of 3 days to 16 weeks, indicating that
inflammatory and angiogenic markers are altered by overuse.81 From a microarray study,
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Molloy and co-authors70 showed that inflammatory and apoptotic genes are altered after 4
weeks of overuse. In a model of human rotator cuff tendinopathy, genes IL-15, -18, -6,
MIF, TNF-α, caspase 3, and caspase 8 were upregulated compared to control, similar to
the findings in the rat model.68 More recently, a slight progressive increase in TNF-α
protein expression from 2 to 4 weeks of overuse with no increase in ED1 (proinflammatory) or ED2 (anti-inflammatory) macrophages in that time frame was shown in
the rat overuse model.8 Inflammatory cytokines including MCP-1, IL-1, IL-6, and IL-13
were decreased at 2 but not 4 weeks of overuse.8 TGF-β3 has also been shown to
decrease at 2 and 4 weeks of overuse.7 These studies suggest a role of inflammation in
the early stages of supraspinatus tendinopathy in the rat overuse model, but whether this
response is pathologic or physiologic is unknown. Until recently, a model of noninjurious exercise to the rat supraspinatus did not exist.
7. Rat Model of Supraspinatus Non-Injurious Exercise
To address the need for a model to allow distinctions between detrimental and
beneficial adaptations to exercise, we developed a non-injurious exercise model to which
the rat supraspinatus overuse model could be compared, as described in the published
study by Rooney et al., 2015.88 In this initial study, adult, male Sprague-Dawley rats were
divided into exercise (EX; n=8) and control cage activity (CA; n=8) groups (IACUC
approved). EX rats ran on a flat treadmill at 10 m/min, 1 h/day, 5 days/wk, for 12
weeks104 while CA rats maintained normal cage activity. Upon completion, rats were
euthanized, weighed, and stored at -20°C.
Tissue Harvest: Rats were thawed, and the right supraspinatus (supra) muscle and
tendon were dissected and weighed, and muscle cross-sectional area (CSA) was
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measured with a custom laser device.79 Tendon at the insertion site was isolated from the
muscle for o-Hydroxy-proline (OHP) assay. The superficial and deep regions of the supra
muscle11 were collected separately for protein analysis. The heart and retroperitoneal and
epididymal fat pads were dissected and weighed. Tendon Mechanics: Rats were thawed,
and the left supra tendon was dissected and prepared for tensile mechanical testing with
preconditioning and ramp to failure.80 Tendon Collagen: OHP, a measure of collagen
content, was determined26,74 and normalized to tendon wet weight. Muscle Protein: A
Western blot was performed to quantify mitochondrial proteins. Total protein from the
supra muscle superficial region was probed for oxidative phosphorylation complexes I-V
using Total OXPHOS antibody cocktail (MitoSciences). Bands were visualized by
chemiluminescence, imaged, and analyzed with commercial software. Mitochondrial
proteins were normalized to α-tubulin, and the relative quantity of target protein in the
EX group compared to CA was calculated. Humerus Bone μCT: μCT (Scanco
VivaCT40) was used to determine trabecular and cortical bone structure. For trabecular
bone, a 2mm region just distal to the growth plate was scanned (15μm isotropic voxels);
for cortical bone, a 1.5 mm region at 60% of the humerus length was scanned (35μm
isotropic voxels). Bone was segmented from marrow using a global thresholding
technique and then subjected to standard microstructural analysis. Humerus Bone 3-Point
Bending: A custom fixture attached to an Instron created a 3-point bend in the humeral
shaft until fracture.84 Statistics: Comparisons between EX and CA were made with t-tests
for significance (p ≤0.05) and trends (p ≤0.1).
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Figure 1.3. Weight Changes with Exercise. Consistent with exercise,
treadmill-trained rats trended toward decreased body weight over time
and had significantly decreased fat pad weight, increased supraspinatus
muscle weight, and no change in heart weight. Mean + StDev
Figure from Rooney , et al. 201588

EX rats had reduced body (-7%) and fat pad (retroperitoneal: -45%, epididymal: 39%) mass. An 8% increase in supra muscle mass was measured with no change in heart
mass (Figure 1.3). Supra muscle CSA significantly increased 10% with exercise (Table
1.3). Tendon Mechanics: Supra tendon CSA and elastic modulus were not different
between groups (Table 1.3). Tendon Collagen: Collagen content of the supra tendon
normalized to wet weight trended toward increased in the EX group (Table 1.3). Muscle
Protein: Supra muscle had increased oxidative phosphorylation proteins (Figure 1.4).
Bone μCT: Trabecular bone in the EX group demonstrated trends toward increased
trabecular number (Tb.N) and connectivity (Conn.D) and decreased spacing (Tb.Sp) as
well as significantly greater degree of anisotropy (DA, Table 1.3). No differences were
found in trabecular bone volume, structure model index, thickness, bone mineral density
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(BMD), or tissue mineral density (TMD, not shown). Cortical bone in the EX group had
significantly increased BMD and TMD (Table 1.3) with no changes in volume or cortical
thickness (not shown). Bone 3-Point Bending: No differences were found for second
moment of area, max load, max displacement, modulus, flexural rigidity, or max stress
(not shown).
Table 1.3. Shoulder Adaptations to Exercise Protocol. Treadmill-trained
rats showed adaptations consistent with exercise in supraspinatus tendon and
muscle, and trabecular (Tb) and cortical (Ct) humerus bone. Mean ± StDev
Tissue
Measurement
CA
EX
p-value
Muscle CSA (mm2)

34.3 ± 3.9

2

CSA (mm )
Failure Load (N)
Tendon Failure Stress (MPa)
Modulus (MPa)
Collagen/Wet Weight (%)

37.7 ± 2.6

*0.04

1.97 ± 0.42 1.97 ± 0.28 0.5
22.3 ± 5.8 26.8 ± 3.0 *0.04
11.6 ± 3.4 14.0 ± 3.2 +0.09
100 ± 42
101 ± 24
0.5
+
25 ± 5
28 ± 1
0.07

Tb Connective Density (1/mm3)
Tb Number (1/mm)
Tb Spacing (mm)
Bone Tb Degree of Anisotropy
Ct Thickness (mm)
Ct BMD (mgHA/cm3)
Ct TMD (mgHA/cm3)
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60 ± 12
3.1 ± 0.7
0.34 ± 0.09
1.79 ± 0.07
0.77 ± 0.02
1116 ± 12
1212 ± 18

70 ± 12
3.5 ± 0.4
0.28 ± 0.04
1.86 ± 0.07
0.80 ± 0.03
1126 ± 10
1227 ± 7

+

0.07
0.10
+
0.08
*0.03
*0.05
*0.05
*0.02
+

Figure 1.4. Oxidative Phosphorylation Proteins. Consistent with
adaptations to aerobic exercise, treadmill-trained rats had increased
expression of oxidative phosphorylation proteins. Relative quantity of
exercise to cage activity after normalizing by tubulin. Mean + StDev
Figure from Rooney , et al. 201588

After 12 weeks of treadmill training, rats showed systemic (decreased body and
fat pad mass) and local shoulder (tendon, muscle, bone) changes consistent with exercise.
Heart mass did not change, indicating that this protocol does not tax the cardiovascular
system. No changes were seen in tendon elastic properties, but stress-relaxation
significantly increased. Other studies on tendon mechanics after training show mixed
results but often find no differences in modulus or CSA.e.g.,57 Unlike the established supra
overuse model, tendons did not have decreased mechanics, indicating that this protocol is
non-injurious to the tendon.97 Supra muscle showed hypertrophy (increased weight and
CSA), indicative of a response to loading, and increased oxidative phosphorylation
proteins, indicative of endurance training. Humerus trabecular bone had increased
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anisotropic orientation, consistent with load-induced bone remodeling. Cortical bone
showed increased BMD and TMD with no volume change, suggesting that bone mass
changes are due to tissue mineralization. Other studies have also shown no changes in
humerus mechanics following moderate treadmill training.e.g.,116 Although these
adaptations to exercise are mild, they are consistent and present across multiple tissues
using multiple assays. This study88 is limited by the quality of tissue available, sample
size, and single time point investigated. In conclusion, this is the first non-injurious rat
shoulder exercise model, which can be compared to the previously established overuse
model97 to differentiate beneficial adaptations and maladaptations to loading.
8. Inflammation
Wound healing is a structured, temporal response that consists of four phases:
hemostasis, inflammation, proliferation, and remodeling. Inflammation is a complex
biologic event that aims to protect and repair tissue. Acute inflammation is an immediate
(minutes to days) response to tissue insult. Two pathways associated with inflammation
are activation of the arachidonic acid (AA) cascade and matrix turnover facilitated by
matrix metalloproteinases (MMPs).
a. Arachidonic Acid Cascade and MMPs
An important pathway in the acute inflammatory response is the acrachidonic acid
cascade (Figure 1.5).40 In this system, arachidonic acid is converted by cyclooxygenase
(COX) to prostaglandins, prostacyclins, or thromboxane or by 5-lipoxygenase (LOX) to
leukotrienes. COX-1 is constitutively expressed, and COX-2 is induced.60 Prostaglandins,
synthesized through a COX-2 specific mechanism, can mediate blood flow to the tissue48
and upregulate MMP expression.103 MMPs are responsible for matrix turnover and if not
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carefully balanced with their inhibitors can result in excess fibrosis or degeneration.78

Figure 1.5. Arachidonic Acid Cascade
(Figure from Hertel 1997)

b. Roles of Inflammation in Tendon Adaptations
Tendon is a dynamic tissue that responds biologically to mechanical loads. In
vitro experiments show that cultured human tendon fibroblasts, known as “tenocytes,”
respond to strain by modulating production of prostaglandin E2 (PGE2), COX-1, COX2,115 and leukotriene B(4),58 components of the arachidonic acid pathway. Direct
administration of PGE2 to these cells reduced proliferation and increased MMP-1 and
MMP-3 protein levels with no effect on collagen type I gene expression.103 Similarly,
PGE2, collagenase, and cell death increased in in vitro loaded tendon explants with no
change in collagen or sulfated GAG.25 Increases in PGE2, collagenase, and cellular
turnover were dependent on both duration and magnitude of loading.24 In vivo, patellar
and Achilles tendons of mice run to exhaustion also showed increased PGE2, which
decreased tendon stem cell proliferation and increased differentiation into nontenocytes.122 Repeated, direct injections of PGE2 in patellar tendons resulted in
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histological changes mimicking tendon degeneration in rabbits.47
Despite the implications that PGE2 may be a contributor to early tendinopathy,
repeated, direct injections improved mechanical properties in another study.30 The
presence of PGE2 may indicate tendon remodeling, which is supported by increased
levels in humans following a bout of exercise.54,55 Also immediately following exercise, a
marker of collagen synthesis and an indicator of collagen breakdown were decreased,
with a rise in collagen synthesis seen 72 hours later.55 PGE2 and inflammatory cytokines
may be involved in converting mechanical load to type I collagen synthesis, the primary
component of tendon.48 Similar to in vitro experiments,118 tendons from mice undergoing
moderate and intense loading protocols demonstrate distinct biologic responses,
suggesting that appropriate loads could be beneficial while intense loads could lead to
tendon degeneration.121 Whether inflammation is a physiologic response to load or
pathologic in early tendon degeneration is unknown.
In an initial study, we examined the response at a molecular level of the rat
supraspinatus tendon following acute and chronic exercise.87 Twenty male, SpragueDawley rats were divided into cage activity (CA) or acute or chronic exercise (EX)
groups. Rats in the acute group ran a single bout of non-injurious exercise on a flat
treadmill and were euthanized 12 or 24 hours after. Rats in the chronic group ran 5
days/week for 1 or 8 weeks and were euthanized 72 hours after their final bout.88 CA
animals maintained normal cage activity for 5 weeks to be within 10% body weight of
the other groups. Supraspinatus muscle and tendon were harvested for RNA extractions
(n=4 per group), and a custom Panomics QuantiGene 2.0 plex array was used to
simultaneously detect and quantify 48 target genes for inflammation, extracellular matrix
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components, matrix turnover enzymes, and factors associated with tendinopathy. Results
were log2 transformed and normalized by the geometric mean of the 3 housekeeping
genes for each sample. Principal components analysis (PCA) confirmed distinctions
between tissues and time points, supporting the study design. Results of this assay
support the hypothesis that a physiologic, mild, acute inflammatory response occurs in
tendon following a single bout of exercise. Specifically, changes in arachidonic acid
cascade components were detected (Table 1.4), supporting investigation of this pathway
and effects of nonsteroidal anti-inflammatory drugs that inhibit this pathway.
Additionally, results support the hypothesized adaptive matrix changes following chronic
loading. Increased collagen expression was detected, consistent with beneficial
adaptation to exercise. Mmp14 and TIMP expression were altered acutely and
chronically, indicative of matrix turnover (Table 1.4). This finding supports investigation
of the role of MMPs in acute and chronic responses of tendon to exercise, as well as
investigation of drugs that inhibit these enzymes. Finally, results suggest that tendon
response to chronic, beneficial exercise is distinct from overuse. Unlike overuse, we did
not find increased expression of cartilage markers (Sox9, Acan, Col2a1), heat shock
proteins (Hspa2, Hspb1), or nitric oxide synthases (Nos2, Nos3) in tendon. This study
provides direct evidence for inflammation (arachidonic acid cascade) and matrix turnover
(MMPs/TIMPs) responses of supraspinatus tendon and muscle to acute and chronic
exercise.

22

Table 1.4. Genes altered acutely and chronically in supraspinatus tendon
following non-injurious exercise
Acute
Chronic
Tendon
Tendon
Ptges
Alox5ap
Ptger4
Inflammation
Tnf
Mmp14
Col1a1
Timp3
Col3a1
Dcn
Matrix
Mmp14
Timp1
Timp3
Igf1
Igf1
Ctgf
Tgfb3
Growth Factors
Vegfa
Bmp7
Tissue-Specific
Sox9
Tendon Degeneration: Heat Shock Proteins
Casp3
Tendon Degeneration: Apoptosis
Tnc
Fn1
Remodeling and Adhesion

c. Roles of Inflammation in Muscle Adaptations
This initial, mild inflammatory response is also believed to be important for
skeletal muscle adaptation to load. At rest, healthy people almost exclusively express
COX-1, but COX-2 appears to play a role in response to muscle injury. PGE2 is the
dominant prostaglandin in human skeletal muscle, and PGF2α is thought to be a regulator
of muscle protein synthesis, contributing to hypertrophy.107 This response to exercise is
intensity-dependent.
In the same gene screening study described previously, we also investigated
changes in rat supraspinatus muscle following non-injurious exercise.87 Similar to the
changes found in tendon, our results supported a mild, acute inflammatory response as
indicated by changes in arachidonic acid cascade genes and a robust chronic adaptive
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response, as indicated by matrix protein changes (Table 1.5).
Table 1.5. Genes altered acute and chronically in supraspinatus muscle
following non-injurious exercise
Acute
Chronic
Muscle
Muscle
Ptges
Ptgfr
Ptger4
Inflammation
Ptgfr
Col1a1
Col1a1
Timp3
Col3a1
Matrix
Timp4
Fmod
Mmp14
Ctgf
Ctgf
Tgfb1
Tgfb3
Growth Factors
Tgfb3
Bmp7
Tissue-Specific
Ppargc1a
Hspb1
Tendon Degeneration: Heat Shock Proteins
Hspa2
Tendon Degeneration: Apoptosis
Tnc
Remodeling and Adhesion

9. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs that are
either nonspecific COX-1 and COX-2 inhibitors or COX-2 specific inhibitors.
Administration of these drugs inhibits production of prostaglandins and thromboxanes.
Examples include naproxen, aspirin, ibuprofen, indomethacin, meloxicam, and celecoxib.
Ibuprofen, an over-the-counter, nonspecific COX inhibitor, is one of the mostly
commonly used NSAIDs.
a. Prevalence of Use
In the United States, acetaminophen, ibuprofen, and aspirin are the top 3
consumed drugs by adults.45 95.7% of college football players had or were using
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NSAIDs.41 75% of high school football players had used NSAIDs in the previous 3
months and 15% used them daily, while NSAID use among Olympic athletes was second
only to vitamins.19 Clearly, many people frequently use these over-the-counter drugs
following injury or prophylactically, so the drug’s effects on musculoskeletal tissues
should be examined.
b. Effect of NSAIDs on Tendon
In vitro studies on tenocytes have shown that administration of NSAIDs reduces
PGE2115,58,2 and DNA2 but increases protein synthesis2 and leukotriene B(4),58 suggesting
that drug administration may have negative effects during the proliferative phase of
healing but beneficial effects during remodeling.2 In accordance with these findings, our
lab has shown that administration of ibuprofen following an acute supraspinatus
detachment and repair produced inferior mechanical properties and fiber organization at
an early time point compared to control.20 Other studies have shown that tenocytes
cultured with ibuprofen had decreased proliferation111 and migration110,111 and increased
MMP expression with no effect on collagen I or III.109 These studies begin to identify
ibuprofen’s effects on tendon; however, they were not designed to replicate an adaptive
response of the tendon to load.
The literature on the effects of NSAIDs on in vivo tendon is equivocal. In
response to an acute bout of exercise in humans, a non-specific COX inhibitor decreased
PGE218,52 abolished the adaptive increase in collagen synthesis,18 and decreased blood
flow52 in tendons. In contrast, NSAID administration in Achilles tendinopathic patients
that underwent an acute bout of running decreased IL-10, an anti-inflammatory cytokine,
but had no other effects.83 In response to chronic resistance training in older adults,
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ibuprofen administration did not affect tendon cross-sectional area, strain, or ultrasound
readings.17 Few other studies have investigated the effects of chronic ibuprofen
administration on tendon. Overall, little is known about the interaction between ibuprofen
and the response of tendons to mechanical loading.
c. Effect of NSAIDs on Muscle
NSAID effects on skeletal muscle have been more widely studied than tendon but
again reveal contradicting results. Following acute loading in humans, NSAID
administration has been shown to reduce the number of muscle satellite cells,66 increase
COX-2 mRNA,67 have no effect on myofibrillar and collagen protein synthesis,67,82 have
no effect on COX-1, HGF, bFGF, VEGF, ColI, Col3, tenascin c, TGF-β, PPARγ,
myostatin, or PGC-1α mRNA,67 and decrease circulating PGF2α.82 In studies on older
adult adaptation to chronic training, ibuprofen surprisingly increased muscle volume and
strength, had no effect on muscle protein content, water content, myosin heavy chain
distribution, COX-1, or COX-2,17 increased PGF2α receptor, and prevented the
characteristic increase of IL-6 and IL-10 that was seen with the placebo group.108 A
review is provided by Trappe and colleagues.107 Overall, muscle protein synthesis
appears to be acutely inhibited by ibuprofen, but this effect is not detected chronically. To
gain insight into the mechanisms behind these findings, animal studies have been
undertaken.
Acute muscle strain injuries in rats administered a non-selective COX inhibitor
demonstrated a delayed inflammatory reaction and muscle regeneration.3,75 Also
worrisome, ibuprofen administration in mice undergoing 4 weeks of wheel running
abolished the correlation between run distance and skeletal muscle adaptations.59
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Frequently, rat muscle overload is used to model hypertrophy. In these studies, the
gastrocnemius and/or soleus muscles are transected, significantly increasing the load seen
by the remaining plantaris or soleus, causing these muscles to hypertrophy.
Administration of NSAIDs inhibited plantaris hypertrophy by 50% in one study,95 but
had no effect in another study.65 A non-specific COX inhibitor administered to rat soleus
muscles decreased the number of MyoD-positive and satellite cells.71 Although the
plantaris overload model is frequently used, it may not mimic the human hypertrophy
scenario: hypertrophy takes place at rates of 25-40% per week in the overloaded rat
plantaris, in contrast to the human hypertrophy rate of 0.75-1%/week.17 The use of an
appropriate animal exercise model that better mimics the human scenario could promote
advancements in the field.107 The inconsistent findings in human and animal studies
could be due to age, timing of NSAID administration, dose, specific NSAID used, and
animal model-human differences. Overall it is unknown how changes in inflammatory
activity are important for mediating the exercise-induced changes in circulation,
metabolism, and matrix of the tendon and muscle.48
10. Doxycycline
a. Background
Doxycycline is a broad-spectrum antibiotic in the tetracycline class. Apart from
its antimicrobial properties, it is also a broad inhibitor of matrix metalloproteinases.94
MMP inhibition through drugs like doxycycline has been suggested as a treatment for a
variety of diseases ranging from periodontal disease to cancer.42
b. Effects on Tendon and Muscle Healing
MMP inhibition has also been suggested as a treatment for skeletal muscle and
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tendon healing.23 Aprotinin, an MMP inhibitor, injected into the Achilles tendon has been
shown to improve chronic tendinopathy in human patients in one study,76 but had no
benefit over placebo in another study.15 For healing rat supraspinatus tendons following
an acute transection and repair, both doxycycline and α-2-macroglobulin (another MMP
inhibitor) showed some beneficial effects, though effects depended on the timing of the
drug administration post-repair.13,12 Doxycycline also reduced the severity of skeletal
muscle reperfusion injury86. Exploring effects of doxycycline in sedentary and exercised
muscle and tendon, which has not been done previously, would help elucidate the role of
MMPs in tissue adaptations to load.
C. Specific Aims
During exercise, muscle and tendon must adapt in order to benefit from the
training. This adaptation may present in the form of protein or organizational changes
that improve the mechanics of the tissue in the desired loading condition. Acute
inflammation is a complex biologic event that aims to protect and repair tissue. Two
important processes related to inflammation are activation of the arachidonic acid
cascade and degradation of matrix proteins by matrix metalloproteinases (MMPs).
Previous studies suggest that inflammation plays an important role in the regeneration of
muscle and tendon following injury; however, the mechanisms governing the role of
inflammation in the adaptation of muscle and tendon to beneficial loading conditions
have not been identified. If the appropriate balance in acute inflammation is not achieved,
the tissue may not be able to adapt, resulting in injury.
The overall objective of this study is to elucidate the role of inflammation in the
adaptation of supraspinatus tendon and muscle to a physiologically-relevant loading
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condition. My global hypothesis is that a mild inflammatory response is a physiologic
requirement for muscle and tendon to adapt to load and perturbation of this inflammatory
response will prevent the tissue from beneficially adapting.
SPECIFIC AIM 1: Define the temporal, acute responses and chronic adaptations
of supraspinatus tendon following non-injurious loading to understand how the tissue
responds to a single physical training session and adapts to exercise over time.
Hypothesis 1a- Acutely, beneficial exercise induces an increase in MMP activity
that quickly resolves by 24 hours in supraspinatus tendon. Tendon mechanical properties
are unaffected 24 hours after a single bout of exercise. Tendon cells will respond to this
exercise by increasing in number.
Hypothesis 1b- Chronically, MMP activity will be increased with greater changes
at earlier time points. Non-injurious exercise produces adaptive matrix changes in the
tendon over time, leading to increased mechanical properties.
SPECIFIC AIM 2: Determine effects of ibuprofen, a nonspecific COX inhibitor,
on tendon and muscle response to non-injurious loading to understand how it affects
tissue adaptations.
Hypothesis 2- Chronic ibuprofen administration will detrimentally affect the
tendon and muscle, impairing its ability to adapt to exercise. Ibuprofen will have no
effect on tissue from sedentary animals.
SPECIFIC AIM 3: Determine effects of doxycycline, an MMP inhibitor, on
tendon and muscle response to non-injurious loading to understand how it affects tissue
adaptations.
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Hypothesis 3- Chronic doxycycline administration will detrimentally affect the
tendon and muscle, impairing its ability to adapt to exercise. Doxycycline will have no
effect on tissue from sedentary animals.
These studies help to define how muscle and tendon beneficially adapt to exercise
and the potential roles for MMPs and the arachidonic acid cascade in these beneficial
adaptations. These studies investigate both acute responses and chronic adaptations,
providing a comprehensive investigation of exercise effects on tendon and muscle.
Furthermore, administration of ibuprofen and doxycycline create clinically relevant
scenarios. These studies will help define the beneficial adaptations to exercise so that
future studies may be better informed when investigating maladaptations to exercise. The
results from these studies provide a foundation for designing more efficient exercise
training protocols, distinguishing beneficial and detrimental effects of exercise, and
developing strategies for prevention of overuse injuries.
D. Study Design
308 male, Sprague-Dawley rats (400-450g at arrival) were included in these
studies, approved by the University of Pennsylvania Institutional Animal Care and Use
Committee (IACUC). In these studies, animals were divided into exercise and cage
activity groups for acute and chronic time points and received ibuprofen (Aim 2),
doxycycline (Aim 3), or no drug (Aim 1 and comparison groups for Aims 2 and 3).
Animals in the acute exercise groups underwent 2 weeks of progressive, downhill
treadmill training followed by 72 hours of rest and then a single bout of the exercise
protocol.87,88 These animals were then euthanized 3, 12, 24, 48, or 72 hours after
completion of their single bout of exercise. Animals in the chronic exercise groups
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underwent 2 weeks of flat treadmill training and then walked on a flat treadmill following
the exercise protocol for 3 days, 1, 2, or 8 weeks and were euthanized 72 hours after
completion of their last bout of exercise to avoid potentially confounding acute effects of
exercise. Animals were compared to control, cage activity groups. At the acute time
points, animals were used for tendon histology (n=6) and MMP activity (n=8). At the 24
hour acute time point and 2 and 8 week chronic time points, animals were used for
tendon mechanical analysis (n=12), tendon histology, and MMP activity. At the 3 day
and 1 week time points, animals were used for tendon histology and MMP activity. The
acute and chronic study designs of Aim 1 are shown in Figure 1.6 and Figure 1.7. In
Aims 2 and 3, animals received ibuprofen (Aim 2) or doxycycline (Aim 3) for one acute
time point (24 hours) and 2 chronic time points (for 2 and 8 weeks) and were compared
to the non-drug treated animals of Aim 1 (Figure 1.8). Animals were used for muscle
histology (n=8), tendon histology, and tendon mechanics.
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Figure 1.6. Aim 1: Acute Effects of Exercise Study Design. All animals underwent 2 weeks of
progressive treadmill training. Experimental animals ran a single bout of exercise early Monday morning
(EX, gray circle). At the time points shown, 8 EX animals were euthanized (white circles) for protein
(n=8) and histological (n=8) analysis. At the 24 hour time point, 13 EX animals were euthanized (n=8
protein, n=6 histology, n=12 mechanics). Thirteen animals that were treadmill trained but did not
undergo an acute bout of EX were euthanized 72 hours after their last bout of training (depicted as X) as
a control group (n=8 protein, n=6 histology, n=12 mechanics).
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Figure 1.7. Aim 1: Chronic Effects of Exercise Study Design. Exercise animals underwent 2
weeks of treadmill training and were euthanized after 3 days, 1 week, 2 weeks, or 8 weeks of
running their exercise treadmill protocol (gray circles). Euthanasia occurred 72 hours after their
last bout of running. At the two earliest time points, 8 EX animals were euthanized for protein
(n=8) and histological (n=8) analysis. At the two later time points, 13 EX animals were euthanized
(n=8 protein, n=6 histology, n=12 mechanics). Cage activity (CA) animals that were not treadmill
trained were euthanized as controls at 2 time points corresponding to ~3 weeks total (2 weeks
“training” + 1 week “exercise”) and 10 weeks total (2 weeks “training” + 8 weeks “exercise”).

E. Chapter Overview
Chapter two describes the characterization of acute responses and chronic
adaptations to the supraspinatus tendon in the rat model of non-injurious exercise. A
recap of the important background information, as well as the methods, results, and
discussions are provided for the assays performed to describe the mechanical,
histological, organizational, and MMP activity changes to the supraspinatus tendon at
acute and chronic time points. Chapter three provides an introduction to the effects of
NSAIDs on connective tissues and describes the methods, results, and discussion for the
assays performed to determine the effect of ibuprofen on the rat supraspinatus in
sedentary and exercised animals. Tendon mechanics and muscle and tendon histology are
discussed. Chapter four provides background on the effects of MMP inhibition on tissue
healing and describes the methods, results, and discussion for the assays performed to
determine the effects of doxycycline to the rat supraspinatus in sedentary and exercised
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animals. Again, tendon mechanics and muscle and tendon histology are discussed.
Chapter five summarizes the findings of these studies and provides potential future
directions using these studies as a foundation.
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Figure 1.8. Aims 2 and 3 Study Designs. Chronic: Exercise animals underwent 2 weeks of treadmill
training, after which they began their full exercise protocol with either ibuprofen or doxycycline
administration for 2 or 8 weeks. Cage activity (CA) animals that were not treadmill trained were
euthanized with drug administration for 2 or 8 weeks. Chronic animals from Aims 2 and 3 were compared
to the 2 and 8 week exercise animals (no drug) of Aim 1. Acute: Animals underwent 2 weeks of
progressive treadmill training and then a single bout of exercise. Drug administration began the day
before the acute bout and continued until euthanasia. Comparisons were made to the 24 hour acute
exercise time point (no drug) of Aim 1. A separate group of cage activity animals maintained normal cage
activity for 2 weeks and were euthanized at the same time point as the acute exercise group but did not
undergo a single bout of exercise; these animals received ibuprofen, doxycycline, or no drug for 3 days.
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Chapter 2: Rat Supraspinatus Tendon Responds Acutely and
Chronically to Exercise
A. Introduction
Following exercise training routines, tendons can beneficially adapt to the
loading. Protein or organizational changes to the tissue may lead to enhanced mechanical
properties. Prior studies have found either increasede.g.,4,6,15 or unchangede.g.,7,9 tendon
stiffness with chronic, non-injurious exercise; however, these changes have not been
characterized over time, and it is unknown how acute tissue responses following a single
bout of exercise lead to beneficial adaptations with repeated bouts of exercise.21 In order
to understand how training can develop into overuse injuries, it is first important to
characterize the process of natural, beneficial adaptations to non-injurious exercise.
Tendons respond to exercise by adapting their extracellular matrix. The primary
extracellular matrix and structural protein of tendons is collagen. Matrix
metalloproteinases (MMPs) are a class of enzymes responsible for facilitating matrix
turnover by degrading proteins such as collagens. If not carefully balanced with their
inhibitors, MMP activity can result in excess fibrosis or degeneration11. MMP expression
is increased in degenerated tendons and also increased with acute injury as a step in the
healing response. Some studies have also found changes in tendon MMP expression
following exercise.e.g.,3,8 Whether MMP activity is a physiologic response to load or
pathologic in early tendon degeneration is unknown.
We have previously established a rat model of beneficial supraspinatus exercise.14
In contrast to the established rat model of supraspinatus overuse17, the non-injurious
exercise protocol does not decrease tendon mechanical properties and shows trends
51

toward increased collagen content, supporting beneficial adaptations after 12 weeks of
exercise.14 This study, however, characterized a single time point, and earlier adaptations
of the supraspinatus tendon to this exercise protocol are unknown. Using this model, we
have also identified alterations in inflammatory-related gene expression acutely and
chronically.13 Supporting the findings of previous studies, MMPs were altered with
exercise acutely (following a single bout of exercise) and chronically (following repeated
bouts of exercise), and collagen gene expression increased. Importantly, acute and
chronic exercise produced distinct gene expression profiles, indicating that these
temporal changes need to be examined to understand how acute processes following a
single bout of exercise translate to chronic tissue adaptations.
The objective of this study was to identify acute responses and chronic
adaptations of supraspinatus tendon to physiologically relevant, non-injurious exercise.
We hypothesized that chronic, beneficial exercise increases tendon mechanical properties
and MMP activity and is increased acutely.
B. Methods
1. Study Design and Treadmill Protocols
This study was approved by the University of Pennsylvania’s Institutional Animal
Care and Use Committee. The rats were housed in an AALAC accredited facility that
maintained a 12/12 hour light/dark cycle, temperatures between 20-26°C, and humidity
between 30-70%, as described in the Guide for Care and Use of Laboratory Animals.2 All
animals were euthanized with controlled flow-rate carbon dioxide.
156 rats (400-450g at start of study) were divided into acute or chronic exercise
(EX) or cage activity (CA) groups. The rat shoulder has previously been shown to mimic
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many of the key features of the human shoulder,16 making it a suitable animal model for
this study.
To investigate the acute effects of a single bout of exercise, animals in the acute
EX groups underwent 2 weeks of progressive, downhill treadmill training to acclimate to
the treadmill (Figure 2.1). Following 72 hours of rest, EX animals underwent a single
treadmill exercise session at a constant speed of 10 meters/minute for 1 hour on a flat
treadmill.13 These animals were then euthanized 3, 12, 24, 48, or 72 hours upon
completion of their single bout of exercise (EX3h, EX12, EX24, EX48, EX72). A
control, treadmill-trained CA group (CA-T) was euthanized 72 hours after their last bout
of treadmill training and did not undergo the single treadmill exercise session. A second
control group used to measure MMP activity maintained normal cage activity for the
duration of treadmill training and did not undergo a single bout of exercise (CA24). For
all other time points, tendon histology and MMP activity were measured. In addition,
tendon mechanics were determined in the EX24 and CA-T groups.
To investigate the chronic adaptations of tendon to exercise, animals in the
chronic EX group underwent 2 weeks of flat treadmill acclimation and then walked on a
flat treadmill at a constant speed of 10 meters/minute, 1 hour per day, 5 days per week14,
for 3 days, 1 week, 2 weeks, or 8 weeks (EX3d, EX1, EX2, EX8, Figure 2.1). These time
points were chosen to investigate the temporal response of the tendon soon after starting a
new exercise routine (3 days, 1 week, 2 weeks) and after having sustained the exercise
routine for an extended duration (8 weeks). Rats were euthanized 72 hours after their
final treadmill session to avoid potentially confounding acute effects of exercise.13 Two
control, CA groups maintained normal cage activity for either an early or a late chronic
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time point. For the early chronic time point, CA animals were kept for a total of 3-4
weeks (CA2), corresponding to the EX1 and EX2 time points. For the late chronic time
point, CA animals were kept for a total of 10 weeks (CA8), corresponding to the EX8
time point. These 2 control CA groups were selected to account for the significant growth
that occurs between the early chronic time points (3 days, 1 week, 2 weeks), and the late
chronic time point (8 weeks). For all time points, tendon histology and MMP activity
were measured. In addition, tendon mechanics were determined in the EX2, CA2, EX8,
and CA8 groups.
For both acute and chronic exercise groups, inclusion was set to >75% completion
of the total treadmill protocol. Animals that completed <10% of the treadmill protocol
(they did not complete the 2 weeks of treadmill training and were removed before
beginning the exercise protocol) were included in the CA groups.
From every animal, each shoulder was designated to histology, MMP activity, or
mechanics. At euthanasia, shoulders allotted to histology and MMP activity were
harvested. For tendon histology, humeral head-supraspinatus tendon-supraspinatus
muscle units were dissected and immediately placed in formalin for fixing. For MMP
activity, tendons were dissected free from bone and muscle and immediately flash-frozen
in liquid nitrogen and stored at -80ºC until homogenization. For mechanics, the animals
were stored at -20ºC, and the shoulders were dissected and prepared at the time of testing.
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A

B

Figure 2.1. Acute (A) and Chronic (B) Study Designs. A) Rats in acute exercise groups underwent 2
weeks of treadmill training followed by 72 hours of rest. These rats were euthanized 3-72 hours after
completion of a single bout of exercise (EX3h, EX12, EX24, EX48, EX72) and were compared to a
control, treadmill-trained group (CA-T). A single non-treadmill trained group maintained normal cage
activity for the duration (CA24). B) Rats in chronic exercise groups underwent 2 weeks of treadmill
training followed by repeated exercise sessions for 3 days, 1 week, 2 weeks, or 8 weeks (EX3d, EX1, EX2,
EX8) and were compared to either an early time point cage activity group (CA2) or a later time point cage
activity group (CA8). Assays were performed on supraspinatus tendon: M- mechanics, H- histology, MMPMMP activity assay

2. Tendon Mechanical Testing
For mechanical testing, animals were thawed, and the left shoulder of each animal
was dissected, keeping the supraspinatus tendon attached to its bony insertion on the
humerus. Verhoeff’s stain lines for optical strain measurements were placed at the bony
insertion site and 2, 4, and 8 mm proximally. Tendon cross-sectional area was measured
with a custom laser device.12 Cyanoacrylate was used to fix the tendon between two
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pieces of sandpaper at the 8 mm stain line and gripped with a custom screw clamp.
Humeri were potted in PMMA, and a custom fixture secured the potted humerus for
testing with an Instron ElectroPuls E3000 affixed with a 250 N load cell and a LVDT for
increased displacement resolution. Tendons were submerged in a 37°C PBS bath and
underwent the following testing protocol: 1) preconditioning (10 triangle cycles from 11.5% strain at 0.25 Hz then held at gauge length for 300s), 2) stress-relaxation to 4%
strain held for 300s, 3) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with
amplitude of 0.125% strain, 4) return to gauge length and held for 60s, 5) stressrelaxation to 8% strain held for 300s, 6) recovery to 4% strain held for 300s, 7) return to
8% strain and held for 300s, 8) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with
amplitude of 0.125% strain, 9) return to gauge length and held for 180s, 10) ramp to
failure at 0.3%/s. Due to slip in the fixture that occurred near 4% strain, only the 8% data
were analyzed (steps 5, 8, 10).
Local 2D Lagrangian strain of the tendon relative to the bone during the ramp to
failure was measured by tracking the stain lines with a custom MATLAB program.
Stiffness was calculated as the slope of the linear region of the load-displacement curve,
and elastic modulus was calculated as the slope of the linear region of the stress-strain
curve. Percent relaxation was calculated as the percent change in the load after 300
seconds of relaxation. The dynamic modulus (|E*|, ratio of the stress-to-strain amplitude)
and tangent of the phase angle between the stress and strain (tan(δ), ratio of the loss-tostorage modulus, a measure of viscoelasticity) were calculated using the middle 5 sine
cycles at each frequency.
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3. Tendon Histology
After fixing in 10% buffered formalin, bone-tendon-muscle units were decalcified
in formic acid decalcifier (Immunocal, American MasterTech, Lodi, CA, USA) and then
processed, embedded in paraffin, and sectioned at 7µm. Sections were stained with
hematoxylin and eosin and the tendon midsubstance was imaged at 200x magnification
and used for traditional (acute and chronic groups) and polarized light microscopy
(chronic groups only). Cell density (cells/mm2) and cell shape (aspect ratio 0-1 with 1
being a circle) were quantified using commercial software (Bioquant Osteo II, Nashville,
TN, USA). Custom MATLAB software was used to analyze the polarized light images
and calculate the circular standard deviation, a measure of the spread of collagen fiber
alignment.5
4. MMP Activity Assay
A SensoLyte 520 generic MMP assay kit (as-71158, Anaspec Inc., Fremont, CA,
USA) was used to determine MMP activity in the tendon samples. This kit can detect
activity of several MMPs, including MMP-1, -2, -3, -7, -8, 9, -12, -13, and -14.
Specimens allotted to the MMP activity assay were manually pulverized with mortar and
pestle. 150µl of assay buffer (provided in MMP activity kit) with 0.1% Triton X-100 was
added to each sample. Samples were centrifuged for 15 minutes 10,000xg at 4ºC, and the
supernatant was transferred to a new tube and stored at -80ºC. Pierce BCA Protein Assay
kit (Thermo Scientific, Waltham, MA, USA) was used to quantify protein yield. Samples
were plated in duplicate on 96-well plates using equal protein quantities for each sample
(36µg protein for acute groups and 39µg for chronic groups due to differences in total
yield), and the MMP activity kit protocol was followed with a 2 hour activation
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incubation time at 37ºC and an endpoint reading 45 minutes after initiating the enzymatic
reaction. Dilutions of purified human MMP-13 were included on each plate to create a
standard curve. Duplicates were averaged for each specimen, and background was
subtracted. The human MMP-13 standard curve was used to normalize the generic MMP
activity of the tendon samples.
5. Statistics
Statistical analysis was performed based on our hypotheses. A pre-study power
analysis estimated a required sample size of at least 10 specimens per group for
mechanical testing to detect a modulus effect size of 1.4 (effect size previously detected
following 4 weeks of overuse17) with 80% power and significance level set to 0.05. In
this study, we sought to obtain at least 12 tendon samples per group for mechanical
testing to account for potentially smaller effects of exercise (versus injury with overuse).
To determine the acute effects of exercise on tendon mechanical properties, a ttest was used to compare EX24 and CA-T groups. To determine the chronic effects of
exercise on tendon mechanical properties, t-tests were performed to compare CA2-EX2
and CA8-EX8 groups separately. Significance was set at p≤0.05 and trends p≤0.1.
To determine acute effects of exercise on tendon histological properties (cell
density, cell shape), a 1-way ANOVA was performed for the EX3h, EX12, EX24, EX48,
EX72, and CA-T groups using the commercial software SYSTAT (SYSTAT 13, San
Jose, CA, USA). If the ANOVA was significant (p≤0.05) or a trend (p≤0.1), then
pairwise comparisons were performed with Fisher’s LSD tests. To determine the acute
effects of exercise on MMP activity, CA-T and CA24 control groups were pooled to form
a single control group (CA-P) after confirming no differences in MMP activity between
58

them (p=0.3 with t-test). Then, a 1-way ANOVA was performed for the EX3h, EX12,
EX24, EX48, EX72, and CA-P groups with Fisher’s LSD tests for pairwise comparisons.
P-values are reported.
To determine chronic effects of exercise on tendon histological properties (cell
density, cell shape, collagen fiber organization) and MMP activity, a 1-way ANOVA was
performed for the early time points (EX3d, EX1, EX2, CA2) using the commercial
software SYSTAT. If the ANOVA was significant (p≤0.05) or a trend (p≤0.1), then
pairwise comparisons were performed with Fisher’s LSD tests. A t-test was used to
compare EX8-CA8 groups with significance at p≤0.05 and trends at p≤0.1. Comparisons
between the early (3 day, 1 week, 2 week) and late (8 week) groups are inappropriate due
to the significant animal growth that occurs during this period. All figures are shown with
mean and standard deviation.
C. Results
1. Tendon Mechanics
24 hours after a single bout of exercise, tendon cross-sectional area was
significantly increased and tendon modulus, maximum load, and maximum stress trended
toward decreased, consistent with mildly inferior mechanical properties (Figure 2.2).
In contrast, chronic exercise resulted in beneficial adaptations of tendon
mechanical properties: increased tendon stiffness, modulus, maximum load, and
maximum stress after 2 weeks of exercise and increased stiffness, maximum load (Figure
2.2), and dynamic modulus (Figure 2.3C) after 8 weeks of exercise. Tendon crosssectional area trended toward increased after 2 weeks of exercise and decreased after 8
weeks of exercise (Figure 2.2A). Additionally, 2 weeks of exercise altered the
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viscoelastic properties of the tendons by significantly decreasing percent relaxation
(Figure 2.2D) and tan(δ) (Figure 2.3E). By 8 weeks, viscoelastic adaptations were nearly
absent with only a trend toward increased percent relaxation (Figure 2.2D) and no
changes in tan(δ) with exercise (Figure 2.3F).
A

B

C

D

E

F

Figure 2.2. Tendon Mechanics. A single bout of exercise followed by 24 hours of rest led to
significantly increased tendon cross-sectional area (A) and trends toward decreased modulus (B),
maximum stress (C), and maximum load (F), suggesting mildly inferior properties. Chronic exercise
resulted in beneficial mechanical adaptations of the tendon after 2 weeks and 8 weeks. n= 9-12 acute,
12-17 at 2 weeks, 11-13 at 8 weeks
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Figure 2.3. Tendon Dynamic Mechanics. A single bout of exercise had minimal effect on dynamic
tendon mechanical properties (A, D). 2 weeks of exercise decreased tan(δ) (E). 8 weeks of exercise
increased dynamic modulus (C). n= 11-12 acute, 12-17 at 2 weeks, 11-12 at 8 weeks

2. Tendon Histology
Exercise did not acutely or chronically affect cell density (Figure 2.4A,B). 48
hours after exercise, cells were rounder than the trained control group (Figure 2.4C).
Cells were also rounder after 3 days, 1 week, and 2 weeks (trend) of exercise compared to
the CA2 group and trended toward rounder after 8 weeks of exercise compared to the
CA8 group (Figure 2.4D). All specimens were highly organized, and chronic exercise did
not affect collagen organization (Figure 2.5). Representative tendon histology images are
shown in Figure 2.6. The mild rounding of cells, no change in cellularity, and highly
organized collagen are in contrast to that seen with injury (Figure 2.7).
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Figure 2.4. Tendon Histology. Exercise did not affect cell density. Cells became rounder
48 hours after a single bout of exercise and after 3 days, 1 week, 2 weeks, and 8 weeks of
chronic exercise. n=6-8 acute, 6-9 chronic

Figure 2.5. Tendon Organization. Chronic
exercise did not affect tendon collagen
organization. n=6-9
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CA-T

EX48

CA2

EX1

Figure 2.6. Representative Tendon Histology Images. 48 hours after a
single bout of exercise and after 1 week of chronic exercise, cells were
rounder than controls. Exercise had no effect on cellularity or collagen
organization. These changes are mild compared to injured tendon
(Figure 2.7).

Figure 2.7. Injured Tendon Histology Images. A) After 8 weeks of overuse,
supraspinatus tendons from rats have increased cellularity, collagen disorganization, and
rounding of cells. (Figure from Soslowsky, et al. 2000 17) B) 2 weeks after a supraspinatus
tendon transection and repair in rats, the tendon shows hypercellularity, cell rounding, and
collagen disorganization. (Figure from Manning, et al. 201110) These histology images
from injured tissues are in contrast to the healthy tendon histology images obtained in this
study (Figure 2.6).
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3. MMP Activity Assay
MMP activity decreased by ~10% at 12 (trend), 24, and 48 hours after exercise
and returned to baseline by 72 hours (Figure 2.8A). 8 weeks of exercise significantly
reduced MMP activity compared to cage activity (Figure 2.8B).
A

B

Figure 2.8. MMP Activity. A single bout of exercise reduced MMP activity acutely with a return to
baseline by 72 hours (A). 8 weeks of chronic exercise reduced MMP activity (B). n=6-8 acute EX,
n=14 CA-P, n=8-12 chronic

D. Discussion
Rat supraspinatus tendons demonstrated both acute responses and chronic
adaptations to a non-injurious exercise protocol. 24 hours after a single bout of exercise,
tendons showed mild trends toward reduced mechanical properties. The tendon
mechanical properties increased after 2 and 8 weeks of chronic exercise, signifying
beneficial adaptations to the protocol and supporting our hypothesis. Although cell
density and collagen organization were unaffected by exercise, cells were rounder at
some time points, which could indicate increased metabolic activity or altered cell type.
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Future studies could use electron microscopy to investigate potentially altered cellular
components. MMP activity decreased acutely and after 8 weeks of chronic exercise.
The mild trends toward decreased mechanical properties (modulus, maximum
stress, maximum load and significantly increased cross-sectional area), following a single
bout of exercise may initiate chronic adaptations. Although these differences were minor
acutely, they were enough to produce significant beneficial adaptations chronically.
Perhaps one distinguishing feature between beneficial and detrimental exercise protocols
is in the amount of damage and subsequent ability to repair initiated by a single bout of
loading. By 24 hours, the supraspinatus tendons from rats undergoing this exercise
protocol had nearly recovered to baseline properties; a more intense protocol may require
longer recovery time before returning to baseline properties. Previous studies have shown
differences in the acute response of tendons following mild compared to intense loading
bouts.20,22 A single bout of exercise may initiate a mild healing response that leads to
beneficial tissue adaptations over time. The connection between tendon microdamage
from a single bout of loading and the resulting chronic adaptations or chronic injury
(maladaptations) should be investigated further.
In contrast to our hypothesis, we found decreased generic MMP activity with
acute and chronic exercise. Although some studies have found increases in MMPs
following exercise,e.g.,3 others have found decreases in MMP-2 mRNA expression19 and
activity.8 MMP-2 is a gelatinase that binds and degrades collagen fragments. Rather than
investigating specific MMPs, we chose to measure generic MMP activity to understand
the net degradative response to exercise. The decreased MMP activity acutely and
chronically may indicate an anabolic instead of a catabolic response to exercise. This
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response is in contrast to injury, which results in increased MMP expression.1,18 MMP
activity returned to baseline by 72 hours of rest following a single bout of exercise, which
suggests that the chronic time points, in which the animals were euthanized 72 hours after
their final bout of loading, were appropriate to avoid the potentially confounding acute
effects of exercise.
In this study, we found more significant mechanical changes after 2 weeks of
exercise than after 8 weeks of exercise, indicating that this adaptive process begins
shortly after initiating a new exercise protocol. As the tissue adapts over time, it may
require a greater loading stimulus to achieve the same matrix adaptations. Previously,
using this same exercise protocol, we found more matrix turnover-related genes altered at
a 1 week time point than an 8 week time point,13 consistent with the increased mechanical
adaptations found earlier compared to later. Future studies that investigate the acute
responses of exercise-trained tendons (i.e., how the tendon responds to a single bout of
exercise following early and later chronic exercise training) may help elucidate the
effects of training on the acute, temporal responses of tendon.
This study has several limitations. Although the rat rotator cuff model has been
used extensively, the use of a quadruped animal does not exactly replicate the human;
however, during forward locomotion, the rat supraspinatus repetitively passes underneath
the acromion,16 mimicking the function of the human shoulder during lateral raise and
overhead activity. Furthermore, although the changes found in this study are mild, they
are consistent with the often mild adaptations seen in human tendons following exercise.
This study investigated a single exercise protocol, and it is unknown how results would
differ if the protocol changed in intensity; however, this protocol has previously been
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shown to be non-injurious to the supraspinatus tendon and produce beneficial adaptations
to the rat shoulder.14 The time points used in this study were chosen to represent early
and later adaptations of tendon to exercise. Although the exact timing of responses may
not be identical in humans due to differences in metabolism, the main concepts can be
translated across species. In this study we performed tendon mechanical analysis on a
single acute time point, 24 hours after completion of a single bout of exercise. It is
unknown how the tendon mechanical properties are altered immediately following an
exercise session or when the properties completely return to baseline. Future studies
should explore the temporal, acute mechanical changes accompanying a single exercise
session. Finally, animals in the acute exercise groups underwent two weeks of
progressive downhill treadmill training followed by 72 hours of rest prior to their single
bout of exercise. Although we do not know how these two weeks of training may impact
the acute tendon responses to exercise versus an untrained group, our comparisons are
valid because we used a trained cage activity group as a control instead of a naïve cage
activity group. In our experience, two weeks of treadmill training is required to minimize
animals stress and reduce the number of excluded animals. Despite these limitations,
results clearly demonstrate that the rat supraspinatus tendon responds acutely and
chronically to exercise.
Taken together, results suggest that mild, acute decreases in MMP activity and
tendon mechanical properties following a single bout of exercise lead to enhanced tendon
mechanical adaptations with repeated bouts of exercise. This study helps to define the
acute and chronic temporal response of supraspinatus tendon to load in an in vivo model.
The results provide a framework for future studies to develop efficient exercise protocols
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that minimize risk of overuse injury. Future studies will examine the biologic mediators
of these adaptations, including the roles of inflammatory and vascular processes.
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Chapter 3: Ibuprofen Differentially Affects Supraspinatus Muscle and
Tendon Adaptations to Exercise in a Rat Model
A. Introduction
In the United States, acetaminophen, ibuprofen, and aspirin are the top 3
consumed drugs by adults.12 Specifically, many athletes self-diagnose and “treat”
themselves with these over-the-counter medications or use them prophylactically: 75% of
high school football players had used nonsteroidal anti-inflammatory drugs (NSAIDs) in
the previous 3 months, while NSAID use among Olympic athletes was second only to
vitamins.7 In addition, 95.7% of college football players have used NSAIDs such as
ibuprofen.11 Previous studies have shown that following acute tendon injury,
administration of ibuprofen, which blocks cyclooxygenases-1 and -2 (COX-1 and COX2) of the arachidonic acid inflammatory cascade, is detrimental,e.g.,8 suggesting that early
inflammation is a required component of successful tissue healing.
A mild inflammatory response may also be important in the adaptation of
musculoskeletal tissues to chronic, non-injurious exercise; however current literature on
the effects of ibuprofen on tissue adaptations is equivocal. For example, in a plantaris
overload model in rats, one study found 50% decreased muscle hypertrophy with
administration of ibuprofen.28 Although the plantaris overload model is frequently used,
its rapid rate of muscle hypertrophy does not mimic the normal rate of human
hypertrophy with exercise,4 which supports the use of a more clinically relevant model.
In another study, ibuprofen administered to mice undergoing 4 weeks of wheel running
eliminated the correlation between run distance and skeletal muscle adaptations.14 In
contrast, following chronic resistance training in older adults, ibuprofen administration
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led to increased muscle hypertrophy and strength but did not affect tendon cross-sectional
area or strain.5 Overall, little is known about the interaction between ibuprofen, a
commonly consumed drug, and the response of muscles and tendons to exercise.
Therefore, the objective of this study was to determine the effects of ibuprofen on the
adaptations of supraspinatus tendon and muscle in a rat model of exercise. We
hypothesized that administration of ibuprofen would abolish the beneficial adaptations
found with exercise but have no effect on sedentary muscle and tendon properties.
B. Methods
1. Study Design and Treadmill Protocols
Following approval by the University’s Institutional Animal Care and Use
Committee, 167 male, Sprague-Dawley rats (400-450g at start of study) were divided into
cage activity (CA) or exercise (EX) groups. These groups were further divided into an
acute time point or two chronic time points with half of these animals receiving ibuprofen
(IBU). The non-drug comparison groups are a subset of another study performed in the
same time frame by the same personnel (described in Chapter 2). Animals in the IBU
groups were trained to drink from a needleless syringe2 and were administered children’s,
berry-flavored, liquid ibuprofen (Major Pharmaceuticals, Livonia, MI, USA) at 20mg/kg
orally every 12 hours as previously described.8
To investigate the acute effects of ibuprofen on muscle and tendon, animals in the
acute EX group underwent 2 weeks of progressive, downhill treadmill training to
acclimate to the treadmill, as previously described.22 Following 72 hours of rest, EX
animals underwent a single treadmill exercise session at a constant speed of 10
meters/minute for 1 hour on a flat treadmill. These animals were then euthanized by
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controlled flow-rate carbon dioxide 24 hours after completion of their single bout of
exercise (EX24). Animals in the IBU groups began receiving ibuprofen 24 hours prior to
the start of their single bout of exercise and continued receiving ibuprofen every 12 hours
until euthanasia (5 doses total, EX24IBU). A separate group of animals maintained
normal cage activity for the 2 week duration and received 5 doses of ibuprofen (every 12
hours) until euthanasia 1.5 hours after their last dose of ibuprofen (CA24IBU). These
animals were compared to a cage activity group that did not receive ibuprofen (CA24,
Figure 3.1A).
To investigate the chronic effects of ibuprofen on muscle and tendon adaptations
to exercise, animals in the chronic EX groups underwent 2 weeks of flat treadmill
acclimation and then walked on a flat treadmill at a constant speed of 10 meters/minute, 1
hour per day, 5 days per week23 for 2 or 8 weeks (EX2, EX8). Control animals
maintained normal cage activity for this duration (CA2, CA8, described in Chapter 2).
Animals in the IBU groups received ibuprofen every 12 hours, 7 days per week for the 2
or 8 week duration (EX2IBU, EX8IBU, CA2IBU, CA8IBU, Figure 3.1B).
For both acute and chronic exercise groups, inclusion was set to >75% completion
of the total treadmill protocol. Animals that completed <10% of the treadmill protocol
(they did not complete the 2 weeks of treadmill training and were removed before
beginning the exercise protocol) were included in the CA groups.
From every animal, each shoulder was designated to muscle/tendon histology or
tendon mechanics. Tendon mechanical testing was not performed on the CA24 or
CA24IBU groups. At time of euthanasia, animals were weighed, shoulders allotted to
histology were dissected, and the supraspinatus muscle was cut transversely through the
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mid-belly. This muscle piece was pinned to Styrofoam to maintain muscle architecture,
covered in OCT, and immediately flash-frozen in liquid nitrogen-cooled isopentane. The
specimens were stored at -80ºC until frozen sectioning. The remaining humeral headsupraspinatus tendon-muscle half was immediately placed in formalin for fixing. For

Figure 3.1. Acute (A) and Chronic (B) Study Designs. A) An acute cage activity group maintained
normal cage activity, received 5 doses of ibuprofen, was euthanized 1.5 hours after their last dose of
the drug (CA24IBU) and was compared to a group that did not receive ibuprofen (CA24). Rats in
acute exercise groups underwent 2 weeks of treadmill training followed by 72 hours of rest. These
rats were euthanized 24 hours after completion of a single bout of exercise (EX24). These animals
were compared to a group that received ibuprofen beginning 1 day before their exercise session and
continuing until euthanasia (EX24IBU). B) For analysis of chronic effects, control cage activity
groups maintained normal cage activity for an early time point (CA2, CA2IBU) or a later time point
(CA8, CA8IBU). Rats in chronic exercise groups underwent 2 weeks of treadmill training followed
by 2 or 8 weeks of the exercise protocol (EX2, EX2IBU, EX8, EX8IBU). IBU groups received
ibuprofen during this 2 or 8 week period. Assays were performed on supraspinatus: M- tendon
mechanics, TH- tendon histology, MH- muscle histology
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mechanics, the animals were stored at -20ºC, and the shoulders were dissected and
prepared at the time of testing.
2. Tendon Mechanical Testing
For tendon mechanical testing, animals were thawed, and the left shoulder was
dissected, keeping the supraspinatus tendon attached to its bony insertion on the humerus.
Verhoeff’s stain lines for optical strain measurements were placed at the bony insertion
site and 2, 4, and 8 mm proximally. Tendon cross-sectional area was measured with a
custom laser device.19 Cyanoacrylate was used to fix the tendon between two pieces of
sandpaper at the 8 mm stain line and gripped with a custom screw clamp. Humeri were
potted in PMMA, and a custom fixture secured the potted humerus for testing with an
Instron ElectroPuls E3000 affixed with a 250 N load cell and a LVDT for increased
displacement resolution. Tendons were submerged in a 37°C PBS bath and underwent the
following testing protocol: 1) preconditioning (10 triangle cycles from 1-1.5% strain at
0.25 Hz then held at gauge length for 300s), 2) stress-relaxation to 4% strain held for
300s, 3) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125%
strain, 4) return to gauge length and held for 60s, 5) stress-relaxation to 8% strain held for
300s, 6) recovery to 4% strain held for 300s, 7) return to 8% strain and held for 300s, 8)
frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125% strain, 9)
return to gauge length and held for 180s, 10) ramp to failure at 0.3%/s. Due to slip in the
fixture that occurred near 4% strain, only the 8% data were analyzed (steps 5, 8, 10).
Local 2D Lagrangian strain of the tendon relative to the bone during the ramp to
failure was measured by tracking the stain lines with a custom MATLAB program.
Stiffness was calculated as the slope of the linear region of the load-displacement curve,
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and elastic modulus was calculated as the slope of the linear region of the stress-strain
curve. Percent relaxation was calculated as the percent change in the load after 300
seconds of relaxation. The dynamic modulus (|E*|, ratio of the stress-to-strain amplitude)
and tangent of the phase angle between the stress and strain (tan(δ), ratio of the loss-tostorage modulus, a measure of viscoelasticity) were calculated using the middle 5 sine
cycles at each frequency.
3. Tendon Histology
After fixing in 10% buffered formalin, bone-tendon-muscle units were decalcified
in formic acid decalcifier (Immunocal, American MasterTech, Lodi, CA, USA) and then
processed, embedded in paraffin, and sectioned at 7µm. Sections were stained with
hematoxylin and eosin and the tendon midsubstance was imaged at 200x magnification
and used for traditional (acute and chronic groups) and polarized light microscopy
(chronic groups only). Cell density (cells/mm2) and cell shape (aspect ratio 0-1 with 1
being a circle) were quantified using commercial software (Bioquant Osteo II, Nashville,
TN, USA). Custom MATLAB software was used to analyze the polarized light images
and calculate the circular standard deviation, a measure of the spread of collagen fiber
alignment.9
4. Muscle Histology
Muscle specimens were cryosectioned at 10µm, transverse to the muscle fibers.
For morphological analysis, sections were stained with an anti-laminin polyclonal
antibody produced in rabbit (Sigma-Aldrich, Saint Louis, MO, USA), incubated with
Alexa Fluor 488 goat anti-rabbit secondary antibody (Life Technologies, Grand Island,
NY, USA), mounted and cover-slipped with ProLong Gold antifade reagent with DAPI
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(Life Technologies, Grand Island, NY, USA), and visualized with epifluorescence on an
Eclipse 90i microscope. Six images were acquired at 100x magnification per specimen
(resulting in analysis of ≥450 fibers per specimen). The number of centrally nucleated
fibers (CNF) were counted and divided by the total number of fibers to determine
percent. The total average fiber cross-sectional area was analyzed with a MATLAB
application.27 For fiber type analysis on chronic groups, sections were simultaneously
stained with anti-myosin heavy chain-1 (MyHC-I) BA-DF, MyHC-IIa SC-71, and
MyHC-IIb BF-F3 antibodies25 (Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA, USA), and anti-laminin antibody (Sigma-Aldrich). MyHC-IIx fibers
were left unstained and were not analyzed for cross-sectional area. Sections were
incubated with secondary antibodies: Alexa Fluor 546 goat anti-mouse IgM (Life
Technologies), DyLight 405 goat anti-mouse IgG 2b (Jackson Immuno, West Grove, PA,
USA), Alexa Fluor 488 goat anti-mouse IgG 1 (Jackson), and Alexa Fluor 647 goat antirabbit IgG (Jackson). Stained sections were mounted and cover-slipped with ProLong
Gold antifade reagent without DAPI (Life Technologies). As previously described, the rat
supraspinatus muscle fiber type distribution differs in the superficial and deep layers of
the muscle;3 therefore, fiber types of these two regions were analyzed separately, and 3
images at 100x magnification were captured for each region. These images were
analyzed with a MATLAB application for muscle fiber type distribution and crosssectional area.27
5. Statistics
Statistical analysis was performed based on our hypotheses. To determine the
effects of ibuprofen on muscle and tendon adaptations, t-tests were used to compare IBU79

treated and non-drug treated groups separately for CA and EX at each time point.
Comparisons between time points are inappropriate due to the significant animal growth
that occurs. Since our hypotheses were specific to the effects of ibuprofen, we did not
make comparisons between exercise and cage activity groups. Significance was set to
p≤0.05. Figures are shown with mean and standard deviation.
C. Results
1. Tendon Mechanics
24 hours after a single bout of exercise, ibuprofen decreased the tendon crosssectional area and increased the modulus (Figure 3.2A,B), bringing the properties to
within 1.7% and 9.4% of previously measured baseline levels, respectively (baseline
determined in Chapter 2). At 2 Hz, administration of ibuprofen increased tan(δ) (Figure
3.4C). No other mechanical properties were changed acutely.
Chronic administration of ibuprofen in the cage activity groups increased
stiffness, modulus, maximum stress (Figure 3.2), and dynamic modulus (Figure 3.3) at 2
weeks and decreased tendon cross-sectional area and increased modulus (Figure 3.2) and
dynamic modulus at 8 weeks (Figure 3.3). Ibuprofen had minimal effect on the
viscoelastic properties of the cage activity groups, increasing tan(δ) at only 0.1 and 1 Hz
after 2 weeks, increasing tan(δ) at 0.1 Hz after 8 weeks, and decreasing tan(δ) at 10 Hz
after 8 weeks (Figure 3.4) with no effect on percent relaxation.
Chronic administration of ibuprofen in the exercise groups decreased tendon
cross-sectional area (Figure3.2A) and increased dynamic modulus (Figure 3.3) after 2
weeks and increased modulus after 8 weeks (Figure 3.2B). Ibuprofen increased tan(δ) at
0.1 Hz after 2 weeks and at 0.1 and 1 Hz after 8 weeks (Figure 3.4) with no effect on
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percent relaxation.
A

B
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D

E

F

Figure 3.2. Tendon Mechanical Properties. Following a single bout of exercise, ibuprofen
decreased tendon cross-sectional area and increased modulus, returning the properties to baseline
(dashed gray line). Chronic administration of ibuprofen did not negatively impact tendon mechanical
adaptations to exercise or cage activity tendon mechanical properties. Open bars- no drug, Solid barsadministered ibuprofen (n=10-16 acute, n=8-17 at 2 weeks, n=9-13 at 8 weeks)

2. Tendon Histology
Acute administration of ibuprofen increased cell density in a cage activity group
(Figure 3.5A) but had no effect on cell shape and no effect when combined with a single
bout of exercise. Administration of ibuprofen for 2 weeks combined with exercise
decreased cell density (Figure 3.5A). 8 weeks of ibuprofen combined with exercise
increased cell density and rounder cells (Figure 3.5). Ibuprofen did not affect tendon
collagen organization (Figure 3.6). Representative tendon histology images are shown in
Figure 3.7. The mild changes in cellularity and cell shape and highly organized collagen
are in contrast to that seen with injury (Figure 2.7, Chapter 2).
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Figure 3.3. Dynamic Modulus. Administration of ibuprofen for 2 weeks increased
dynamic modulus at all frequencies. Dynamic modulus also increased at 8 weeks in the
cage activity group. Open bars- no drug, Solid bars- administered ibuprofen (n=10-11
acute, n=12-17 at 2 weeks, n=11-13 at 8 weeks)
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Figure 3.4. tan(δ). Ibuprofen mildly increased tan(δ) at 2 Hz (C) 24 hours after a single
bout of exercise. At 0.1 Hz (A), administration of ibuprofen for 2 and 8 weeks increased
tan(δ) in the exercise and cage activity groups. Tan(δ) also increased with ibuprofen at 1
Hz (B) for the 2 week cage activity and 8 week exercise groups. Tan(δ) at 10 Hz (D)
decreased in the 8 week cage activity group with administration of ibuprofen. Open barsno drug, Solid bars- administered ibuprofen (n=11-16 acute, n=11-17 at 2 weeks, n=11-13
at 8 weeks)

A

B

Figure 3.5. Tendon Histology. Ibuprofen had minimal effect on tendon cell density (A) and cell
shape (B). Open bars- no drug, Solid bars- administered ibuprofen (n=7-9 acute, n=6-9 at 2 weeks,
n=6-8 at 8 weeks)
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Figure 3.6. Tendon Organization. Ibuprofen had no effect on tendon collagen organization at
2 and 8 weeks. Open bars- no drug, Solid bars- administered ibuprofen (n=6-8)
CA24

CA24IBU

EX2

EX2IBU

Figure 3.7. Representative Tendon Histology Images. Ibuprofen mildly
increased cellularity acutely in the cage activity group and decreased cellularity
with 2 weeks of exercise.

3. Muscle Histology
For all groups, the average percent of centrally nucleated fibers was below 1%,
and ibuprofen had no effect (Table 3.1). The average total fiber cross-sectional area
across decreased with administration of ibuprofen at 2 weeks in the exercise group and at
8 weeks in both the cage activity and exercise groups (Figure 3.8).
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Group
CA24
EX24
CA2
EX2
CA8
EX8

Table 3.1. Centrally Nucleated Fibers, %
No drug
Ibuprofen
% CNF
% CNF
Sample size (n)
Sample size (n)
(mean ± stdev)
(mean ± stdev)
0.31 ± 0.06
7
0.32 ± 0.21
8
0.49 ± 0.40
7
0.30 ± 0.22
9
0.32 ± 0.22
8
0.20 ± 0.06
6
0.34 ± 0.08
7
0.26 ± 0.14
6
0.40 ± 0.40
6
0.35 ± 0.26
6
0.61 ± 0.25
7
0.42 ± 0.29
6

Figure 3.8. Average Muscle Fiber Cross-Sectional Area.
Administration of ibuprofen decreased average muscle fiber crosssectional area in the 2 week exercise group and both of the 8 week
groups. Open bars- no drug, Solid bars- administered ibuprofen
(n=7-9 acute, n=6-9 at 2 weeks, n=6-8 at 8 weeks)

Muscle fiber-specific changes were also evident with administration of ibuprofen.
Similar to what has been shown previously,3 we found distinctions between the
superficial and deep regions of the supraspinatus muscle, with the superficial region
showing no MyHC-I staining, smaller MyHC-IIa fibers, and a greater proportion of
MyHC-IIb fibers (Figure 3.9).
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Deep

Superficial

Figure 3.9. Deep and Superficial Region Supraspinatus Muscle Fiber Type Distribution. Deep and
superficial regions of the supraspinatus muscle showed distinct fiber types. The superficial region had
no MyHC-I staining, smaller MyHC-IIa fibers, and greater proportion of MyHC-IIb fibers.
Yellow: MyHC-I, Green: MyHC-IIa, Blue: MyHC-IIb, Red: Laminin

Specifically, in the superficial region of the muscle, ibuprofen decreased the
percent of MyHC-IIb positive fibers and increased the percent of MyHC-IIx positive
fibers in the 2 week cage activity group and decreased the percent of MyHC-IIa positive
fibers in the 2 week exercise group (Table 3.2). In the deep region of the muscle,
ibuprofen increased the percent of MyHC-IIx positive fibers in the 8 week exercise group
(Table 3.2). Ibuprofen significantly decreased the cross-sectional area of MyHC-IIb
positive fibers in the superficial region of the 2 week exercise group and the MyHC-IIa
positive fibers in the superficial region of the 8 week cage activity group (Table 3.3). No
ibuprofen-induced, fiber type-specific cross-sectional area measurements were found in
the deep region of the supraspinatus muscle.
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Table 3.2. Fiber Type Distribution, %. Superficial and deep regions of the
supraspinatus muscle were analyzed separately for percent fiber type. The superficial
region had no MyHC-I staining. (n=6-9 at 2 weeks, n=6-8 at 8 weeks) Mean ± StDev, * =
ibuprofen had significant effect (p<0.05) compared to corresponding non-drug treated
group
Superficial
Deep
MyHC- MyHC- MyHC- MyHC- MyHC- MyHC- MyHCGroup
IIa
IIb
IIx
I
IIa
IIb
IIx
9±3
66±6
25±7
13±2
29±5
26±7
32±3
CA2
8±5
*50±17 *41±19
11±2
28±7
27±9
34±8
CA2IBU
16±6
57±10
28±7
13±3
37±6
21±8
29±5
EX2
*9±3
52±17
39±18
14±4
36±7
19±8
31±7
EX2IBU
11±5
60±8
28±4
16±3
30±3
18±5
36±3
CA8
9±2
60±7
31±6
14±5
32±5
15±5
39±5
CA8IBU
18±6
51±8
31±5
13±4
42±6
16±7
29±2
EX8
13±6
50±18
38±21
12±2
40±6
15±7
*32±4
EX8IBU
Table 3.3. Fiber Type Cross-Sectional Area, µm2. Superficial and deep regions of the
supraspinatus muscle were analyzed separately for fiber type cross-sectional area. The
superficial region had no MyHC-I staining. (n=5-9 at 2 weeks, n=6-7 at 8 weeks) Mean ±
StDev, * = ibuprofen had significant effect (p<0.05) compared to corresponding non-drug
treated group
Superficial
Deep
MyHCMyHCMyHCMyHCMyHCGroup
IIa
IIb
I
IIa
IIb
1455±198
3614±510 1755±228 2127±204
4048±365
CA2
1476±229
3440±418 1653±228 2018±367
3807±925
CA2IBU
1611±166
3848±547 1769±190 2220±196
4056±617
EX2
1499±172 *2985±342 2101±475 2459±619
3475±753
EX2IBU
1845±180
4225±485 2069±333 2783±481
4552±658
CA8
4441±512
CA8IBU *1585±191 4048±495 2105±442 2600±531
1890±304
4669±415 2083±357 2720±291
5088±349
EX8
1824±211
4333±751 2029±472 2613±606 4685±1275
EX8IBU

D. Discussion
In contrast to our hypothesis, results suggest that chronic intake of ibuprofen at
pharmacologic doses does not detrimentally affect supraspinatus tendon mechanical
adaptations to exercise. Tendon mechanical properties were not diminished and in some
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instances increased with ibuprofen. This finding suggests that the arachidonic acid
cascade may not play a major role in the adaptions of tendon to load in a non-injurious
exercise model, in contrast to that seen with acute injury models.e.g.,1,8,10,18 On the other
hand, total muscle fiber cross-sectional area decreased with ibuprofen at chronic time
points, and some fiber type-specific changes were detected, indicating that chronic
administration of ibuprofen impacts hypertrophy of sedentary and exercised
supraspinatus muscles.
Previous in vitro studies on tenocytes have shown that ibuprofen reduces
proliferation33 and migration,32,33 increases MMP expression, and has no effect on
collagen types I or III.31 A tendon-bone healing co-culture model has shown COX
inhibition leads to reduced cell viability, proliferation, and migration.26 Although these
studies suggest important effects of NSAIDs on tendon, they were not designed to
replicate in vivo conditions. Current literature on the in vivo effects of NSAIDs on tendon
and muscle is unclear. Previous studies on tendon have reported the acute effects of
ibuprofen combined with exercise to include decreases in collagen synthesis6 and blood
flow13 or minimal effects.21 In our study we detected an acute decrease in tendon crosssectional area and increase in tendon modulus when ibuprofen was combined with a
single bout of exercise, bringing these properties closer to previously measured baseline
levels; however, since this study investigated only a single acute time point (24 hours
after exercise), it is unknown whether these changes represent delayed or accelerated
recovery.
Confirming a previous study,3 we detected apparent regional differences in
muscle fiber type distribution within the supraspinatus, and future studies should
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investigate the functional implications of these two distinct regions. Our finding of
decreased muscle fiber cross-sectional area supports a previous study that showed
ibuprofen reduced muscle hypertrophy in rats.28 Furthermore, while some studies have
found no changes in myofibrillar and collagen protein synthesis in muscle with
administration of NSAIDs,16,20 in subjects given ibuprofen in conjunction with highintensity eccentric resistance exercise, skeletal muscle fractional synthesis rates were
attenuated, implying that the drug suppressed the beneficial muscle protein synthesis
response to exercise.30 Other studies have shown that acute administration of NSAIDs led
to fewer muscle satellite cells.15,17 Finally, prostaglandin F2α (PGF2α) is thought to be
regulator muscle protein synthesis, contributing to muscle hypertrophy.29 Prostaglandins
are a downstream product of COX activity, so ibuprofen may be decreasing PGF2α
production. Following a single bout of exercise combined with ibuprofen, reduced
muscle protein synthesis, decreases in satellite cells, which are thought to mediate
hypertrophy,24 or reduced PGF2α may have led to the decreased muscle fiber crosssectional area we measured chronically. Future studies should measure the acute effects
of this exercise protocol on these parameters. Overall, the highly organized structure of
the tendon collagen and the very few muscle fibers with centrally located nuclei in this
study suggest that these tissues in this study were healthy and were not damaged by
ibuprofen.
In general, muscle is more responsive to exercise than tendon, implying that
different processes regulate the adaptations of these tissues to load. Supporting this, in a
gene screening study we found distinct responses of supraspinatus muscle and tendon to
both acute and chronic exercise.23 Therefore, it makes sense that treatments, like
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ibuprofen, would have tissue-dependent and activity-dependent effects that must be
considered when making clinical recommendations for treatment.
This study is not without limitations. First, muscle fiber type was only measured
in the chronic groups, and MyHC-IIx was left unstained and unanalyzed. Some of the
decreases in total fiber cross-sectional area could be due to changes in MyHC-IIx, which
were not measured; however, the decreases in total muscle fiber cross-sectional area do
include MyHC-IIx fibers and therefore represent the global changes to the muscle.
Additionally, it is unknown whether the measured decreases in muscle fiber crosssectional area and altered fiber type distributions lead to functional differences of the
whole muscle. The results of this study provide evidence for future investigations on the
physiologic properties of the muscle including force production and fatigue. Additionally,
this study investigates a single exercise protocol, and it is unknown how ibuprofen may
affect supraspinatus tendon and muscle with a more intense exercise protocol; however,
this protocol has previously been shown to induce beneficial adaptations to the rat
shoulder without inducing chronic injury,22,23 indicating that it is a physiologically
relevant model of non-injurious exercise. Finally, future studies should investigate the
structural protein changes within the tissue that lead to the properties altered in this study
as well as the baseline and exercise-induced temporal expression of COX enzymes and
vascularity.
In conclusion, chronic administration of ibuprofen does not impair supraspinatus
tendon mechanical properties in a rat model of exercise but does decrease supraspinatus
muscle fiber cross-sectional area. These findings suggest the arachidonic acid cascade is
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not a main regulator of tendon adaptations to exercise but may be important in muscle
growth.

91

E. References
1. Almekinders LC, Gilbert JA. Healing of experimental muscle strains and the effects of
nonsteroidal antiinflammatory medication. Am J Sports Med 1986 JulAug;14(4):303-8.
2. Atcha Z, Rourke C, Neo AH, Goh CW, Lim JS, Aw CC, Browne ER, Pemberton DJ.
Alternative method of oral dosing for rats. J Am Assoc Lab Anim Sci 2010
May;49(3):335-43.
3. Barton ER, Gimbel JA, Williams GR, Soslowsky LJ. Rat supraspinatus muscle atrophy
after tendon detachment. J Orthop Res 2005 Mar;23(2):259-65.
4. Carroll CC, Dickinson JM, LeMoine JK, Haus JM, Weinheimer EM, Hollon CJ,
Aagaard P, Magnusson SP, Trappe TA. Influence of acetaminophen and ibuprofen
on in vivo patellar tendon adaptations to knee extensor resistance exercise in older
adults. J Appl Physiol (1985) 2011 Aug;111(2):508-15.
5. Carroll CC, Whitt JA, Peterson A, Gump BS, Tedeschi J, Broderick TL. Influence of
acetaminophen consumption and exercise on achilles tendon structural properties in
male wistar rats. Am J Physiol Regul Integr Comp Physiol 2012 Apr;302(8):R990-5.
6. Christensen B, Dandanell S, Kjaer M, Langberg H. Effect of anti-inflammatory
medication on the running-induced rise in patella tendon collagen synthesis in
humans. J Appl Physiol (1985) 2011 Jan;110(1):137-41.
7. Ciocca M. Medication and supplement use by athletes. Clin Sports Med 2005
Jul;24(3):719,38, x-xi.
8. Connizzo BK, Yannascoli SM, Tucker JJ, Caro AC, Riggin CN, Mauck RL,
Soslowsky LJ, Steinberg DR, Bernstein J. The detrimental effects of systemic
92

ibuprofen delivery on tendon healing are time-dependent. Clin Orthop Relat Res
2014 Aug;472(8):2433-9.
9. Gimbel JA, Van Kleunen JP, Mehta S, Perry SM, Williams GR, Soslowsky LJ.
Supraspinatus tendon organizational and mechanical properties in a chronic rotator
cuff tear animal model. J Biomech 2004 May;37(5):739-49.
10. Hammerman M, Blomgran P, Ramstedt S, Aspenberg P. COX-2 inhibition impairs
mechanical stimulation of early tendon healing in rats by reducing the response to
microdamage. J Appl Physiol (1985) 2015 Jul 9.
11. Holmes N, Cronholm PF, Duffy AJ,3rd, Webner D. Nonsteroidal anti-inflammatory
drug use in collegiate football players. Clin J Sport Med 2013 Jul;23(4):283-6.
12. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of
medication use in the ambulatory adult population of the united states: The slone
survey. JAMA 2002 Jan 16;287(3):337-44.
13. Langberg H, Boushel R, Skovgaard D, Risum N, Kjaer M. Cyclo-oxygenase-2
mediated prostaglandin release regulates blood flow in connective tissue during
mechanical loading in humans. J Physiol 2003 Sep 1;551(Pt 2):683-9.
14. Machida M, Takemasa T. Ibuprofen administration during endurance training cancels
running-distance-dependent adaptations of skeletal muscle in mice. J Physiol
Pharmacol 2010 Oct;61(5):559-63.
15. Mikkelsen UR, Langberg H, Helmark IC, Skovgaard D, Andersen LL, Kjaer M,
Mackey AL. Local NSAID infusion inhibits satellite cell proliferation in human
skeletal muscle after eccentric exercise. J Appl Physiol (1985) 2009
Nov;107(5):1600-11.
93

16. Mikkelsen UR, Schjerling P, Helmark IC, Reitelseder S, Holm L, Skovgaard D,
Langberg H, Kjaer M, Heinemeier KM. Local NSAID infusion does not affect
protein synthesis and gene expression in human muscle after eccentric exercise.
Scand J Med Sci Sports 2011 Oct;21(5):630-44.
17. Monda M, Vicidomini C, Viggiano A, Sampaolo S, Di Iorio G, Viggiano A,
Viggiano E, De Luca B. Inhibition of prostaglandin synthesis reduces the induction
of MyoD expression in rat soleus muscle. J Muscle Res Cell Motil 2009;30(34):139-44.
18. Obremsky WT, Seaber AV, Ribbeck BM, Garrett WE,Jr. Biomechanical and
histologic assessment of a controlled muscle strain injury treated with piroxicam.
Am J Sports Med 1994 Jul-Aug;22(4):558-61.
19. Peltz CD, Perry SM, Getz CL, Soslowsky LJ. Mechanical properties of the long-head
of the biceps tendon are altered in the presence of rotator cuff tears in a rat model. J
Orthop Res 2009 Mar;27(3):416-20.
20. Petersen SG, Miller BF, Hansen M, Kjaer M, Holm L. Exercise and NSAIDs: Effect
on muscle protein synthesis in patients with knee osteoarthritis. Med Sci Sports
Exerc 2011 Mar;43(3):425-31.
21. Pingel J, Fredberg U, Mikkelsen LR, Schjerling P, Heinemeier KM, Kjaer M,
Harisson A, Langberg H. No inflammatory gene-expression response to acute
exercise in human achilles tendinopathy. Eur J Appl Physiol 2013 Aug;113(8):21019.

94

22. Rooney SI, Tobias JW, Bhatt PR, Kuntz AF, Soslowsky LJ. Genetic response of rat
supraspinatus tendon and muscle to exercise. International Symposium on Ligaments
& Tendons XIV, Las Vegas, NV 2015 March 27, 2015.
23. Rooney SI, Loro E, Sarver JJ, Peltz CD, Hast MW, Tseng WJ, Kuntz AF, Liu XS,
Khurana TS, Soslowsky LJ. Exercise protocol induces muscle, tendon, and bone
adaptations in the rat shoulder. Muscles Ligaments Tendons J 2015 Feb 5;4(4):4139.
24. Rosenblatt JD, Yong D, Parry DJ. Satellite cell activity is required for hypertrophy of
overloaded adult rat muscle. Muscle Nerve 1994 Jun;17(6):608-13.
25. Schiaffino S, Gorza L, Sartore S, Saggin L, Ausoni S, Vianello M, Gundersen K,
Lomo T. Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J
Muscle Res Cell Motil 1989 Jun;10(3):197-205.
26. Schwarting T, Pretzsch S, Debus F, Ruchholtz S, Lechler P. The effect of
cyclooxygenase inhibition on tendon-bone healing in an in vitro coculture model.
Mediators Inflamm 2015.
27. Smith LR, Barton ER. SMASH - semi-automatic muscle analysis using segmentation
of histology: A MATLAB application. Skelet Muscle 2014 Nov 27;4:21,5040-4-21.
eCollection 2014.
28. Soltow QA, Betters JL, Sellman JE, Lira VA, Long JH, Criswell DS. Ibuprofen
inhibits skeletal muscle hypertrophy in rats. Med Sci Sports Exerc 2006
May;38(5):840-6.
29. Trappe TA, Liu SZ. Effects of prostaglandins and COX-inhibiting drugs on skeletal
muscle adaptations to exercise. J Appl Physiol (1985) 2013 Sep;115(6):909-19.
95

30. Trappe TA, White F, Lambert CP, Cesar D, Hellerstein M, Evans WJ. Effect of
ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J
Physiol Endocrinol Metab 2002 Mar;282(3):E551-6.
31. Tsai WC, Hsu CC, Chang HN, Lin YC, Lin MS, Pang JH. Ibuprofen upregulates
expressions of matrix metalloproteinase-1, -8, -9, and -13 without affecting
expressions of types I and III collagen in tendon cells. J Orthop Res 2010
Apr;28(4):487-91.
32. Tsai WC, Hsu CC, Chen CP, Chen MJ, Lin MS, Pang JH. Ibuprofen inhibition of
tendon cell migration and down-regulation of paxillin expression. J Orthop Res 2006
Mar;24(3):551-8.
33. Tsai WC, Tang FT, Hsu CC, Hsu YH, Pang JH, Shiue CC. Ibuprofen inhibition of
tendon cell proliferation and upregulation of the cyclin kinase inhibitor p21CIP1. J
Orthop Res 2004 May;22(3):586-91.

96

Chapter 4: Doxycycline Improves Sedentary, but not Exercised,
Supraspinatus Tendon and Muscle in a Rat Model
A. Introduction
Rotator cuff tendinopathy, which primarily affects the supraspinatus tendon, is a
common clinical condition. Matrix metalloproteinases (MMPs) are enzymes that degrade
extracellular matrix proteins such as collagens, the main structural component of tendon.
MMPs have been implicated in the progression of tendon degeneration, which is
supported by numerous studies that have found alterations in expression.1,3,22 While
changes in MMP expression are characteristic of tendinopathy, non-injurious exercise
also produces changes in tendone.g.,7,12 and musclee.g.,19,20,24 MMP expression, consistent
with matrix turnover and beneficial adaptations. Potentially, one key distinguishing
feature between maladaptations and beneficial adaptations to exercise is the role of
MMPs.
MMP inhibition has been proposed as a method to improve skeletal muscle and
tendon healing.6 Doxycycline, in addition to being a commonly prescribed antibiotic
medication, is a broad-spectrum MMP inhibitor that has been widely used clinically.
Studies have investigated the effects of doxycycline on tendon healing, reporting
contradictory results. Following acute detachment and repair of the rat supraspinatus
tendon, doxycycline improved collagen organization and improved load to failure of the
tendons at 2 but not 4 weeks.5 After acute Achilles tendon injury in a rat model,
doxycycline inhibited MMP activity, leading to improved collagen organization and
tendon mechanical properties in one study,11 but decreased tendon ultimate load in
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another study.13 Doxycycline also reduced the severity of skeletal muscle reperfusion
injury.16 These studies were designed to investigate doxycycline effects on acute injuries
and not chronic tissue adaptations. It is unknown how doxycycline affects muscle and
tendon adaptations to exercise or homeostasis in sedentary tissues.
The objective of this study was to investigate the effects of doxycycline as a
broad-spectrum MMP inhibitor on sedentary and exercised supraspinatus tendon and
muscle with our previously developed rat model of non-injurious exercise.18 Using this
model we have demonstrated distinct acute and chronic effects of exercise to the muscle
and tendon and found several altered genes associated with matrix turnover.17 We
hypothesized that administration of doxycycline would abolish the beneficial adaptations
found with exercise but have no effect on sedentary muscle and tendon properties.
B. Methods
1. Study Design and Treadmill Protocols
Following approval by the University’s Institutional Animal Care and Use
Committee, 171 male, Sprague-Dawley rats (400-450g at start of study) were divided into
cage activity (CA) or exercise (EX) groups. These groups were further divided into an
acute time point or two chronic time points with half of these animals receiving
doxycycline (DOX). The non-drug comparison groups are a subset of another study
performed in the same time frame by the same personnel (as described in Chapter 2).
Animals in the DOX groups were administered an oil suspension of doxycycline hyclate
(Wedgewood Pharmacy, Swedesboro, NJ, USA) orally every 24 hours at a dose of 10
mg/kg (standard veterinary clinical dose). This dose has previously been shown to induce
significant changes in the healing Achilles tendon through MMP inhibition.11
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To investigate the acute effects of doxycycline on muscle and tendon, animals in
the acute EX group underwent 2 weeks of progressive, downhill treadmill training to
acclimate to the treadmill, as previously described.17 Following 72 hours of rest, EX
animals underwent a single treadmill exercise session at a constant speed of 10
meters/minute for 1 hour on a flat treadmill. These animals were then euthanized by
controlled flow-rate carbon dioxide 24 hours after completion of their single bout of
exercise (EX24). Animals in the DOX groups began receiving doxycycline 24 hours prior
to the start of their single bout of exercise and continued receiving doxycycline every 24
hours until euthanasia (3 doses total, EX24DOX). A separate group of animals
maintained normal cage activity for the 2 week duration and received 3 doses of
doxycycline (every 24 hours) until euthanasia 1.5 hours after their last dose of
doxycycline (CA24DOX). These animals were compared to a cage activity group that did
not receive doxycycline (CA24, Figure 4.1).
To investigate the chronic effects of doxycycline on muscle and tendon
adaptations to exercise, animals in the chronic EX groups underwent 2 weeks of flat
treadmill acclimation and then walked on a flat treadmill at a constant speed of 10
meters/minute, 1 hour per day, 5 days per week18 for 2 or 8 weeks (EX2, EX8). Control
animals maintained normal cage activity for this duration (CA2, CA8, described in
Chapter 2). Animals in the DOX groups received doxycycline every 24 hours, 7 days per
week for the 2 or 8 week duration (EX2DOX, EX8DOX, CA2DOX, CA8DOX, Figure
4.1).
For both acute and chronic exercise groups, inclusion was set to >75% completion
of the total treadmill protocol. Animals that completed <10% of the treadmill protocol
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(they did not complete the 2 weeks of treadmill training and were removed before
beginning the exercise protocol) were included in the CA groups.
A

B

Figure 4.1. Acute (A) and Chronic (B) Study Designs. A) An acute cage activity group
maintained normal cage activity, received 3 doses of doxycycline, was euthanized 1.5 hours after
their last dose of the drug (CA24DOX) and was compared to a group that did not receive
doxycycline (CA24). Rats in acute exercise groups underwent 2 weeks of treadmill training
followed by 72 hours of rest. These rats were euthanized 24 hours after completion of a single bout
of exercise (EX24). These animals were compared to a group that received doxycycline beginning
1 day before their exercise session and continuing until euthanasia (EX24DOX). B) For analysis of
chronic effects, control cage activity groups maintained normal cage activity for an early time point
(CA2, CA2DOX) or a later time point (CA8, CA8DOX). Rats in chronic exercise groups
underwent 2 weeks of treadmill training followed by 2 or 8 weeks of the exercise protocol (EX2,
EX2DOX, EX8, EX8DOX). DOX groups received doxycycline during this 2 or 8 week period.
Assays were performed on supraspinatus: M- tendon mechanics, TH- tendon histology, MHmuscle histology

From every animal, each shoulder was designated to muscle/tendon histology or
tendon mechanics. Tendon mechanical testing was not performed on the CA24 or
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CA24DOX groups. At time of euthanasia, animals were weighed, shoulders allotted to
histology were dissected, and the supraspinatus muscle was cut transversely through the
mid-belly. This muscle piece was pinned to Styrofoam to maintain muscle architecture,
covered in OCT, and immediately flash-frozen in liquid nitrogen-cooled isopentane. The
specimens were stored at -80ºC until frozen sectioning. The remaining humeral headsupraspinatus tendon-muscle half was immediately placed in formalin for fixing. For
mechanics, the animals were stored at -20ºC, and the shoulders were dissected and
prepared at the time of testing.
2. Tendon Mechanical Testing
For tendon mechanical testing, animals were thawed, and the left shoulder was
dissected, keeping the supraspinatus tendon attached to its bony insertion on the humerus.
Verhoeff’s stain lines for optical strain measurements were placed at the bony insertion
site and 2, 4, and 8 mm proximally. Tendon cross-sectional area was measured with a
custom laser device.14 Cyanoacrylate was used to fix the tendon between two pieces of
sandpaper at the 8 mm stain line and gripped with a custom screw clamp. Humeri were
potted in PMMA, and a custom fixture secured the potted humerus for testing with an
Instron ElectroPuls E3000 affixed with a 250 N load cell and a LVDT for increased
displacement resolution. Tendons were submerged in a 37°C PBS bath and underwent the
following testing protocol: 1) preconditioning (10 triangle cycles from 1-1.5% strain at
0.25 Hz then held at gauge length for 300s), 2) stress-relaxation to 4% strain held for
300s, 3) frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125%
strain, 4) return to gauge length and held for 60s, 5) stress-relaxation to 8% strain held for
300s, 6) recovery to 4% strain held for 300s, 7) return to 8% strain and held for 300s, 8)
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frequency sweep (0.1, 1, 2, 10 Hz) of 10 sine cycles with amplitude of 0.125% strain, 9)
return to gauge length and held for 180s, 10) ramp to failure at 0.3%/s. Due to slip in the
fixture that occurred near 4% strain, only the 8% data were analyzed (steps 5, 8, 10).
Local 2D Lagrangian strain of the tendon relative to the bone during the ramp to
failure was measured by tracking the stain lines with a custom MATLAB program.
Stiffness was calculated as the slope of the linear region of the load-displacement curve,
and elastic modulus was calculated as the slope of the linear region of the stress-strain
curve. Percent relaxation was calculated as the percent change in the load after 300
seconds of relaxation. The dynamic modulus (|E*|, ratio of the stress-to-strain amplitude)
and tangent of the phase angle between the stress and strain (tan(δ), ratio of the loss-tostorage modulus, a measure of viscoelasticity) were calculated using the middle 5 sine
cycles at each frequency.
3. Tendon Histology
After fixing in 10% buffered formalin, bone-tendon-muscle units were decalcified
in formic acid decalcifier (Immunocal, American MasterTech, Lodi, CA, USA) and then
processed, embedded in paraffin, and sectioned at 7µm. Sections were stained with
hematoxylin and eosin and the tendon midsubstance was imaged at 200x magnification
and used for traditional (acute and chronic groups) and polarized light microscopy
(chronic groups only). Cell density (cells/mm2) and cell shape (aspect ratio 0-1 with 1
being a circle) were quantified using commercial software (Bioquant Osteo II, Nashville,
TN, USA). Custom MATLAB software was used to analyze the polarized light images
and calculate the circular standard deviation, a measure of the spread of collagen fiber
alignment.10
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4. Muscle Histology
Muscle specimens were cryosectioned at 10µm, transverse to the muscle fibers.
For morphological analysis, sections were stained with an anti-laminin polyclonal
antibody produced in rabbit (Sigma-Aldrich, Saint Louis, MO, USA), incubated with
Alexa Fluor 488 goat anti-rabbit secondary antibody (Life Technologies, Grand Island,
NY, USA), mounted and cover-slipped with ProLong Gold antifade reagent with DAPI
(Life Technologies, Grand Island, NY, USA), and visualized with epifluorescence on an
Eclipse 90i microscope. Six images were acquired at 100x magnification per specimen
(resulting in analysis of ≥450 fibers per specimen). The number of centrally nucleated
fibers (CNF) were counted and divided by the total number of fibers to determine
percent. The total average fiber cross-sectional area was analyzed with a MATLAB
application.23 For fiber type analysis, sections were simultaneously stained with antimyosin heavy chain-I (MyHC-I) BA-DF, MyHC-IIa SC-71, and MyHC-IIb BF-F3
antibodies21 (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City,
IA, USA), and anti-laminin antibody (Sigma-Aldrich). MyHC-IIx fibers were left
unstained and were not analyzed for cross-sectional area. Sections were incubated with
secondary antibodies: Alexa Fluor 546 goat anti-mouse IgM (Life Technologies),
DyLight 405 goat anti-mouse IgG 2b (Jackson Immuno, West Grove, PA, USA), Alexa
Fluor 488 goat anti-mouse IgG 1 (Jackson), and Alexa Fluor 647 goat anti-rabbit IgG
(Jackson). Stained sections were mounted and cover-slipped with ProLong Gold antifade
reagent without DAPI (Life Technologies). As previously described, the rat supraspinatus
muscle fiber type distribution differs in the superficial and deep layers of the muscle;4
therefore, fiber types of these two regions were analyzed separately, and 3 images at 100x
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magnification were captured for each region. These images were analyzed with a
MATLAB application for muscle fiber type distribution and cross-sectional area.23
5. Statistics
Statistical analysis was performed based on our hypotheses. A pre-study power
analysis using data from a previous published study11 that administered the same dose of
doxycycline and investigated rat Achilles tendon healing estimated a required sample size
of 10 specimens per group to detect a doxycycline effect size of 1.2 on tendon stiffness.
To determine the effects of doxycycline on muscle and tendon adaptations, t-tests were
used to compare DOX-treated and non-drug treated groups separately for CA and EX at
each time point. Comparisons between time points are inappropriate due to the significant
animal growth that occurs. Since our hypotheses were specific to the effects of
doxycycline, we did not make comparisons between exercise and cage activity groups.
Significance was set to p≤0.05 and trends at p≤0.1. Figures are shown with mean and
standard deviation.
C. Results
1. Tendon Mechanics
Combined with an acute bout of exercise, administration of doxycycline
decreased tendon cross-sectional area and increased tendon modulus and maximum stress
(Figure 4.2), bringing properties to within 0.2-10% of previously measured baseline
levels (baseline determined in Chapter 2). Doxycycline also increased dynamic modulus
(Figure 4.3). The viscoelastic properties of percent relaxation (Figure 4.2D) and tan(δ)
(Figure 4.4) were not altered by doxycycline combined with acute exercise.
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Figure 4.2. Tendon Mechanics. Administration of doxycycline combined with a single bout of
exercise returned tendon cross-sectional area, modulus, and maximum stress to baseline (gray dashed
line) by 24 hours. Tendon cross-sectional area was reduced chronically and modulus and maximum
stress were increased. Doxycycline had differential effects on percent relaxation, stiffness, and
maximum load in chronic cage activity and exercise groups. Open bars- no drug, Solid barsadministered doxycycline (n=10-15 acute, n=12-17 at 2 weeks, n=10-14 at 8 weeks)

In chronic groups, administration of doxycycline decreased tendon cross-sectional
area (trends for CA2, CA8, EX8) and increased modulus (trend for EX2) for all groups
(Figure 4.2) and increased dynamic modulus at all frequencies for the 2 week time point
(exercise and cage activity) and 8 week cage activity time point (Figure 4.3). Dynamic
modulus was not altered with administration of doxycycline in the 8 week exercise group.
Doxycycline increased stiffness and maximum load (trend for CA8) in the chronic cage
activity groups but decreased stiffness (trend for EX2) and maximum load (trend for
EX8) in the chronic exercise groups (Figure 4.2). Similarly, at 2 weeks, doxycycline
significantly increased maximum stress in the cage activity group but trended toward
decreasing maximum stress in the exercise group (Figure 4.2). Viscoelastic properties
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were also altered with administration of doxycycline: percent relaxation decreased with 2
weeks of cage activity but increased with 2 weeks of exercise and 8 weeks of cage
activity (Figure 4.2D). Doxycycline increased tan(δ) for all chronic groups at 0.1 Hz
(trend for CA2) and all chronic groups except the 2 week cage activity group at 1 Hz
(trend for CA8, Figure 4.4). At 2 and 10 Hz, doxycycline reduced tan(δ) with 2 weeks of
cage activity but trended toward increasing tan(δ) with 2 and 8 weeks of exercise (Figure
4.4).

A

B

C

D

Figure 4.3. Dynamic Modulus. Administration of doxycycline combined with a
single bout of exercise increased tendon dynamic modulus by 24 hours, approaching
and exceeding baseline properties. Chronically, dynamic modulus increased at the 2
week time point for both cage activity and exercise groups but only increased in the
cage activity group for the 8 week time point. Open bars- no drug, Solid barsadministered doxycycline (n=11-13 acute, n=13-17 at 2 weeks, n=10-14 at 8 weeks)
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Figure 4.4. Tan(δ). Administration of doxycycline combined with a single bout of
exercise had no effect on tan(δ). Chronically, tan(δ) increased with doxycycline at 0.1
Hz for all groups and 1 Hz for all groups except 2 week cage activity. Differential
effects of doxycycline on tan(δ) in cage activity and exercise groups occurred at 2 and
10 Hz. Open bars- no drug, Solid bars- administered doxycycline (n=11-15 acute,
n=12-17 at 2 weeks, n=11-14 at 8 weeks)

2. Tendon Histology
Acute administration of doxycycline had no effect on cell density or cell shape
and only trended toward decreasing cell density when combined with a single bout of
exercise (Figure 4.5). At the 8 week time point, doxycycline decreased cell density in
cage activity and exercise groups. Doxycycline administration resulted in rounder cells in
the cage activity groups at 2 and 8 weeks and the exercise group at 8 weeks (Figure 4.5).
Tendon collagen circular standard deviation decreased, indicating increased organization,
with 8 weeks of doxycycline in the cage activity group (Figure 4.6). Representative
tendon histology images are shown in Figure 4.7. The mild changes in cell density and
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cell shape and highly organized collagen are in contrast to that seen with injury (Figure
2.7, Chapter 2).

A

B

Figure 4.5. Tendon Histology. Administration of doxycycline had minimal acute effects. Chronic
administration led to fewer and rounder cells at 8 weeks and rounder cells in the cage activity group
at 2 weeks. Open bars- no drug, Solid bars- administered doxycycline (n=7-8 acute, n=7-9 at 2
weeks, n=6-8 at 8 weeks)

Figure 4.6. Tendon Organization. After 8 weeks of cage activity, doxycycline increased collagen
organization. Open bars- no drug, Solid bars- administered doxycycline (n=7-8 at 2 weeks, n=6-8 at
8 weeks)
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Figure 4.7. Representative Tendon Histology Images. Doxycycline mildly
decreased cellularity and increased the rounding of cells in 8 week cage activity
and exercise groups. Doxycycline improved collagen organization in the 8 week
cage activity group.

3. Muscle Histology
For all groups, the average percent of centrally nucleated fibers was below 1%,
and doxycycline had no effect (Table 4.1). Doxycycline decreased the average total
muscle fiber cross-sectional area in all the exercise groups (trend for EX2) but did not
affect the cage activity groups (Figure 4.8).

Group
CA24
EX24
CA2
EX2
CA8
EX8

Table 4.1. Centrally Nucleated Fibers, %
No drug
Doxycycline
% CNF
% CNF
Sample size
Sample size
(mean ±
(mean ± stdev)
(n)
(n)
stdev)
0.31 ± 0.06
7
0.34 ± 0.30
8
0.49 ± 0.40
7
0.36 ± 0.20
7
0.32 ± 0.22
8
0.29 ± 0.25
7
0.34 ± 0.08
7
0.39 ± 0.24
7
0.40 ± 0.40
6
0.55 ± 0.23
6
0.61 ± 0.25
7
0.59 ± 0.33
7
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Figure 4.8. Average Muscle Fiber Cross-Sectional Area.
Administration of doxycycline decreased average muscle fiber
cross-sectional area in the exercise groups but not the cage
activity groups. Open bars- no drug, Solid bars- administered
doxycycline (n=7-8 acute, n=7-9 at 2 weeks, n=6-8 at 8 weeks)

Similar to what has been shown previously,4 we found distinctions between the
superficial and deep regions of the supraspinatus muscle (Figure 3.9, Chapter 3). Muscle
fiber-specific changes were evident with administration of doxycycline. Specifically, in
the superficial region of the muscle, doxycycline trended toward increasing the percent of
MyHC-IIa positive fibers and decreasing the percent of MyHC-IIx positive fibers in the 2
week cage activity group, decreasing the percent of MyHC-IIb positive fibers and
increasing the percent of MyHC-IIx positive fibers in the 2 week exercise group, and
increasing the percent of MyHC-IIx positive fibers in the 8 week cage activity group
(Table 4.2). In the deep region of the muscle, doxycycline trended toward increasing the
percent of MyHC-IIa positive fibers while decreasing MyHC-IIb and MyHC-IIx positive
fibers in the 2 week cage activity group and decreasing the percent of MyHC-IIb positive
fibers in the 2 week exercise group (Table 4.2). At 8 weeks, doxycycline trended toward
increasing the percent of MyHC-IIa positive fibers while decreasing the percent of
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MyHC-IIx positive fibers in the cage activity group and increasing the percent of MyHCIIx positive fibers in the exercise group (Table 4.2).
Fiber-specific cross-sectional area was also altered with administration of
doxycycline (Table 4.3). In the superficial region of the muscle, doxycycline decreased
MyHC-IIa (trend) and MyHC-IIb fiber cross-sectional areas in the 2 week exercise
group. MyHC-IIa fibers in the superficial region of the muscle trended toward decreased
cross-sectional area with administration of doxycycline in the 8 week cage activity and
exercise groups. In the deep region of the muscle, MyHC-I fiber cross-sectional area
significantly increased and MyHC-IIb cross-sectional area significantly decreased in the
2 week exercise group administered doxycycline. After 8 weeks of exercise, doxycycline
significantly decreased MyHC-IIb fiber cross-sectional area and trended toward
decreasing MyHC-IIa fiber cross-sectional area.
Table 4.2. Fiber Type Distribution, %. Superficial and deep regions of the
supraspinatus muscle were analyzed separately for percent fiber type. The superficial
region had no MyHC-I staining. (n=5-9 at 2 weeks, n=6-8 at 8 weeks) Mean ± StDev, + =
doxycycline trended toward having an effect (p<0.1) compared to non-drug treated group
Superficial
Deep
MyHC- MyHC- MyHC- MyHC- MyHC- MyHC- MyHCGroup
IIa
IIb
IIx
I
IIa
IIb
IIx
9±3
66±6
25±7
13±2
29±5
26±7
32±3
CA2
+
+
+
+
67±3
22±2
14±2
35±9
21±8
29±5
CA2DOX +11±3
16±6
57±10
28±7
13±3
37±6
21±8
29±5
EX2
+
+
+
14±6
49±12
38±17
14±3
40±5
16±3
31±5
EX2DOX
11±5
60±8
28±4
16±3
30±3
18±5
36±3
CA8
+
+
+
10±7
57±8
33±7
15±5
36±9
16±8
33±4
CA8DOX
18±6
51±8
31±5
13±4
42±6
16±7
29±2
EX8
+
15±2
54±6
31±6
12±1
41±6
16±7
31±3
EX8DOX
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Table 4.3. Fiber Type Cross-Sectional Area, µm2. Superficial and deep regions of the
supraspinatus muscle were analyzed separately for fiber type cross-sectional area. The
superficial region had no MyHC-I staining. MyHC-IIx fibers were not stained and not
analyzed for cross-sectional area. (n=5-9 at 2 weeks, n=6-7 at 8 weeks) Mean ± StDev, *
= doxycycline had significant effect (p<0.05) compared to corresponding non-drug
treated group, + = doxycycline trended toward having an effect (p<0.1) compared to nondrug treated group
Superficial
Deep
MyHCMyHCMyHCMyHCMyHCGroup
IIa
IIb
I
IIa
IIb
1455±198
3614±510 1755±228 2127±204
4048±365
CA2
3682±334 1830±324 2190±321
3946±332
CA2DOX 1491±262
1611±166
3848±547 1769±190 2220±196
4056±617
EX2
+
EX2DOX 1462±190 *3348±240 *1994±192 2281±355 *3140±518
1845±180
4225±485 2069±333 2783±481
4552±658
CA8
4441±512
CA8DOX +1636±289 4270±474 2105±442 2600±531
1890±304
4669±415 2083±357 2720±291
5088±349
EX8
+
+
2533±150 *4619±416
EX8DOX 1745±101 4474±651 1929±276
D. Discussion
In contrast to our hypothesis, administration of doxycycline significantly affected
sedentary supraspinatus tendon properties. Surprisingly, in the cage activity groups,
doxycycline resulted in beneficial increases in tendon mechanics and organization. These
same increases were not always present in exercised tendons. In fact, doxycycline
combined with chronic exercise led to decreases in stiffness and maximum load. Acutely,
doxycycline combined with a single bout of exercise reduced tendon cross-sectional area
and increased modulus and maximum stress, bringing these properties closer to
previously measured baseline levels; however, since this study investigated only a single
acute time point (24 hours after exercise), it is unknown whether these changes represent
delayed or accelerated recovery. Dynamic modulus also increased acutely.
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These findings of beneficial adaptations of tendons from sedentary animals
administered doxycycline suggest that MMP activity levels are higher in sedentary
tendons than in tendons undergoing exercise. Indeed, an MMP activity assay revealed
decreased generic MMP activity in supraspinatus tendons from rats after 8 weeks of
chronic exercise compared to cage activity as well as decreased MMP activity 12, 24, and
48 hours following a single bout of exercise (Chapter 2). These findings suggest that
underused tendons express heightened catabolic processes, including matrix degradation
facilitated by MMPs. A previous in vitro study found increased MMP-13 mRNA
expression with stress deprived tendons, and administration of ilomastat (broad-spectrum
MMP inhibitor) recovered the gene expression, returning the TIMP:MMP ratio to
baseline.9 Similarly, the MMP inhibitors doxycycline and ilomastat administered to rat
tail tendons that were subjected to one week of in vitro stress deprivation prevented the
detrimental loss of mechanical properties.2 The results of the current study support the
findings of these two previous studies, suggesting that disuse or underuse of tendons
results in heightened MMP activity and consequently degenerative processes.
Doxycycline inhibits the MMP activity to prevent these detrimental losses. Exercise can
also benefit by decreasing MMP activity and thereby allowing for enhanced tendon
mechanical properties compared to sedentary.
Muscle from animals undergoing exercise combined with doxycycline had
decreased total fiber cross-sectional area; this change was not evident in cage activity
groups. Confirming a previous study,4 we detected apparent regional differences in
muscle fiber type distribution within the supraspinatus, and future studies should
investigate the functional implications of these two distinct regions. The 2 week cage
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activity group administered doxycycline demonstrated trends toward increased percent of
MyHC-IIa positive fibers, which is an adaptation that can be found with beneficial
exercise.8,15 Exercise combined with doxycycline for 2 weeks resulted in a significant
increase in MyHC-I muscle fiber cross-sectional area in the deep region of the
supraspinatus muscle and significant decreases in MyHC-IIb muscle fiber cross-sectional
area in both superficial and deep regions, suggesting that the fatigue-resistant type I fibers
may be playing a more important role than the fatigable type IIb fibers; however, by 8
weeks of exercise combined with doxycycline, only a significant decrease in type IIb
fiber cross-sectional area is found. Overall, changes in muscle fiber cross-sectional area
were much more evident in the exercise than the cage activity groups.
Several studies have shown alterations in MMP and TIMP expression with
tendinopathy. It is believed that an imbalance in these enzymes leads to the advanced
degeneration of the tendon. With beneficial adaptation to exercise, the synthesis-todegradation ratio is in favor of synthesis, whereas with maladaptation leading to
tendinopathy, degradation overpowers synthesis. The results of this study support that
even sedentary levels of use can result in a shift towards degradation, and administration
of doxycycline can recover some of these lost properties.
This study is not without limitations. First, muscle fiber type was only measured
in the chronic groups, and MyHC-IIx was left unstained and unanalyzed. Some of the
decreases in total fiber cross-sectional area could be due to changes in MyHC-IIx, which
were not measured; however, the decreases in total muscle fiber cross-sectional area do
include MyHC-IIx fibers and therefore represent the global changes to the muscle.
Additionally, muscle function was not measured in this study in an effort to reduce the
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number of animals used, and it is unknown whether the changes in muscle fiber type
proportion and cross-sectional area result in functional differences; however, the results
in this study provide support for future investigations of muscle physiologic properties
including force production and fatigue. Furthermore, to reduce the number of animals
used in this study, tendon mechanical properties were not measured in the CA24CA24DOX sedentary groups, so it is unknown what influence the drug has on tendon
mechanical properties acutely and how this may lead to the chronic adaptations that were
measured; however, we did not detect any cell density or cell shape changes within the
tendon due to acute administration of doxycycline. In this study, doxycycline was
administered orally, as is normally done clinically. Although we did not confirm that
doxycycline administration decreased local MMP activity, the dose we used (10mg/kg
daily) has previously been shown to induce clinically relevant serum levels of the drug,
decrease MMP activity in a rat Achilles transection after 4 weeks, and improve tendon
healing,11 providing substantial support for this dose. Given our findings of activitydependent effects of doxycycline to the muscle, future studies should measure MMP
activity in the supraspinatus muscle following acute and chronic exercise. Finally, this
study investigated a single exercise protocol, and it is unknown how results would change
with increased intensity of exercise; however, we have previously shown that this
protocol produces significant adaptations to the rat shoulder without inducing
supraspinatus tendon injury, indicating that it is a physiologically relevant model of noninjurious exercise.17,18
In this study, we detected several effects of doxycycline on sedentary tissues that
mimicked the beneficial effects of exercise: enhanced tendon mechanical properties,
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consistently healthy tendon histology with improved collagen organization, and trends
toward increased proportion of MyHC-IIa muscle fibers without reducing the average
muscle fiber cross-sectional area or increasing the number of centrally nucleated fibers.
Future studies should further explore these exercise mimetic properties of doxycycline on
sedentary tissues. In conclusion, results of this study suggest that administration of
doxycycline at pharmaceutical doses induces beneficial supraspinatus tendon adaptations
without negatively affecting the muscle in sedentary animals, supporting the use of
doxycycline to combat degenerative processes associated with underuse; however, when
combined with exercise, doxycycline does not produce the same beneficial adaptations in
rat supraspinatus tendons and reduces muscle fiber cross-sectional area, suggesting that
doxycycline is not advantageous when combined with activity. Future studies can explore
the effects of doxycycline in overuse and stress-deprived conditions.
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Chapter 5: Conclusions and Future Directions
A. Introduction
In this dissertation, a rat model of supraspinatus exercise was used to explore the
temporal tendon and muscle adaptations to load and the influences of ibuprofen and
doxycycline. Acute mechanical and histological responses following a single bout of
exercise and chronic mechanical, histological, and organizational adaptations in the
tendon to exercise were defined (Chapter 2). This model was then used to investigate
how ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, affects
supraspinatus tendon mechanical properties, tendon histological properties and
organization, muscle fiber type, and muscle fiber cross-sectional area to elucidate the role
of the arachidonic acid cascade in muscle and tendon responses to load (Chapter 3).
Finally, this model was used to investigate how doxycycline, an inhibitor of matrix
metalloproteinases, affects supraspinatus tendon mechanical properties, tendon
histological properties and organization, muscle fiber type, and muscle fiber crosssectional area to elucidate the role of matrix degrading enzymes on muscle and tendon
(Chapter 4). The main findings and conclusions from these chapters and proposed future
directions are discussed in this final chapter.
B. Rat Supraspinatus Tendon Responds Acutely and Chronically to Exercise
Tendon can beneficially adapt to exercise, but it is unknown how acute responses
following a single bout of exercise lead to chronic, beneficial adaptations. The objective
of this study was to identify the acute responses and chronic adaptations of rat
supraspinatus tendon in a physiologically relevant, non-injurious exercise model. We
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hypothesized that chronic exercise would result in superior tendon mechanical properties,
and acute exercise would result in increases in matrix metalloproteinase (MMP) activity.
Consistent with our hypothesis, tendon mechanical properties increased after 2
and 8 weeks of chronic exercise. In contrast, 24 hours after a single bout of exercise,
tendon showed trends toward reduced mechanical properties. This mild decrease in
tendon mechanical properties acutely may initiate the chronic, beneficial adaptations seen
in this study. We detected more significant mechanical changes after 2 weeks of exercise
than after 8 weeks, which suggests that this adaptive process begins soon after initiating a
new exercise routine. This finding supports a previous gene screening study we
performed that found more matrix turnover-related genes altered at an early time point
than a later time point.42
Exercise did not impact tendon cellularity or organization, suggesting that unlike
tendinopathic conditions, the exercised tendon remained healthy. Cells became rounder
with exercise, which could be due to altered cell type or metabolic activity, which was
not measured in this study.
In contrast to our hypothesis, generic MMP activity decreased following a single
bout of exercise and after 8 weeks of chronic exercise. This finding suggests that exercise
induces a net anabolic instead of catabolic response, which may be one distinguishing
factor between optimal tissue use and under or overuse.
In summary, this study used a previously validated rat model of supraspinatus
exercise43 to investigate the temporal acute and chronic responses of tendon. Mild, acute
decreases in MMP activity and tendon mechanical properties following a single bout of
exercise led to enhanced tendon mechanical adaptations with repeated bouts of exercise.
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These characterizations of non-injurious exercise will help future studies distinguish
deleterious responses of tendon to load and investigate the biologic mediators of tendon
adaptations or maladaptations to exercise, overuse, and disuse.
C. Ibuprofen Differentially Affects Supraspinatus Muscle and Tendon Adaptations
to Exercise in a Rat Model
Ibuprofen is one of the most used drugs by adults, particularly athletes, who
commonly use ibuprofen prophylactically or as “treatment.” Ibuprofen is an inhibitor of
cyclooxygenases-1 and -2 (COX-1, COX-2), which are components of the arachidonic
acid inflammatory cascade. Previous studies suggest that early inflammation is important
for successful tissue healing following acute injury, and ibuprofen can be detrimental to
this healing; however, the effects of ibuprofen on tissue adaptations to exercise is
equivocal with some studies finding detrimental effects and others finding no effect. The
objective of this study was to determine the effects of ibuprofen on the adaptations of
supraspinatus tendon and muscle in a rat model of exercise. We hypothesized that
administration of ibuprofen would abolish the beneficial adaptations found with exercise
but have no effect on sedentary muscle and tendon properties.
In contrast to our hypothesis, results suggest that chronic intake of ibuprofen at
pharmacologic doses does not detrimentally impact supraspinatus tendon mechanical
adaptations to exercise. Following chronic administration of ibuprofen, tendon
mechanical properties were not impaired and in some instances increased. Administration
of ibuprofen combined with a single bout of exercise brought tendon cross-sectional area
and modulus closer to baseline properties, suggesting altered recovery. Whether this
recovery is accelerated or delayed should be investigated with additional time points in
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future studies. Tendon organization was not impacted by ibuprofen, suggesting that the
tissue remained healthy. Similarly, the number of centrally nucleated muscle fibers
remained less than 1%, suggesting the muscle fiber were not undergoing regenerative
processes due to injury.
In contrast, chronic administration of ibuprofen decreased average muscle fiber
cross-sectional area, and a few muscle fiber type-specific changes were detected as well.
Taken together, these findings suggest that the arachidonic acid cascade is not a primary
mechanism responsible for inducing tendon adaptations to non-injurious exercise;
however, the arachidonic acid cascade appears to be important for muscle growth. This
study adds to the growing body of literature on the effects of nonsteroidal antiinflammatory drugs on musculoskeletal tissues and suggests that athletes should consider
the risks and benefits before taking ibuprofen.
D. Doxycycline Improves Sedentary, but not Exercised, Supraspinatus Tendon and
Muscle in a Rat Model
Matrix metalloproteinases (MMPs) are enzymes that degrade extracellular matrix
proteins. MMP inhibition has been proposed as a method to improve skeletal muscle and
tendon healing and some studies have shown improved healing following acute injury
with administration of MMP inhibitors; however, the roles of MMPs and therefore the
effects of MMP inhibition on muscle and tendon adaptations to exercise are unknown.
The objective of this study was to investigate the effects of doxycycline as a broadspectrum MMP inhibitor on sedentary and exercised supraspinatus tendon and muscle in
a rat model of non-injurious exercise. We hypothesized that doxycycline would abolish
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the beneficial adaptations found with exercise but have no effect on sedentary muscle and
tendon properties.
In contrast to our hypothesis, doxycycline significantly improved sedentary
supraspinatus tendon mechanical properties and tendon collagen organization without
adversely affecting the muscle; however, when administered to animals undergoing an
exercise protocol, doxycycline did not produce these same beneficial effects. Combined
with exercise, doxycycline increased tendon modulus but decreased tendon stiffness and
maximum load. In addition, the average muscle fiber cross-sectional area was reduced in
exercised, but not sedentary, animals administered doxycycline.
These results support previous studies that have shown increased MMP activity
with stress-deprived tendons and that administration of MMP inhibitors can prevent the
associated loss of tendon mechanical properties. The MMP activity assay in Chapter 2
also revealed decreased MMP activity in exercised compared to sedentary tendons. These
results suggest that in a sedentary state, tendon MMP activity is heightened, which leads
to matrix degradation; administration of doxycycline as an MMP inhibitor can reduce the
matrix degradation in sedentary tendons, leading to enhanced tendon mechanical
properties. Furthermore, MMP activity may be important for muscle adaptations to
exercise, as supported by the reduced muscle fiber cross-sectional area with
administration of doxycycline. Taken together, MMP inhibition with doxycycline may be
a useful treatment option for sedentary tissues but is not advantageous when combined
with non-injurious activity. This study examines the roles of MMP inhibition in sedentary
and exercised muscle and tendon, and future studies can explore the effects of
doxycycline in overuse and stress-deprived conditions.
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E. Final Conclusions
In this dissertation, we characterized a rat model of supraspinatus exercise by
examining both acute responses and chronic adaptations of tendon. We then used this
model to explore the roles of cyclooxygenases-1 and-2 through inhibition with ibuprofen
and matrix metalloproteinases through inhibition with doxycycline in sedentary and
exercised rat supraspinatus muscle and tendon. We found that supraspinatus tendon
beneficially adapts to non-injurious exercise by enhancing its mechanical properties and
decreasing MMP activity. Administration of ibuprofen does not adversely affect this
adaptation in tendon but does lead to reduced muscle fiber cross-sectional area
chronically. Administration of doxycycline enhanced supraspinatus tendon mechanical
properties in sedentary animals but not in exercised animals and led to decreases in
muscle fiber cross-sectional area specific to exercised groups.
We conclude that the pathways responsible for muscle and tendon adaptations to
exercise may differ depending on the tissue, and decisions regarding the use of drugs like
ibuprofen and doxycycline should take into account differential, tissue-specific responses
as well as activity-dependent effects.
F. Future Directions
Based on these findings, several possible future directions should be considered
for this rat model of supraspinatus exercise.
1. Additional Biologic Assays
In this study, we measured MMP activity in tendon and investigated traditional
histologic metrics including cellularity, cell shape, and collagen organization for tendon;
however, a more comprehensive analysis of the biologic mechanisms responsible for the
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changes detected in muscle and tendon as a response to exercise or as a response to drug
administration should be performed. Specifically, given the changes measured as a result
of ibuprofen and doxycycline, a natural next step is to explore the inflammatory
processes in muscle and tendon. First, proteins associated with the arachidonic acid
cascade should be measured. These include cyclooxygenases-1, and -2, prostaglandins
(particularly PGE2 and PGF2α), thromboxane, lipoxygenase, and leukotrienes. It has
previously been shown that tenocytes respond to strain by modulating production of these
proteins,32,52 and this pathway has been implicated in the initiation of tendon degenerative
processes;13,14,21,46,55 however, it is unknown what role this pathway plays in noninjurious exercise. One study found improved tendon properties with prostaglandin
injections16 and others have found physiologic (not pathologic) increases following
exercise,29,30 suggesting that this pathway may be important for beneficial adaptations to
load. Additionally, prostaglandins, exercise, and ibuprofen are known to alter blood flow,
so vascularity, blood flow, and angiogenesis would be interesting mechanisms to
investigate in future studies. Second, an in depth exploration of the specific MMPs and
their inhibitors (TIMPs) altered with exercise should be measured. MMP-2, -3, -9, -13,
and -14 have all been cited as potential key regulators of matrix turnover and are known
to be altered with injury.2,12,18,20,27,28,34,41,44 Potentially, a key distinguishing feature
between injurious maladaptations and non-injurious adaptations to load is in the
expression of MMPs relative to TIMPs. MMP activity within the muscle as a result of
acute and chronic exercise should also be measured. Third, in this dissertation, tendon
collagen organization was unchanged with exercise, and it is unknown what contributes
to the enhanced mechanical properties measured chronically. Measurement of collagen
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content using o-hydroxyproline assay, collagen cross-linking, and collagen fibril size
would help elucidate the structural adaptations that allow for the functional adaptations.
Fourth, cell types within the tendon and muscle as a response to exercise should be
explored. Early inflammation is characterized by infiltration of inflammatory cells,
including mast cells, macrophages, and neutrophils. These cells initiate the repair
response by releasing cytokines and chemokines to recruit additional inflammatory cells
and stimulating fibroblast proliferation. Pro-inflammatory cytokines, which are known to
be altered in injured states, can also induce COX-224 and MMP expression.35 Whether an
early inflammatory response initiates chronic tissue degeneration in overuse conditions is
debated. Determining whether an acute inflammatory response occurs in muscle and
tendon as a result of non-injurious exercise will begin to address physiologic versus
pathologic processes. To determine protein expression of all of these targets,
immunohistochemistry can be performed on muscle and tendon histological sections.
Finally, to understand why the cells increased in roundness, electron microscopy could be
used to investigate cellular contents, and metabolic activity assays could be used to
determine cellular activity. Similarly, proliferation assays could be performed,
particularly since ibuprofen has previously been shown to reduce cellular proliferation
and migration in vitro.49,50
2. Additional Muscle Assays
In this study, we determined the percent of centrally nucleated muscle fibers and
measured muscle fiber cross-sectional area and type; however, it is unknown whether the
changes detected in these studies lead to changes in physiologic muscle function. First,
the acute and chronic temporal response of muscle to exercise should be examined (e.g.,
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Aim 1 of this dissertation repeated with supraspinatus muscle). Assays include fiber
morphological and type analysis, determination of the percent of fibers with centrally
located nuclei, and measurement of biologic proteins described above across multiple
time points to fully characterize the adaptive processes within the tissue. Second,
physiologic muscle functional measurements should be added. Ex vivo measurements
include fatigue index, contraction time, rate of force development, rate of relaxation, and
twitch force, as previously described.40 In addition, measurement of oxidative
phosphorylation metabolic proteins would further elucidate muscle adaptations to aerobic
training.43 Finally, identification of satellite cells, which are believed to play important
roles in muscle adaptations to exercise, can be performed through histological staining.
Future studies should also explore the apparent differences between the
superficial and deep regions of the supraspinatus muscle. The difference in fiber type
distributions in these two regions has previously been identified3 and was also confirmed
in the studies presented in this dissertation; however, it is unknown what functional role
these regions play. Physiologic measurements of the muscle regions could be performed
to determine whether these fiber type differences impact muscle contraction profiles and
regional fatigability. Motor units could be analyzed. Importantly, compositional
differences that lead to functional differences in the muscle may impact the loading
profile experienced by the tendon, leading to altered regional (bursal and joint side)
tendon properties. Previous studies have shown variations in human regional tendon
mechanical25,26 and biological36 properties, but these regions have not been investigated
in the rat. Inhomogeneous tendon properties could lead to delamination failures of the
tendon.
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3. Other Loading Conditions
To investigate how exercise goes from good to bad, other loading conditions
should be examined and compared to the results found in this study. Specifically, future
studies should explore the acute and chronic responses of muscle and tendon to an
overuse protocol45 (increased loading) and immobilization (decreased loading) following
a study design similar to Chapter 2 with the additional biologic assays described above.
By identifying the acute responses and maladaptive tissue properties in these loading
conditions and comparing them to non-injurious exercise, we can begin to understand
how damage initiates and progresses. Once this process has been characterized, then
different treatments can be explored. Ibuprofen and doxycycline may be expected to have
different effects on muscle and tendon from overuse and immobilized loading scenarios
than in beneficial exercise. Ibuprofen is commonly taken by athletes and laborers with
strenuous loading protocols, but it is unknown how the drug may impair or improve
muscle and tendon adaptations in this more intense loading environment. As previously
described, prior studies have found load-dependent increases in arachidonic acid cascade
proteins, suggesting that a heightened response may be seen following overuse and
indicating that ibuprofen may have a different effect than in non-injurious exercise. Study
designs to test hypotheses that ibuprofen is beneficial to tendon and muscle following
overuse and immobilization would be similar to Chapter 3. MMP inhibition has been
proposed as a treatment for tendinopathy caused by overuse and stress-deprivation, which
results in increased expression of MMPs as previously mentioned. Furthermore, the
finding in this dissertation of beneficial effects of doxycycline in sedentary but not
exercised animals leads to the hypothesis that doxycycline may be beneficial to reduce
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tendon and muscle atrophy and degeneration in immobilized states. Study designs to test
hypotheses that doxycycline is beneficial for muscle and tendon in overuse and
immobilized loading scenarios would be similar to the study design of Chapter 4. Results
would help guide clinical treatment protocols for muscle and tendon loading-induced
injuries.
4. Age
In these studies, we used young-adult, skeletally mature rats; however, it is
unknown how results would change if the rats were middle-aged or elderly. A recent
study found that exercise mitigates the detrimental effects of aging on tendon stem
cells.54 Associated with increased age is an increase in baseline inflammation levels.38
Because overuse injuries affect both the young and middle-aged people, and rotator cuff
tear incidence increases with age, it is important to consider these age groups as distinct
populations in how they may respond to exercise and anti-inflammatory treatments.
Muscle regeneration following injury is delayed in older individuals, and this may be
attributed to an altered inflammatory response.38 Resistance training benefits older adults,
but muscle adaptation to exercise is slower than in young adults.40 In aged rats
undergoing repetitive reaching and grasping, a model of overuse activity in the upper
extremity, flexor digitorum tendons had increased pro-inflammatory cytokines IL-1β and
IL-6, which was not seen in young adult rats.22 Additionally, after 12 weeks of activity,
the supraspinatus tendon had increased vascularity and cellularity (due to macrophages
and fibroblasts in the peritendon) in aged animals but not young.22 These findings suggest
an impaired inflammatory response following overuse injury in older compared to
younger adults. Age may also affect response to NSAID treatment. Ibuprofen
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administration to older adults undergoing chronic resistance training did not affect
patellar tendon cross-sectional area, strain, or ultrasound readings but surprisingly
increased muscle volume and strength.8 This finding contrasts the suggestion in other
studies that NSAIDs may impair acute muscle and tendon adaptation to load.
Additionally, ibuprofen in conjunction with chronic resistance training in older adults did
not affect muscle protein content, water content, myosin heavy chain distribution, COX1, or COX-2,8 increased PGF2α receptor, and prevented the characteristic increase of IL-6
and IL-10.48 A review is provided by Trappe and colleagues.47 While some studies
suggest that ibuprofen administration may impede tissue regeneration following injury or
adaptation to exercise, and this dissertation showed ibuprofen was not detrimental in
tendon of young-adult rats undergoing exercise, anti-inflammatory drugs may enhance
tissue adaptation in older adults due to the presumed deleterious increase in baseline
inflammation. In addition, MMP expression has been shown to be enhanced in tendons
from older animals and further enhanced with cyclic loading,15 suggesting that MMP
inhibition with doxycycline would be beneficial. To test these hypotheses that ibuprofen
and doxycycline benefit muscle and tendon adaptations to exercise in older adult rats,
older adult rats would be randomized into a drug treated or non-drug treated group and
undergo exercise for 2 or 8 weeks to investigate chronic adaptations. Results would help
clinicians form treatment plans specific to older and younger adult populations.
5. Gender
In this dissertation, we used male rats; however, prior studies have found higher
incidence of shoulder complaints in women than men,51 women and men have
significantly different tendon structural and mechanical properties,37 and adaptations to
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exercise in the patellar tendons of women may be attenuated compared to men.53 These
findings suggest that males and females have different responses to load which may lead
to different injury risks. To test the hypothesis that gender influences adaptations to
exercise (with females exhibiting fewer beneficial adaptations), female rats would
undergo 2 and 8 weeks of exercise or cage activity and be compared to male rats. A
separate group of female, ovariectomized rats, which creates estrogen deficiency (e.g.,
postmenopausal women) would help to explore the specific role of the hormone estrogen
in these adaptations. Results from this study would help explain the role of gender in
adaptations or maladaptations to exercise.
6. De-Training
De-training is the process by which previously gained improvements to fitness are
lost when an exercise routine is stopped. These changes can be rapid, and if an exercise
routine is started again too quickly (as in the transition from pre- to in-season training),
then injuries can develop. A previous study has shown detrimental effects of de-training
on rat patellar tendon,17 but no studies have investigated de-training in the supraspinatus
tendon. More specifically, the biologic processes that govern the loss of beneficial
adaptations are unknown. Given the beneficial findings in this dissertation of doxycycline
in sedentary animals, doxycycline may also be advantageous to avoid tissue property
losses due to de-training. To test this hypothesis, rats would be divided into a 4 week
exercise group and a 2 week exercise group followed by 2 weeks of cage activity as detraining. Half of the detrained group would receive doxycycline during the 2 week detraining period. Results would help elucidate the role of MMPs in de-training and inform
the practices of clinicians and coaches.
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7. Acute Responses to Exercise in Trained Animals
In Chapter 2, we found more significant mechanical changes after 2 weeks of
exercise than after 8 weeks, which was similar to a screening study we performed that
found more matrix-related gene changes after 1 week than 8 weeks.42 Based on this
finding, we speculated that as the tissue adapts to a new training routine, it requires
increases in intensity in order to elicit the same mechanical and biological responses. This
speculation suggests that acute responses to exercise in trained, fit tendon and muscle are
reduced compared to the acute responses to exercise when a new exercise routine is just
being established. To test this hypothesis, animals would be divided into a treadmill
trained + acute bout of exercise group (as in Chapter 2) or a group that undergoes
treadmill training + 8 weeks of exercise + acute bout of exercise. Tendon mechanical
properties and tendon and muscle biological responses would be compared. Similarly,
these groups could be compared to animals undergoing 8 weeks of overuse45 to test
whether degenerate tendons respond differently to an acute bout of loading. A prior study
suggests that inflammatory signaling is not increased in tendinopathic tendon 2 hours
after a single bout of exercise, but these were not compared to uninjured, exercised
tissues.39 Results from the proposed studies would help identify how acute exercise
sessions lead to chronic adaptations or maladaptations.
8. Recovery
In the current study, we investigated the mechanical properties of supraspinatus
tendon 24 hours after a single bout of exercise and found mild trends toward reduced
properties; however, it is unknown how these properties change immediately following
exercise and when they return to baseline levels. We speculated that these mild decreases
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in mechanics help initiate the chronic tendon adaptations we detected and that one
difference between beneficial and detrimental loading protocols is in how the tissue
responds to and recovers from a single bout of exercise. For example, a more intense
exercise session may require a longer time for properties to recover, suggesting greater
amounts of rest are required to avoid injury, whereas increasing the resting time between
bouts of this non-injurious exercise protocol may lead to reduced adaptations. To
investigate this, more thorough acute responses and recovery profiles should be defined
for the non-injurious exercise protocol (mechanical testing immediately after exercise and
48 hours after exercise), and the overuse45 protocol (described in c. Other Loading
Conditions). Then, to test the hypothesis that enhanced recovery time between sessions
would diminish injury with the overuse protocol, animals would run on the treadmill
every other day (or every 2 days, depending on the recovery profile) and would be
compared to animals that ran the same number of sessions but ran every day. To test the
hypothesis that enhanced recovery time would reduce beneficial adaptations with the
non-injurious exercise protocol, animals would walk every other day (or every 2 days,
depending on the recovery profile) and be compared to animals that walked the same
number of sessions but every day.
9. Acute Responses Lead to Chronic Adaptations
In this dissertation, we proposed that the acute decreases in MMP activity and
tendon mechanical properties lead to the beneficial chronic adaptations we measured;
however, this is a research area that has significant potential for future growth. We found
increased tendon cross-sectional area 24 hours after a single bout of exercise but not
chronically, and we do not know what contributes to this acute increase. Presumably,
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collagen content is not the main contributor since it would take longer than 24 hours for
such a response, we would expect structural properties (stiffness, max load) to be
increased, and we would expect the tendon cross-sectional area to be increased
chronically. Instead, this increase in cross-sectional area may be due to increased water
content, which may be regulated by aggrecan expression. Water content and aggrecan
were not measured in the current dissertation but should be evaluated in future studies.
Proteoglycans like aggrecan and versican and some glycoproteins like hyaluronan can be
upregulated rapidly, within days.11 It has been proposed that a rapid response of the
tendon to unaccustomed load may be to increase aggrecan production, which would
enhance water content to increase the tendon cross-sectional area and minimize stress in
the tendon as a protective mechanism until the tendon recovers.11 Whether this proposed
mechanism occurs in this model of exercise is unknown and should be evaluated further.
In addition, after more comprehensive evaluation of the acute responses of tendon and
muscle to exercise (sections a and b above), these measured responses can be targeted
(inhibited/overexpressed) to determine which are required for chronic adaptations to
exercise. Then, these same responses can be altered in sedentary animals to determine
whether manipulation can lead to chronic exercise-like benefits without activity.
10. Temporal Drug Administration
In the current studies, ibuprofen and doxycycline were administered daily for the
entire duration (2 or 8 weeks); however, as previously described, the biologic processes
governing the early and later adaptations to exercise may differ.11 Furthermore, a
previous study has noted that early administration of ibuprofen following a rotator cuff
repair impaired healing, and later administration had no effect.10 As already described, a
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heighted matrix turnover response may exist at earlier time points,42 during which time
ibuprofen and doxycycline may have greater effects than at later time points. To test the
temporal effects of these drugs on supraspinatus tendon and muscle adaptations, which
would help identify the stages of tissue adaptations to load, animals would undergo 4
weeks of exercise. One group would receive ibuprofen or doxycycline during the first 2
weeks (“early”), another group would receive ibuprofen or doxycycline during the second
2 weeks (“late”), and a third group would not receive any drug. The results of these
studies would help clinicians optimize treatment plans and delineate the temporal stages
of tissue adaptations to exercise (i.e., early inflammatory period as the tissue responds to
a new exercise routine vs. later proliferative period as the tissue becomes accustomed to
the training).
11. Prevention of Overuse Injuries
In this dissertation, we have shown that a rat model of exercise induces beneficial
mechanical adaptations to the supraspinatus tendon, but it is unknown whether these
adaptations are enough to prevent future injury as the intensity of the exercise protocol
increases. Many coaches would like to be able to appropriately train their athletes as they
build strength and endurance while preventing overuse injury. To test whether this
exercise protocol can reduce future injury, animals would undergo two weeks of exercise
training to induce beneficial adaptations, followed by 4 weeks of overuse training,45
which has previously been shown to induce injury. This group of animals would be
compared to a group that only undergoes 4 weeks of overuse training. The hypothesis is
that the exercise-trained group would have reduced tendon degeneration.
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12. Fatty Atrophy
In massive rotator cuff tears, one common negative feature is fatty atrophy of the
muscle. This muscle degeneration can make rotator cuff repairs unfeasible.
Accompanying this atrophy is significant fibrosis that is mediated by increases in
MMPs.31 This fatty atrophy is believed to be irreversible. A rat model of rotator cuff fatty
atrophy has been created and has demonstrated increased intramuscular fat in the rotator
cuff muscle.23 Whether matrix metalloproteinase inhibitors may slow the fibrotic
degeneration of the muscle and tendon in these scenarios is unknown. A future study
could investigate the benefits of doxycycline administration in conjunction with rotator
cuff tears in an effort to decrease the progression of fatty atrophy.
13. Systemic Diseases
In the current studies, healthy rats were used; however, a range of systemic
diseases can impact rotator cuff muscle and tendon. For example, high cholesterol1,4-6 and
diabetes7,9 may impact rotator cuff tendon properties and healing. In addition, MMP
expression is increased in the wounds of diabetic patients, indicating that treatments
aimed at reducing MMP activity may benefit.33 For both of these common conditions,
exercise is often prescribed as treatment for the systemic disease, but it is unknown how
local muscle and tendon are affected. Combining exercise with animal models of these
diseases may help identify the systemic as well as local tissue benefits of exercise as
treatment.
14. Other Tendons and Muscles
In the current studies, the supraspinatus tendon and muscle were explored;
however, other muscles and tendons may also be impacted by exercise, ibuprofen, and
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doxycycline. For example, the Achilles tendon and associated gastrocnemius and soleus
muscles, which would also be loaded by walking on a treadmill, would be expected to
show adaptations to exercise; however, whether these adaptations are the same as those
found in the supraspinatus is unknown. It has previously been shown that the Achilles
and supraspinatus tendons show distinct responses to an overuse treadmill protocol,
wherein the Achilles tendon does not develop degeneration but the supraspinatus tendon
does.19 In addition, the soleus muscle is primarily a slow extensor whereas the
gastrocnemius is primarily a fast extensor, so the inherent fiber type differences in these
two muscles and their subsequent responses to exercise and pharmacologic drugs would
be of interest in future studies. Future studies could also explore the effects of exercise on
the other rotator cuff tendons/muscles (infraspinatus, subscapularis), the biceps, the
tibialis anterior, and the plantaris. Other tissues such as cartilage (e.g., glenoid articular
cartilage) and bone (e.g., humerus, tibia, fibula, femur) may also be of interest.
15. Genome Analysis for Predisposition
Despite undergoing the same training protocols, some individuals develop injury
while others do not. Experiments such as genome-wide association studies (GWAS) or
single-nucleotide polymorphism (SNP) on patients and healthy people could be useful in
identifying molecular variations among individuals that may lead to a predisposition for
injury or altered responses to treatments, such as pharmacologic interventions.
16. Final Conclusions
In this chapter, we have proposed several future directions to characterize
temporal muscle and tendon adaptations to exercise, define beneficial and detrimental
changes, understand how acute sessions of exercise lead to chronic adaptations (or
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maladaptations), and investigate potential drug treatments for altered loading states.
Results from these studies will inform development of exercise training routines that
minimize and prevent injury and treatment strategies for when injury does occur.
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Appendices: Experimental Protocols
Appendix 1: Rat Treadmill Protocols
EXa: Acute Exercise on Flat Treadmill
Animals undergo 2 weeks of overuse training on a -10° treadmill, followed by a single
bout of exercise
Tach Reading
Protocol
Week
Day Duration
(rpm)
T1.1
1
Mon
0-10 min 37
T1.2
1
Tues 0-15 min 40
T1.3
1
Wed
0-20 min 43
T1.4
1
Thurs 0-25 min 46
T1.5
1
Fri
0-30 min 49
T2.1
2
Mon
0-30 min 51
0-5 min Build up
T2.2
2
Tues
5-40 min 54
0-5 min Build up
T2.3
2
Wed
5-45 min 57
0-10 min Build up
T2.4
2
Thurs
10-50 min 60
0-10 min Build up
T2.5
2
Fri
10-60 min 63
Exercise Single bout Mon
0-60 min 37 (flat!)
EXc: Chronic Exercise on Flat Treadmill
Animals undergo 2 weeks of training followed by their full protocol for up to 8 weeks
Tach Reading
Protocol
Week
Day Duration
(rpm)
T1.1
1
Mon 0-10 min 37
T1.2
1
Tues 0-15 min 37
T1.3
1
Wed 0-20 min 37
T1.4
1
Thurs 0-25 min 37
T1.5
1
Fri
0-30 min 37
T2.1
2
Mon 0-40 min 37
T2.2
2
Tues 0-45 min 37
T2.3
2
Wed 0-50 min 37
T2.4
2
Thurs 0-55 min 37
T2.5
2
Fri
0-60 min 37
EX1.1
up to 8 weeks Mon 0-60 min 37
EX1.2
up to 8 weeks Tues 0-60 min 37
EX1.3
up to 8 weeks Wed 0-60 min 37
EX1.4
up to 8 weeks Thurs 0-60 min 37
EX1.5
up to 8 weeks
Fri
0-60 min 37
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Appendix 2: Rat Syringe Training
This protocol is meant to train rats to drink from a syringe for subsequent oral
administration of drugs like ibuprofen or doxycycline. We have found that the rats love
children’s berry-flavored ibuprofen, but dislike doxycycline (despite being an oil
suspension, tutti fruiti flavor) due to its bitter taste. Most likely, doxycycline animals will
need to be restrained and force-fed, but the ibuprofen animals will happily drink on their
own. Note that all drug animals should be syringe-trained.
Day 1: Place a wooden popsicle stick that has a strip of honey on it in each cage. Rats
are free to sniff and eat the honey to avoid neophobia. Once the rats have eaten the
honey from the stick, create a mixture of honey and water (much more water than honey,
not a very viscous solution) and draw it up into a needleless 1ml syringe. Open the lid of
the cage and allow the rats to sniff and lick the syringe. Dispense a few drops of the
honey solution onto the rats’ noses and paws as they sniff the syringe. As they groom
this off, they will discover that it tastes delicious. Do not expect animals to freely drink
from the syringe on their first day (though some might).
Day 2: Assuming all animals cleaned their honey sticks yesterday, begin with the honeywater syringe training. Similarly, allow the animals to freely explore the syringe and
squirt some fluid out as they come close so they can taste it. If the rats did not clean their
honey stick yesterday, again place a popsicle stick with a strip of honey into their cage.
Day 3: Repeat honey-water syringe training.
Day 4: Last day of honey-water syringe training. By this day, nearly all animals should
be comfortable drinking from the syringe.
Note: For the first 2 or so doses of ibuprofen administration, rats probably will not drink
from the syringe because it is a new taste; however, since they have been syringe trained,
they know how to drink from the syringe, and they just need a couple doses to realize that
they enjoy the taste of the ibuprofen and they will begin drinking on their own. As
already mentioned, doxycycline animals likely will need restraint. Simply hold the
animal and use your thumb and index finger to grasp their jaw as you gently squirt the
fluid inside their cheek. Do not try to get all 0.5 ml in their mouth at once; do about half
of it at a time to allow them to swallow so they don’t spit it all out.
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Appendix 3: Rat Supraspinatus Tendon and Muscle Dissection
This protocol is adapted from the Multi-Tendon protocol, 1/20/2011.
Equipment and Supplies Needed:
#11 blades (1 per shoulder)
Blade holder
Hemostats
Rat toothed pick ups
Protocol:
1) Clamp the paw with hemostats (handles facing anteriorly). Externally rotate limb
by flipping hemostats over and tucking underneath rat’s abdomen.
2) Using the flat portion of the blade, make an incision along the spine of the scapula
and expose shoulder and arm.
3) Starting at the cephalic vein, incise up along the posterior border of the scapular
spine (down to bone) and peel away the trapezius anteriorly.
4) Laterally cut away the bursa, cut the AC joint, and peel away clavicle.
5) Grab the acromion with the pick ups, lift off of the body and cut away connective
tissue, then twist pick ups to break away acromion.
6) Carefully incise along the edges of the supraspinatus while peeling the muscle
away from the scapula. Make vertical “lines” with your blade tip along the
scapula to fully isolate the supraspinatus muscle.
7) Follow the medial border of the scapula to divide the supraspinatus from the
subscapularis muscle and expose the joint.
8) Follow the humeral head with the blade to cut the other rotator cuff
tendons/biceps and free the humeral head from the glenoid.
9) Cut away excess muscle from the humeral head and expose down to the elbow
joint. Dislocate the elbow joint to remove the humerus from the body.
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Appendix 4: Rat Supraspinatus Muscle and Tendon Tissue Harvest for MMP
Activity
Dissection Prep (day before)
1. For all samples that will be used for protein assays/MMP activity assay:
While wearing gloves (to prevent contamination), label Eppendorf tubes (lid and
side of tube) with date, rat ID number, and tissue type (see key below). Each
rat should have the following 3 labeled tubes:
 1 right supra tendon (R-SUP-T)
 1 right supra muscle (R-SUP-M)
 1 right excess supra muscle (R-SUP-EM)
Place labeled tubes in Eppendorf tube holder with lids closed.
2. Label biohazard bags (1 per animal) with animal ID number and date of
sacrifice. Also label an index card with this information and a place to write the
animal weight. Place index card in pocket of biohazard bags.
3. Gather all equipment and materials:
 Blue “diapers”
 Black pad (1 per dissector)
 Specimen cup for ethanol (1 per dissector)
 Specimen cup for PBS
 Liquid nitrogen container
 PBS squirt bottle
 Gauze
 Rat-toothed pick-ups (1 per dissector)
 Blade holder (1 per dissector)
 #11 blades (at least 2 per rat)
 Curved hemostats (1 per dissector)
 Bone cruncher (optional)
 List of rats to be sacrificed and corresponding assays
 Paper towel
 Scale with bowl for animal
 Labeled biohazard bags (1 per animal)
 Labeled Eppendorf tubes (3 per animal)
 Lab notebook
 Pen and permanent marker
Dissection Prep (day of)
1. Fill cup(s) with 70% ethanol.
2. Fill cup with PBS.
3. Get liquid nitrogen.
4. Cover dissection table with blue “diapers.”
5. Line CO2 chamber with paper towel.
6. Spray and wipe all equipment and surfaces with ethanol.
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Dissection
1. Sacrifice animal (1 at a time if 1 dissector or up to 1 cage with 2 animals at a time
for 2 independent dissectors). Confirm death with extended duration in CO2
chamber, cessation of breath, and lack of heart beat.
2. Weigh animal. Record weight in lab notebook and appropriate index card
(located in pocket of biohazard bag).
3. Working quickly, dissect the right shoulder to isolate the humerus, supraspinatus
tendon, and supraspinatus muscle (Appendix 2).
Note: When not using tools, store in ethanol. Swirl in PBS before using again.
4. Rinse in PBS by swishing specimen in PBS to remove excess blood and loose
hair.
For steps 5-7, diligence and patience are key to ensure tissue is as isolated as possible!
5. Place sample on black pad (bursal side down for stability). Use curved forceps to
grasp muscle and use blade to cut a muscle chunk from the curved side, avoiding
cutting the tendon. Be sure to take both deep and superficial regions of the
muscle. Place in properly labeled Eppendorf tube, and immediately submerge in
liquid nitrogen.
6. Once muscle sample is taken, use back of blade to scrape remaining muscle from
tendon. Place this remaining muscle in properly labeled Eppendorf tube, and
immediately submerge in liquid nitrogen. This is a tube of “extra” muscle to be
used just in case.
7. Once tendon is free of muscle, use blade to transect tendon at bony insertion. Cut
away any remaining non-tendon tissue. Immediately place tendon in properly
labeled Eppendorf tube and submerge in liquid nitrogen.
8. Change blade and rinse all tools in ethanol and then PBS. Wipe black pad with
ethanol.
9. Once shoulders are dissected, soak gauze in PBS and place over shoulder of rat to
reduce freezer burn. Place rat in properly labeled biohazard bag.
10. Repeat steps 1-10 on next animal. Between animals, make sure all tools and
surfaces have been rinsed and wiped dry with ethanol and are free of tissue.
Always use a new blade. Change paper towel lining CO2 chamber.
11. Store dissected rats in -20°C freezer. Be sure to label biohazard bag with any
missing body parts (e.g., “No Shoulders”) using a permanent marker.
12. Store tissue samples in -80°C freezer until ready for homogenization.
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Appendix 5: Rat Supraspinatus Muscle and Tendon Tissue Harvest for Histology
This protocol is intended to be used on a single shoulder. Tendon will be preserved for
longitudinal paraffin histology, and muscle will be preserved for transverse muscle
histology (cryo). The muscle embedding/sectioning protocol was developed upon
watching Dr. Beth Barton freeze, embed, and cryosection a rat supraspinatus tendon.
Materials Needed:
 Razor blade –or– blade holder and #11 blades
 Histology cassettes with foam or folded KimWipes
 KimWipes
 Formalin in specimen cup
 Small insect pins (e.g., item # 26002-20 from Fine Science Tools)
 Insulated container to hold liquid nitrogen
 Small aluminum foil tin to hold isopentane
 Isopentane (2-methylbutane)
 Base of Styrofoam cup or Styrofoam plate
 OCT
 Permanent marker + pencil
 Aluminum foil
 Long forceps (to submerge in liquid nitrogen)
Prep
1. Label 1 histology cassette per specimen with the sample ID, initials (SIR), and
date on at least 2 sides. Be sure to use pencil!
2. Fill a specimen cup with formalin. Label specimen cup (using permanent marker)
with the date, specimen numbers, formalin, and name.
3. Cut Styrofoam to fit muscle, and label (using permanent marker) the underside
with the specimen ID and date. Label top with P for proximal (medial) and D for
distal (lateral, tendon side).
4. Fill insulated container with liquid nitrogen.
5. Fill aluminum foil tin with isopentane deep enough to submerge muscle
specimens. Float aluminum boat filled with isopentane in liquid nitrogen.
6. Fully dissect humeral head- tendon- muscle unit from one shoulder of recently
euthanized rat (Appendix 2).
Muscle
1. Rinse bone-tendon-muscle unit in PBS to remove pieces of hair or excess blood.
2. Using a razor blade or scalpel, cut transversely through the midbelly of the
supraspinatus muscle/tendon.
3. Blot piece of muscle using a KimWipe to remove excess PBS.
4. Put small amount of OCT on labeled Styrofoam (be sure label is on the underside
and will not be covered by specimen/OCT). Use just enough OCT to provide a
surface for the tissue to stick.
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5. Place the deep layer of the muscle (side where you can see tendon more clearly)
down on the OCT-coated Styrofoam.
6. Pin the muscle (proximal and distal in a triangle shape) to keep the muscle taut
but not stretched (i.e., “resting length” of the muscle).
7. Lift the muscle up slightly on the posts (helps prevent sticking).
8. Cover the muscle in OCT using the least amount of OCT possible (more OCT
means the tissue will take longer to freeze, increasing the odds of freezing
artifact).
9. Submerge muscle/Styrofoam in isopentane for ~15 seconds, until it turns opaque
white and is frozen.
10. Wrap unit in labeled aluminum foil and float in liquid nitrogen or dry ice while
working on other samples. Do NOT allow unit to thaw.
11. Store at -80°C until ready to section.
Tendon
1. Sandwich the bone-tendon-muscle unit (now missing some muscle) between a
piece of folded KimWipe that fits within a histology cassette.
2. Place unit in properly labeled histology cassette.
3. Place cassette with specimen directly in formalin. Specimen should stay in
formalin for 1 week before being switched into Immunocal for decalcification.
4. Decalcification should occur for 1 week on a shaker. Change immunocal on
second day. After 1 week, the humeral head should be soft enough to cut with a
scalpel or 20G needle without feeling “crunchy.” Continue immunocal until no
longer crunchy.
5. At this point, specimens should be cut in half (using scalpel) through the width of
the tendon/bone (coronal plane) and transferred into labeled “A” and “B”
cassettes.
6. Transfer to 70% ethanol until processing.
7. Processing is performed at the VA using the 3mm tissue protocol.
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Appendix 6: Supraspinatus Muscle Cryosectioning
This protocol is intended to be used on rat supraspinatus muscle samples embedded in
OCT upon harvest, flash frozen, and stored at -80°C. The muscle embedding/sectioning
protocol was developed upon watching Dr. Beth Barton freeze, embed, and cryosection a
rat supraspinatus tendon.
Materials Needed:
 Razor blade –or– blade holder and #11 blades
 OCT
 Pencil
 Slides (LabStorage Systems MS-P30001/CS)
 Slide box- narrow for 50 slides (Genesee Scientific 29-105B)
 Microtome blades
Embedding
1. Remove specimen from -80C freezer and place in cooled (-20°C) cryostat for 30
minutes to allow specimen to equilibrate.
2. Gently pull out pins from tissue (represented by “x” in the figure below), and
remove specimen from Styrofoam.
3. Using razor/blade, cut a ~5mm piece of muscle (dashed line in figure) from the
distal end of the specimen (labeled “D” on the Styrofoam, the side that has 2 pins
instead of 1). For these specimens, the “distal” end has been cut in the mid-belly.
If the sample is large enough, also cut off the most distal edge, which has pin
holes. Note: The deep region of the muscle is down on the Styrofoam, and the
superficial portion is up. Careful: Cutting too quickly or forcefully or attempting
to cut before allowing the specimen to equilibrate to the cryostat temperature may
result in a shattered specimen!
x
x

D

P

x

4. Place a coating of OCT on the small cryostat button, and immediately place the
cut muscle sample on top. The most recently cut edge of the muscle (more
proximal) should be down on the OCT so that sectioning will begin at the most
distal edge (mid-belly) and work towards the proximal (non-tendinous) end of the
muscle. Note: Do not completely cover the specimen with OCT or you will end
up with a much larger section than necessary; however, do make sure that the
sample is stable and will not fall off the button due to excessive torque (e.g., if it’s
too large of a section or doesn’t have enough OCT surrounding the bottom edge).
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Sectioning
1. Secure the button in the cryostat so specimen is horizontal.
Blade angle: 10°
Temperature: -20°C
Sections: 10μm
2. Deface specimen until whole muscle cross-section is obtained.
3. Begin sectioning at 10μm, collecting every good section.
Tips:
 Do not attempt to create a ribbon like paraffin sectioning; sections do not always stick
together and may slide under each other.
 On a good day, the clear plastic protector can be flipped down during sectioning to
allow for a single smooth frozen section to be obtained—on most days, this doesn’t
work, and a paintbrush technique must be used. If using this plastic piece, make sure
the piece is slid all the way to the left, stabilized by the two pins.
 If using the paintbrush technique, gently and slowly use the paintbrush to unroll the
section while cutting. Keep the section connected to the block or the section will roll
up completely as you try to collect it on the slide. Try flipping the section up to grab
it on the slide.
 Do not complete your stroke to bring the button back up until after collecting a
section on your slide. As the button raises back up, it could hit/ruin your freshly cut
section.
 To grab a section, simply touch it to the slide. Sections will not adhere if the slide is
too cold; warm up the slide by leaving at room temperature or gently rubbing the
back of the slide with your finger.
 If things aren’t going well, try a new blade or try again another day—don’t waste the
specimens!
4. Label each slide using pencil with the specimen ID, date, and slide number
(beginning at 1 for the most distal slide, increasing in number as going proximal).
5. Collect 4 sections per slide.
6. During collection, store slides in cryostat. For long-term storage, keep slides at 80°C.
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Appendix 7: Supraspinatus Tendon Paraffin Sectioning
Embedding:
1. Place processed samples in cassettes in paraffin wax tray. Allow to
equilibrate for 20-30 minutes.
2. Fill a mold with a small layer of paraffin and place on the cold block. When
this wax begins to solidify, place the sample (flat, cut side down) on the wax
and press to flatten it. Make sure samples are not angled.
3. Place cassette lid on top of the mold and fill with paraffin.
4. Place on freezing stage until hard.
Sectioning:
1. Fill bowl with ice and add a small amount of water.
2. Soak samples in ice bath for at least 20 minutes prior to sectioning.
3. Turn water bath on to reach 40-50ºC.
4. Set the microtome blade angle to 15º.
5. Mount the block on the microtome so that it sections evenly across the surface
and so that the sample is being cut horizontally.
6. Deface the block just until tendon is reached.
7. Place defaced block back in ice bath and continue onto other specimens.
8. When ready to section, place sample in Mollifex tissue softener for 5 minutes.
9. Section at 7µm and collect every good section.
10. Cut ribbon into sections of 2 and place in water bath to remove wrinkles.
Collect on slide labeled in pencil with specimen ID, date, and slide number.
11. Collect as many slides per specimen as possible.
12. Bake slides 1 hour at 60ºC to ensure sections adhere.
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Appendix 8: Tendon Histology H&E Staining
De-waxing
3 minutes
3 minutes
3 minutes

Xylene
Xylene
Xylene

Dehydration
2 minutes
2 minutes
2 minutes
2 minutes
2 minutes
2 minutes
2 minutes

100% Ethanol
100% Ethanol
100% Ethanol
95% Ethanol
95% Ethanol
70% Ethanol
DH2O

Stain
10 minutes

Hematoxylin (clean off iodized surface)

Rinse
Until water is clear
3 Dips
2 minutes
3 Dips
2 minutes
2 minutes

DH2O
Clarifier
DH2O
Bluing
DH2O
95% Ethanol

Stain
10 seconds

Eosin

Rehydration
2 minutes
2 minutes
2 minutes
2 minutes
2 minutes

95% Ethanol
95% Ethanol
100% Ethanol
100% Ethanol
100% Ethanol

Final cleaning
3 minutes
3 minutes
3 minutes

Xylene
Xylene
Xylene

Coverslip
Dry flat overnight in hood
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Appendix 9: Tendon H&E and Polarized Light Imaging
This protocol is divided into three sections:
1. Color Images @ 2.5, 5, 10, 20X
2. Polarized light images (uncomp & comp @ 20X)
3. Analyzing these images using PolarWare program written in Matlab
________________________________________________________________________
1. Taking color images
The setup on the microscope from top to bottom should be: eyepiece, rotating analyzer,
objective, slide, stage, condenser, compensator (only for compensated images as
described below), rotating polarizer
a. Turn on the microscope and the camera (plug firewire cable into either input on side
of camera).
b. On the computer connected to the microscope, load QCapture Pro software. Click on
the camera icon to bring up the capture menu. Click Preview to view the image
c. Select setting Lucas BF and make sure Acq resolution at 1280 x 960 FF, Pvw
resolution 640 x 980 FF and Capture depth 24 bit color
d. Before putting slide on, auto white balance  reset area to full frame
 calculate
e. Put slide on and click calculate auto exposure
f. Using the 2.5X objective, find the region of interest and focus the
specimen. Orient the specimen at ~45°. (Knobs on stage move the
stage and knob on side focuses). Continue to increase to 5X, 10X and
20X until you have the region you want at 20X (aim for maximum
focus number which is shown at the bottom of the preview image)
g. Zoom back out to 2.5X and take image at 2.5X, 5X, 10X, and 20X
(auto expose at each magnification and remember to maximize the
focus). Create a folder with the specimen number and within that create a folder
called “Color.” Label the files:
32-XXX_Slide#_locationonslide_magnification (e.g., 32-081_22_2_2X)
h. After taking the 20X image, stay in the same location to do polarized light at 20X.
2. Taking polarized light images
a. Take the noncompensated images first. With the 20X objective in place, load the
PolLightUncomp (8 bit mono) profile. Without the analyzer and polarizer, click
Auto White Balance and select a region of the slide that does not contain the
specimen. Slide the analyzer and polarizer in place and click Auto Exposure (do not
auto expose between images, only once at the beginning of noncomp and comp
images).
b. Insert the analyzer all the way in (located top left) and the polarizer (under the stage)
and make sure the compensator is not in the polarizer for the first set of images
c. Set the analyzer to 180 degrees and the polarizer to 270 degrees. This position
will be considered 45 degrees when saving the images. Rotate through the various
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d.

e.

f.

g.
h.

i.

angles of the polarizer/analyzer to ensure that the images do not saturate. If
saturation occurs, simply turn down the light.
Rotate both the analyzer and polarizer in a clockwise direction by the same
increment (10). For both noncompensated and compensated images, pictures need to
be taken across a 90 range in 10 increments.
Press Snap and save each picture as a .tiff file. For each specimen, go to the folder
created in step g of section 1 above with the specimen number. Within this, create
separate folders for compensated (“comp”) and noncompensated (“uncomp”) images.
Save pictures using a 3 digit filename format. For example, a picture taken at 45
should be saved as 045. Repeat until a span of 90 (image named 135) has been
reached.
Insert the compensator in its slot above the polarizer with the nail pointing down.
The compensator must be oriented 45 counterclockwise from analyzer and polarizer
(i.e., compensator nail should be pointing at 225 degrees –always aligned with the
blue dot – on the polarizer).
Load the PolLightComp (24 bit) profile and click Auto Exposure
Repeat steps d-f; however, this time rotate the compensator in a clockwise
direction with the analyzer and polarizer (make sure that compensator is always
oriented 45 from the analyzer and polarizer while you are rotating, pointing to the
dot). Instead of going from light to dark (or vice-versa) as you rotate analyzer
compensator and polarizer, the images should go from blue to red (or vice versa).
Turn off camera by unplugging firewire cable and turn off microscope lamp.

3. Using PolarWare
a. Run Matlab.
b. Set the correct path (U:\software cooker-freezer\polarware\rc). Where U is the
soslowskylab max drive.
c. Type in “polarware_gui;”.
d. Press button “NON-compensated”.
e. Navigate to the correct directories where the noncompensated and compensated
images are saved and click on a noncompensated image.
f. Change parameters:
Bundle spacing determines the pixel distance between adjacent bundles (left,
right, top, bottom)
Bundle spacing = 50
Bundle size determines the size of each bundle. This value must be odd.
Bundle width = 7
g. Input the specimen name in the Output File Prefix box (e.g., 32-008_mid).
h. Press button “NON-Bundle” and save the INTD file in a new folder labeled
“QPLM.”
i. Press button “NON-Fit” and save the NNF file.
j. Press button “COM-Bundle” and save the INTD file.
k. Press button “COM-Fit” and save the CNF file.
l. Press button “Shift noncomp” and save the SNF file.
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m. Press button “Apply Mask”. Change automask parameters to desired values:
Phi-CI Threshold = 15
Phi-Sensitivity Threshold = 1.0
(Note, these values were determined to be appropriate for Sarah’s thesis after
analysis of all the 2/8 wk EX/CA specimens).
n. Go through each bundle and ensure that the quiver plot seems appropriate for the
region. Any bundle located in a gap in the tissue, on muscle, or on a cell should be
masked to avoid including in analysis. To manually remove bundles, click “Point
Mask” in the Mask GUI. Click on any bundles that should be removed and press
enter on the keyboard when done.
o. Press button “Save Mask” and save the MSK file
p. Press button “OUTPUT RESULTS” and copy the data to an Excel file.
q. Copy the following 3 output figures to a PowerPoint:
Figure 19: Fiber Direction Histogram
Figure 10: Noncomp Node File Threshold Figure
Figure 2: Bundle Figure
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Appendix 10: BioQuant Software for Tendon Histology Cellularity and Cell Shape
Open Existing Data Set
1. File>> Open Data Set>> select your data volume(SIR_thesis_Chronis_mid)>> select
a data set(anyone works (ie. 32-090_Mid_21_1_20X)>> press “Open”
a. This is just to make sure you are working with a template that has the
correct arrays to measure
Note: Data Directory should be on C:\BQDATA\ in order for the name of your data
volume to appear in the scroll menu. If you click “Browse” and search within the
BQDATA folder there will only be numbered folders, e.g. “DATA170”.
Create New Data Volume
1. Open existing data set, which has
functions you desire (e.g.
SIR_thesis_chronic_mid)
*To keep functions that calculate
total area, cell count, cell shape, and
cell area, base new data set off of
old one
2. File>> New Data Set>> Create
New Data Volume
*To create new Data Volume,
which has aforementioned
prewritten function
3. Keep Data Directory as C:\BQDATA\
4. Finish wizard
*Note which Data Volume you created
(e.g. “DATA170”). This will be used
to save data as a .txt file.
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Analyze an image
1. Image>> Type: Image File>> Open Single>> select image to analyze

Select the image you want (20x color) and it should pop up on the big screen
2. Before doing anything else, create a new data set:
File>> Quick Data Set>> rename the new data
set>> Current Data Set>> Create
3. Choose correct camera
magnification/calibration:
a) Underneath where you opened your
image click:
Calibration>> File>> Load…>> e.g. Leica.cal

4. Now see this box:
a. Make sure to select the correct
magnification (X20-L if you have
used the polarizing scope)
b. This is a key step, make sure the
correct magnification is selected
throughout your entire analysis
5. Next define ROI (Region of Interest) you are
interested in analyzing
Usually full screen, but if not:
Irregular>> click “Spacebar to End”>>
Define>> select ROI with mouse
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Push spacebar and RIGHT CLICK to end. (There will be a green outline)
Now this area will be the only area analyzed
6. Select Array:
a) Double click on A2 Cell Area (Notice all values are (0))
b) This will make the area you defined in step 5 turn pink
c) In the both on the right make sure the Type: General is selected and click
preview and the measure. A number will appear in the Raw Data: Current
Array window and that is your total area

d) Now double click in the Available array
box A1 Cell Area (make sure
magnification is set to X20-L after you
double click
e) This will allow you to measure the
specific cells you are interested in with
your ROI
f) Now continue on with step 7
7. Adjust Threshold
Press “Select”>> click on cells>> same color regions will turn pink
Once satisfied, right click.

This tool is useful but sometimes it does not select all the cells or it selects areas that
aren’t cells. After using this tool you can use the paintbrush and eraser in the
threshold section to clean up the picture and make sure you have only selected the
cells you want to measure. (More details about this in step 10-13). You can adjust the
size of the eraser and paintbrush by using the scroller on the mouse. In order to get
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out of using either tool you must right click. Once you have the cells you want
selected move to step 8.
8. Press “Preview”
Yellow outline will form around each cell.
Note: Each yellow-bordered region is what Bioquant will recognize as a cell, not the
pink. If you like what you see click measure and your data will appear in the raw data
window

9. Useful Tool:
a. Press “Show”
i. Pink fill will disappear. Qualitatively measures accuracy of pink on
cells.

b. Press “Show” again to make pink fill reappear.
10. Fine-tune selection: Draw Threshold
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Use mouse to color in cells>> use mouse scroller to adjust marker size>> right click to
end

Note: Right clicking allows your cursor to exit the picture window, and it also creates
yellow borders around each cell. Note that Bioquant only registers these yellow-bordered
regions as cells, not the pink.
11. Fine-tune selection: Erase Threshold (the eraser sign below Draw Threshold)
Use mouse to color over unwanted regions>> use mouse scroller to adjust eraser
size>> right click to end

Note: Watch out for small, yellow regions that Bioquant picks up without your
knowledge. Erase these.
Note: look at text file for cells with area~0. These “cells” are actually this yellow noise.
12. To more quickly switch between the eraser tool and the paintbrush tool, press either
of the two arrows located by your thumb. You must already have selected either the
paintbrush or eraser for this shortcut to work.
Doing so will unselect the “pesky” yellow borders, thereby allowing you to better see
the cells and ultimately increase accuracy of cell shape selection and differentiation
between cells. The yellow borders will reappear via a right-click.
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13. To increase accuracy of cell shape drawings:
a. Decrease cursor speed by pressing the negative shortcut on the mouse.
b. Using the smallest marker size of the paintbrush, draw an enclosed border for
each cell instead of filling the entire cell in.

14. When satisfied>> click “Preview”>> click “Measure”
15. When done File>> Save Data
Export Data as a .txt File
1. File>> Data Manager
2. Uncheck: Desktop>> My Computer>>OS (C:)>> BQDATA>> Click
“DATA###(Your Data Set)”
a. Data 254 for Sarah’s Thesis
3. Click on the icon of a folder with binoculars on top on the toolbar
4. The folder with all your previous data sets will appear, select whichever data set you
want to save to a .txt file and right click on it and select save to file
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Appendix 11: Laminin-DAPI Immunofluorescence Staining on Muscle Cryosections
This protocol, modified from one originally used by Ed Pistilli in the Khurana lab, is
intended for muscle cryosections that have been stored in the -80C freezer. Total
protocol is ~3.5 hours. I normally do 20 slides at once.
Reagents Needed:
Vehicle solution: 10% normal goat serum (NGS), 1% Triton X-100 in PBS (made fresh)
For 14 ml: 12.46 ml PBS + 140 μl Triton X-100 + 1.2 ml NGS
Cut pipette tip for Triton X-100 (viscous); add this to the PBS first, then vortex,
then add NGS
PBS (for immunoassays)
Anti-Laminin (Sigma L9393) produced in rabbit
Secondary Antibody Alexa Fluor 488 Goat Anti-Rabbit IgG
(Life Technologies A-11008)
Spin at 10,000 rcf for 1 min at room temperature prior to use to avoid non-specific
binding
ProLong Gold Antifade reagent with DAPI (Invitrogen P36935, Cell Center)
Clear nail polish
Equipment and Supplies Needed:
Cover slips
PAP pen
Pipettors and tips
15 ml tubes
KimWipes
Black slide box for IHC/IF
Vacuum set-up
Protocol:
1. Thaw slides at room temperature and let them air dry (~10 minutes).
2. Wash slides with PBS (quick washes).
3. Circle each section with a PAP pen.
4. Block with vehicle solution for 30 minutes at room temperature. From this point on,
store slides in humidity chamber (wet KimWipes and place them in the black
immunoassay slide box).
5. Use vacuum system to remove excess vehicle solution from sections. Incubate with
anti-laminin 1:1000 in vehicle solution for 1 hour at room temperature.
(For 4ml: 4 ml vehicle + 4 µl anti-laminin)
6. Wash 3 times 5 minutes each with PBS.
7. Incubate with secondary antibody 1:500 in vehicle solution for 45 minutes in the
dark at room temperature. From this point on, the sections are photosensitive; avoid
direct light when possible.
(For 2.5 ml: 2.5 ml vehicle + 5μl secondary antibody)
8. Wash 3 times 5 minutes each in PBS.
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9. Mount coverslip on slides with ProLong Gold Antifade with DAPI. Avoid air
bubbles.
10. Allow slides to cure for 24 hours at room temperature in the dark on a flat, dry
surface.
11. Seal edges of coverslip with clear nail polish. Store at room temperature in dark slide
box.

171

Appendix 12: Muscle Fiber Type Staining on Cryosections
This protocol, modified from one originally used by Emanuele Loro in the Khurana lab,
is intended for muscle cryosections that have been stored in the -80C freezer. I normally
do 20 slides at once.
Reagents Needed:
Blocking Solution: 4% BSA in PBS (for 5.5 ml, add 220 mg BSA to 5.5 ml PBS)
1% BSA solution: Add 1.5 ml 4% BSA to 4.5 ml PBS
PBS (for immunoassays)
Primary antibody solution: See chart below.
For ~3ml: 3 ml 1% BSA + 30µl each MyHC antibody +3µl anti-laminin
Secondary antibody solution: See chart below.
For ~3ml: 3ml 1% BSA + 30 µl IgG2b + 7.5 µl IgG1 + 6 µl IgM + 6 µl antirabbit IgG
ProLong Gold Antifade reagent without DAPI
Clear nail polish
Antigen

Primary ab
Clone
BA-D5
supernatant

Primary
ab Isotype
IgG2b

Primary
Secondary
Secondary
ab dilution
ab
ab dilution
1:100
Goat Anti
1:100
MyHC-I
mouse IgG2b
DyLight 405
(Jackson
Immuno)
IgG1
1:100
Goat Anti
1:400
MyHC-2A SC-71
supernatant
mouse IgG1
Alexa 488
(Jackson
Immuno)
IgM
1:100
Goat Anti
1:500
MyHC-2B BF-F3
purified
mouse IgM
Alexa 546
(Jackson
Immuno)
* Type 2x fibers will not be stained, therefore will appear as black
MyHC antibodies are from the Developmental Studies Hybridoma Bank at the
University of Iowa
Equipment and Supplies Needed:
Cover slips
PAP pen
Pipettors and tips
15 ml tubes
KimWipes
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Black slide box for IHC/IF
Vacuum set-up
Protocol:
1. Thaw slides at room temperature and let them air dry (~10 minutes).
2. Circle each section with a PAP pen.
3. Wash twice with PBS.
4. Block with 4% BSA in PBS for 1 hour at room temperature. From this point on,
store slides in humidity chamber (wet KimWipes and place them in the black
immunoassay slide box).
5. Use vacuum system to remove excess vehicle solution from sections.
6. Wash 2 times 2 minutes each with PBS.
7. Incubate with primary antibody solution for 1 hour at 37ºC.
8. Wash 3 times 5 minutes each with PBS.
9. Incubate with secondary antibody solution for 30 minutes in the dark at 37ºC. From
this point on, the sections are photosensitive; avoid direct light when possible.
(For 2.5 ml: 2.5 ml vehicle + 5μl secondary antibody)
10. Wash 3 times 5 minutes each with PBS.
11. Mount coverslip on slides with ProLong Gold Antifade without DAPI. Avoid air
bubbles.
12. Allow slides to cure for 24 hours at room temperature in the dark on a flat, dry
surface.
13. Seal edges of coverslip with clear nail polish. Store at room temperature in dark slide
box.
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Appendix 13: Muscle Histology Imaging
Using the Eclipse 90i
Laminin-DAPI Imaging
1. With the Eclipse set to the green filter and using a 4x objective, scan the 4
sections per slide and choose the section that has the least freezing, sectioning,
and staining artifact.
2. Switch to 10x objective and scan over the chosen specimen to identify 6 regions
to image. These regions should be spread throughout the specimen. Avoid
freezing artifact when possible.
3. Begin taking images. For each region, focus, auto-expose, and capture for the
green filter AND the DAPI filter. Save each of these images as TIFs with the
following file names:
32-xxx_slide number_section number_laminin_image number 1-6
32-xxx_slide number_section number_DAPI_image number 1-6
4. Merge these two channels and save the merged file as a JPG (color) with the
following file name:
32-xxx_slide number_section number_merged_image number 1-6
5. Repeat to take images of 6 regions.
Fiber Type Imaging
1. With the Eclipse set to the greem filter and using a4x objective, scan the 4
sections per slide and choose the section that has the least freezing, sectioning,
and staining artifact.
2. Switch to 10x objective and the DAPI filter. This will expose the MyHC-I fibers
as blue. For the supraspinatus muscle, this region is small and located on the edge
of the fiber.
3. Identify 3 regions within the MyHC-I section of the muscle and image. We will
call this section of the muscle “region 2.”
4. For each of the “region 2” images, capture the following as TIFs:
MyHC-I with DAPI filter: 32-xxx_slide number_section number_myhc1_image
number 1-3
MyHC-2a with green filter: 32-xxx_slide number_section
number_myhc2a_image number 1-3
MyHC-2b with TRITC filter: 32-xxx_slide number_section
number_myhc2b_image number 1-3
Laminin with Cy5 filter: 32-xxx_slide number_section number_laminin_image
number 1-3
5. For each of the “region 2” images, merge to create the following JPGs (color):
MyHC-I (blue) + Laminin (red): 32-xxx_slide number_section number_myhc1laminin_image number 1-3
MyHC-2a (green) + MyHC-2b (blue) + Laminin (red): 32-xxx_slide
number_section number_myhc2a-myhc2b-laminin_image number 1-3
6. Repeat to capture 3 regions within “Region 2.” By the end, you should have 6
jpgs for this region.
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7. Now, move on to Region 1, which is larger and does not contain MyHC-1
expressing fibers. Repeat the above steps but don’t worry about capturing any
images with the DAPI filter since there are no MyHC-1 fibers! Again, capture 3
regions within Region 1. By the end you should have only 3 jpgs for this region
(since you don’t need a myhc1-laminin merged image; you only need myhc2amyhc2b-laminin merged images)

175

Appendix 14: Muscle Histology Analysis Using SMASH MATLAB Application
These directions are directly modified from SMASH_Instructions, a Word document that
is contained in the SMASH download options online:
http://figshare.com/articles/SMASH_semi_automatic_muscle_analysis_using_segmentati
on_of_histology_a_MATLAB_application/1247634
SMASH is a MATLAB application written by Lucas Smith for segmentation and analysis
of fluorescently stained transverse muscle histology sections.
Smith LR, Barton ER. SMASH- semi-automatic muscle analysis using segmentation of
histology: a MATLAB application. Skelet Muscle 2014 Nov;27:4-21.
1. Follow provided SMASH_Instructions to install the SMASH app on Matlab 2014
and locate the excel file to alter the default parameters
2. Input the following defaults and ensure the default output folders exist to prevent
an error during data output
a. For fiber type analysis, fiber outline channel = 1
b. For Laminin-DAPI analysis, fiber outline channel = 2
Default Values
Pixel Size (um/pixel)
0.645
Fiber outline channel (red = 1, green =2, blue
=3)
1
Nuclei channel (red = 1, green =2, blue =3)
3
Fiber type channel (red = 1, green =2, blue
=3)
2
Object channel (red = 1, green =2, blue =3)
2
Segmentation smoothing factor
6
Nuclear smoothing factor
10
Object smoothing factor
10
Minimum fiber area (um2)
750
Maximum fiber area (um2)
10000
Maximum eccentricity
0.98
Minimum convesity
0.7
Nuclear distance from boarder (um)
15
Minimum nuclear size (um2)
5
Fiber properties output folder
Enter pathway for output folder
Fiber type output folder
Enter pathway for output folder
Central nuclei output folder
Enter pathway for output folder
Objects output folder
Enter pathway for output folder
I. Running Muscle Histology Analysis and selecting File
1. Select the “SMASH_App” App from the App Menu.
2. Locate and press the “Select File” button.
3. Navigate to and select the jpeg image file you would like to analyze
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a. Always select the original image file, not the mask file created by the
program.
b. The selected file name will appear on the screen
4. In the Select Function window select the analysis function to perform and press
“Select Parameters.”
a. Initial Segmentation must be run before any other functions.
b. It is also recommended that fiber filter is run prior to other analysis
functions.
II. Initial Segmentation
5. Manually modify the parameters for initial segmentation from the defaults if
necessary and press the “Run Function” button
a. If a mask for the file is already created you will be asked to overwrite the
previous mask to continue.
6. Examine the image that is produced containing white lines over the fiber borders
and if it is satisfactory press the “Manual Edit” button, otherwise change the
Segmentation Filter value and press “Run Function” again.
a. General segmentation values range from 4 to 8 (lower number is a more
segmented image)
b. The Zoom and drag button at the top toolbar allow the user to scan the
image in detail.
7. Manually fix any undersegmentation using the Edit Segmentation menu tools
a. Draw Line
i. Once pressed, any previously drawn line is saved.
ii. Pan and zoom to the conjoined fiber.
iii. Freehand draw a line to create a boarder to fully separate the fiber.
iv. Ensure that no tools are selected so that the freehand draw is
active.
v. Repeat until all fibers are properly segmented.
b. Undo: Press if the most recent fiber drawn was not drawn correctly.
c. Done: Press when all fibers have been segmented.
i. A new mask file will be saved.
III. Fiber Filter
1. Manually modify the parameters for filtering fibers from the defaults if necessary
and press “Run Function”
2. Inspect image that appears to determine if it is satisfactory.
a. If filter parameters should be changed edit them in the window and repress “Run Function.”
b. If the filtering was satisfactory press “Manual Filter.”
3. Navigate to any objects that are not fibers using pan and zoom and press any key
a. Locate and open the original image for comparison
4. Click on all visible objects that are not fibers.
a. A cross hair will be placed on the image where clicked.
b. To remove most recent selection press “backspace” or “delete.”
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c. To end selecting double-click on final selection, ctrl/alt click on final
selection, or press “Enter.”
5. The image will show the fibers removed and allow you to make a selection to
confirm fiber removal
a. Yes: to delete selected fibers and continue to select fibers at step 3).
b. No: keep all fibers selected, but continue to select fibers at step 3).
c. Done: to delete selected fibers, save the modified mask file and proceed to
further analysis.
Note: If Yes is pressed after the last fiber to be filtered place a new cross
hair over a non-fiber area to bring up the menu.
IV. Fiber properties
6. Manually modify the parameters for fiber properties from the defaults if necessary
and press “Run Function”
7. Examine the histograms and choose if you would like to output the data to Excel
by pressing “Yes” or “No.”
For Fiber Type Analysis:
V. Fiber Typing
8. Manually modify the parameters for fiber typing from the defaults and press “Run
Function”
a. Fiber Type Color:
i. Region 1: Green = type 2a; Blue = type2b
ii. Region 2: Blue = type 1; Green = type 2a; Blue = type 2b
9. Examine the image with pan and zoom to determine if calls for fiber type are
appropriate.
10. If you would like to change the automatic threshold for fiber types enter the new
threshold value and press “Adjust”, otherwise press “Accept.”
a. Locate and open the original image for comparison
b. The histogram of average intensity is helpful in determining appropriate
thresholds.
11. Choose if you would like to output the data to Excel by pressing “Yes” or “No.”
a. Note: If analyzing more than one fiber type on an image, rename the excel
file
12. To analyze another fiber type on the same image, repeat steps 8-11 and change
the fiber type color.
For Laminin-DAPI Analysis:
VI. Centrally Nucleated Fibers
13. Manually modify the parameters for CNFs from the defaults and press “Run
Function”
14. Examine the image with pan and zoom to determine if calls for CNFs are
appropriate.
a. Locate and open the original image for comparison.
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15. If you would like to change the automatic threshold for nuclei enter the new
threshold value and press “Adjust”, otherwise press “Accept.”
a. Pointing over the nuclear image in the top left to display pixel intensity
info can be helpful for determining an appropriate threshold value
16. Choose if you would like to output the data to Excel by pressing “Yes” or “No.”
**Note: if samples have freezing/staining/sectioning artifact, it will be more reliable to
manually count the number of centrally nucleated fibers instead of using this program.
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Appendix 15: Tendon Mechanical Testing Prep
This protocol is for the preparation of rat supraspinatus tendon for mechanical testing.
Equipment and Supplies Needed:
KimWipes
Protocol:
1. Dissect supraspinatus muscle-tendon-bone unit (refer to Supraspinatus
Dissection Protocol).
2. Let specimen sit in PBS for 5 minutes.
3. Blot specimen on KimWipe to remove excess PBS.
4. Gismo supraspinatus muscle starting at the distal (tendon) edge, making passes
every 2 mm.
5. Fine dissect supraspinatus tendon (refer to Supraspinatus Tendon Fine
Dissection Protocol).
6. Add stain lines (refer to Supraspinatus Tendon Stain Lines Protocol).
7. Gismo tendon (refer to Supraspinatus Tendon Gismo Protocol).
8. Pot tendon (refer to Supraspinatus Tendon Potting Protocol).
9. Sandpaper tendon (refer to Supraspinatus Tendon Potting Protocol).
10. Load tendon in ElectroPuls Instron and test (refer to Supraspinatus Tendon
Mechanical Testing Protocol).
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Appendix 16: Supraspinatus Tendon Fine Dissection for Mechanical Testing
This protocol is meant for fine dissecting the rat supraspinatus tendon prior to application
of stain lines/Gismo for mechanical testing.
Equipment and Supplies Needed:
#11 blades
Blade holder
Hemostats
Jeweler’s forceps
Micro-scissors
Black pad
Wax
Protocol:
1. Use back of blade to scrape muscle away from tendon.
2. Use jeweler’s forceps and micro-scissors to remove all “goo” from tendon
insertion site and mid-substance. “Goo” is pinkish or yellowish, not the bright
white color of the tendon. It also moves differently from the tendon.
Remove any tissue that is not well-formed enough to bear load; leave tissue that
bears load.
Manually grip end of tendon and apply minimal amount of load.
Non-load bearing (remove): Tissue that move but doesn’t stretch or deform
under load
Load bearing (keep): Tissue that stretches under load and therefore bears load
3. Keep tendon fully hydrated!
4. Make sure to fine dissect all sides of the tendon, focusing particularly on the
insertion site. Change the grip of the hemostats to fine dissect the joint and bursal
sides.
5. At the very end, use the micro-scissors to cut directly into the bone between the
infra-supra insertions to ensure that they are fully separated and remove any
excess rotator cuff tendons that may be in the way for Gismo.
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Appendix 17: Supraspinatus Tendon Stain Lines for Mechanical Testing
This protocol is for an 8 mm gauge length rat supraspinatus tendon for mechanical
testing.
Equipment and Supplies Needed:
KimWipes
6-0 silk suture
Verhoeff’s stain
Weigh boats
Ruler (mm)
Pink dental wax
Verhoeff’s Stain
A- 5% hematoxylin solution (0.4g Hematoxylin + 20 ml 95% EtOH)
B- 10% aqueous ferric chloride (2g Ferric chloride + 20 ml dH2O)
C- Weigert’s iodine solution (2g potassium iodide + 1g iodine + 100 ml dH2O)
Dissolve all solids and add in order B to A, then C to A in the following ratio of A:B:C =
2:1:1
Solutions A, B, and C can be made up ahead of time and stored separately. Solution C
should be stored in a dark bottle. Place small amount (~0.5 to 1 ml) of stain in angled
weigh boat or in an Eppendorf tube.
Protocol:
1. Set up pink dental wax to be the height of the humeral head so that the tendon can
lie flat. Place ruler under top layer of wax so that it does not get stain all over it
but so that the numbers can still be seen.
2. Blot tendon with KimWipe to remove excess PBS so stain does not spread.
3. Lie tendon flat with bursal side up, joint side down on wax.
4. Dip suture in stain (wait until small stain bubbles appear on suture).
5. Place first (0mm) stain line at point of insertion, as shown in picture. The
insertion site is slightly angled; follow this angle. The goal is to place the stain
line directly on the insertion site so that it does not move under tension.
6. Place the remaining stain lines measuring from the highest point of the insertion
stain line. Stain lines are indicated by black rectangles in the figure below and are
spaced from the 0 stain line by the number of millimeters indicated.
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Appendix 18: Supraspinatus Tendon Cross-Sectional Area Measurement
This protocol is to determine the supraspinatus tendon cross-sectional area for
mechanical testing (8 mm gauge length).

Protocol:
1. Blot tendon with KimWipe to remove excess PBS.
2. Place tendon bursal side down and ensure tendon is lying flat with no space
between tendon and base; if necessary, angle humerus using pink dental wax.
3. Do not save: Zero Gismo at first (insertion) stain line. Move Gismo to just after
humeral head so that a complete pass could be made without interruption and
record distance (A). This distance will vary between specimens. Stop the
program but do NOT re-zero.
4. Save: Start the program in capture (save) mode. Immediately zero the thickness
but NOT x or y. Make first pass across width of tendon at non-zeroed distance
“A” (where you left off before saving). The remaining passes are indicated by the
distance (in millimeters) from the start (where Gismo was zeroed). Be sure to
note if Gismo does not correspond with stain lines. If distance A is so large that it
goes beyond the 2nd stain line, adapt the Gismo protocol by only doing those
passes that are appropriate. For example, if A = 2.54 mm, make passes at 2.54
mm, 3 mm, 4 mm, 6 mm, and 8 mm.
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Appendix 19: Supraspinatus Tendon Potting/Sandpaper for Mechanical Testing
Equipment and Supplies Needed:
Small pots (cut to 1” length): Harvel Clear ¼” SCH 40 P NSF-61
PMMA
1x PBS
3 mL syringe
Sandpaper (P400) cut into 1.2 x 1.5 cm rectangles
Small curved forceps
Loctite glue
Potting Protocol:
1. Ensure pot fits inside testing fixture.
2. Tape bottom of pot, and label pots with specimen ID on side of pot and on bottom
of tape.
3. Fill pot with PMMA.
4. Insert humerus into PMMA so that the humeral head rests above the lip of the pot.
Be sure to keep the humerus out of the pot far enough so that the tendon insertion
site is clearly visible when viewed how the camera would see them during
loading. Be sure not to get PMMA on tendon.
5. Wrap tendons into a “turban” and set them on the top of the humeral head.
6. Let PMMA cure. Keep an eye on the tendons to ensure that they do not dry out.
7. Once PMMA begins to cure, mix up another batch of PMMA and fill syringe.
8. Coat humeral head with second pot (to keep growth plate from fracturing during
loading). Avoid getting PMMA on tendon. Be sure PMMA does not interfere
with the tendon loading direction.
9. Wrap tendons into a “turban” and set them on the top of the humeral head.
10. Once PMMA begins to harden, remove tape and put pots into specimen cup filled
with 1x PBS. This can be stored in the fridge overnight.
Sandpaper Protocol
1. Dab tendon on KimWipe to remove moisture from sandpaper region- tendon will
slip from sandpaper during testing if not dried first!
2. Cover one piece of sandpaper with glue.
3. Place tendon on sandpaper with sandpaper towards tendon. Be sure bottom of
sandpaper aligns with top stain line and that the tendon is set in the direction it
will be loaded. Spread tendon to lie flat on glue.
4. Add glue to second piece of sandpaper. Place second piece of sandpaper on top
of tendon.
5. Pinch tendon/sandpaper sandwich for ~30 seconds to let glue cure.
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Appendix 20: Supraspinatus Tendon Mechanical Testing
This protocol is for the preparation of rat supraspinatus tendon for mechanical testing on
the ElectroPuls Instron.
Equipment and Supplies Needed:
Fixture for supaspinatus tendon testing on the ElectroPuls
Grips
Camera/image capture program
BioPuls bath
Protocol:
1. Use 250 N load cell (smallest available for ElectroPuls).
2. Set up fixture in BioPuls bath so that the tendon will point towards the window of
the bath for image capture.
3. Heat bath to 37°C.
4. Plug in the LVDT for fine displacement control.
5. Restore LVDT calibration.
6. Ensure Instron is tuned to a specimen with a stiffness of 16 N/mm.
7. Load specimen into fixture.
8. Zero load when the tendon is slack.
9. Manually pre-load tendon to 0.165 N, and zero the digital displacement and
“strain 1” (LVDT).
10. Set limits.
11. Open WaveMatrix, and load the Rat Supra_SIR Thesis protocol.
12. Simultaneously begin Instron protocol, zero time on the image capture program,
and set a timer for 34 min.
13. When timer buzzes, remove LVDT from Instron. Begin image capture at 175s
into the last step (25) of the protocol, capturing 2 frames per second.
14. Stop image capture program and end/finish Instron protocol when the specimen
begins to fail.
15. Manually raise the Instron to better visual how specimen failed (e.g., at grip, midtendon, insertion, shear, etc.). Record this failure method.
16. Remove specimen from tank.
17. Acquire calibration image by taking image of a ruler (millimeter side).
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WaveMatrix Testing Protocol
Rat Supra_SIR Thesis (8 mm gauge)
STEP 1| Ramp to 1% strain @ 0.1%/s (0.008 mm/s)
STEP 2| Preconditioning 1-1.5% strain, 0.25 Hz, 10 triangle cycles
STEP 3| Return to gauge length @0.1%/s (0.008 mm/s)
STEP 4| Hold 300s
STEP 5| Ramp to 4% strain (0.32 mm) @ prescribed 50%/s (4 mm/s)
STEP 6| Hold 300s
STEP 7| 10 sine cycles, 0.1 Hz, amp = 0.01 mm (0.125%)
STEP 8| 10 sine cycles, 1 Hz, amp = 0.011 mm
STEP 9| 10 sine cycles, 2 Hz, amp = 0.013 mm
STEP 10| 10 sine cycles, 10 Hz, amp = 0.015 mm
STEP 11| Return to gauge length @ 0.1%/s (0.008 mm/s)
STEP 12| Hold 60s
STEP 13| Ramp to 8% strain (0.64 mm) @ prescribed 50%/s (4 mm/s)
STEP 14| Hold 300s
STEP 15| Recovery to 4% strain (0.32 mm) @ prescribed 50%/s (4 mm/s)
STEP 16| Hold 300s
STEP 17| Return to 8% strain (0.64 mm) @ 0.1%/s (0.008 mm/s)
STEP 18| Hold 300s
STEP 19| 10 sine cycles, 0.1 Hz, amp = 0.01 mm (0.125%)
STEP 20| 10 sine cycles, 1 Hz, amp = 0.011 mm
STEP 21| 10 sine cycles, 2 Hz, amp = 0.013 mm
STEP 22| 10 sine cycles, 10 Hz, amp = 0.015 mm
STEP 23| Return to gauge length @ 0.1%/s (0.008 mm/s)
STEP 24| Hold 180s  Remove LVDT, capture images at 175s into this step
STEP 25| Ramp to failure @ 0.3%/s (0.024 mm/s)
Bolded steps indicate LVDT control. All other steps are digital position control.
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Appendix 21: Supraspinatus Tendon and Muscle Cross-Sectional Area
Measurement
Gismo Protocol
1. Setup
2. Muscle analysis
3. Tendon Analysis

1. Setup
a) Open MATLAB R2012a
b) In the current folder box at the top change the directory to:
\\medfiles\ort\McKay_Lab_Folders\shared\Software_released\Gismo_area\release
d
c) Type “gismo_area;” and click enter and a GUI will pop up on the side with Load,
Mark Gismo, Local Area etc…
2. Muscle analysis
a) Click Load and select the .txt Gismo file you want to analyze.
b) Click Mark Gismo and use the cursor to select the sides of each peak going from
left to right. When all the peaks are marked click enter. Create a folder with the
name of the tendon and save all files there.
c) An area vs. length bar graph will pop up. Eyeball the peak in the middle region (a
range of 4mm). On the GUI toolbar type your estimated middle region (ex. 4 – 8)
and click Local Area. Another graph will pop up showing if your area included
the whole peak. Try and include as much of the peak as possible and be even on
both sides. You can adjust your region by changing the numbers and clicking
Local Area. An example of this is shown below. Once you have a good region go
to the Matlab main console and copy the Local Area information to the excel file.
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3. Tendon Analysis
a) Repeat steps a) and b) from muscle analysis.
b) Look at four regions: insertion (0-2mm), midsubstance (2-4mm), whole tendon
(0-4mm) and then the region from 4-8mm (sandpaper). In order to get the data for
each region plug in the region to the local area boxes and click Local Area. You
do not need to enter 0 for the insertion or whole tendon regions; instead, use the
initial starting point that gismo automatically inserts in the local area box (i.e., the
distance “A” value recorded during your Gismo measurements). Once you
calculate the Local Area from each region go to the Matlab main console and
copy the Local Area information to the excel file.

188

Appendix 22: Frequency Sweep Analysis for Tendon Mechanical Testing
Frequency sweep analysis
4. Setup
5. csv2txt_ePuls
6. LoadAndFitSine_v3
7. GetLength

1. Setup
d) Open MATLAB R2012a
e) In the current folder box at the top change the directory to:
\\max\software cooker-freezer\SLRP\Cooker\v1.0.1_Matlab M files combined
2. csv2txt_ePuls
a) Type “csv2txt_ePuls;”
b) Select the Instron Test1.steps.tracking.csv file
c) The program will create a new file in the same location with the same name but
with .txt after
d) To streamline the process, you can type csv2txt_ePuls; csv2txt_ePuls;
csv2txt_ePuls; for as many specimens as you have to retain the same folder
information.
3. LoadAndFitSine_v3
a) Type “LoadAndFitSine_v3;” and click enter and a window will pop up to open a
file. Open the file created in step 2.
b) A screen will pop up asking for Input Parameters. For the Vector of block
numbers enter “[7 8 9 10 19 20 21 22]” and for the Vector of frequencies enter
“[0.1 1 2 10 0.1 1 2 10]”.
c) Another screen will pop up to enter the Cycle # start and end. Enter 4 for the start
and 9 for the end.
d) Twenty four graphs will pop up that contain the graphs of the frequency sweep in
order from 4% to 8%. Look at each graph and make a note about the graph. Notes
can include if the graph in noisy, has a plateau or weird line shape. Two examples
graphs are shown below. The one on top is a 10 Hz frequency at 8% strain. This
graph is good, no funny line shapes, or noise. The second graph is of a 2 Hz
frequency at 4% strain. This graph is noisy and also you can see a plateau at the
minimum points of the green line. These are the type of notes you should take in
the excel file.
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e) After recording the notes from the graphs, copy over the data in the Matlab
console to the excel file.
4. GetLength
a) Type “GetLength;”
b) Type “y” to select a new calibration image (each new specimen should have its
own calibration image)
c) Select the calibration image (ruler image) for that specimen. Maximize the
image.
d) Click to the left of one tick mark on the ruler and then to the left of another tick
mark on the ruler to span a region of ~10-15 mm (easy to do multiples of 5 mm).
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Enter this span in mm and click OK.
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e) Select the first image saved for the specimen. This image should be when the
specimen is in an unloaded state prior to the ramp to failure. Maximize the
image.
f) Use the cross-hairs to click to select the bottom of the tendon (in the middle of
the insertion stain line) and then click to select the top of the tendon at the
sandpaper.
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g) In the MATLAB command window, copy and paste the “mmpermix” value into
the Excel spreadsheet in the “calib” tab. In Excel, take the inverse of this value
(1/mmpermpix) to determine the calibration in pixels/mm.
h) In the MATLAB command window, copy and paste the “L0_mm” value into the
Excel spreadsheet in the “GetLength” column of the Fresh Data tab.
5. Calculations
a) Stress at each frequency is calculated as Force/Area. The force is taken from the
Instron output, and the area is tendon cross-sectional area (2-4 mm).
b) Strain at each frequency is calculated as ΔLength/Length. The ΔL is taken from
the displacement amplitude of the sine waves, and the length is measured from the
pre-loaded tendon image using the GetLength Matlab function.
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c) Dynamic modulus at each frequency is calculated as Stress/Strain. Stress and
strain are calculated as described above.
d) Tangent δ at each frequency is calculated as tan(δ). The tangent of the phase
angle is equal to the ratio of the loss modulus to the storage modulus.
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Appendix 23: Optical Strain Analysis from Tendon Mechanical Testing Images
Optikos Protocol
8. Setup
9. Optikos command
10.
Apply_disp
11.
Trk2element
12.
El2d_stiffness
13.
Calib_image

1. Setup
a) Open MATLAB R2012a
b) In the current folder box at the top change the directory to:
\\medfiles\ort\McKay_Lab_Folders\shared\Software_released\optikos\released
c) On the computer go to where your data files are stored. Open the file called
“Test1.steps.tracking_csv.txt” in excel. Edit the document so that only four
columns exist in this order: Time-Disp-Load-Block (copy column C over column
G and then delete columns B,C & D). Save this file as
“Test1.steps.tracking_optikos_csv.txt”
2. Optikos command
a) Type “optikos;” into the command line and click enter and a GUI will pop up on
the side with Load at the top.
b) Load the images for your specimen. If you load one the rest will automatically
load.
c) Change the display from Not Enhanced to Contrast + Filtered
d) Click Instron Restrict and load the file you created earlier called
“Test1.steps.tracking_optikos_csv.txt”. Once you load this a bubble will pop up
called Image capture correction where you can adjust the time your testing began.
Usually it is 0.0 and click enter and record this in the excel file.
e) A screen will pop up asking you to choose the maximum displacement as well as
a graph. Click ok and use the cursor
to choose the point where the slope
is maximum, before tendon failure.
After you select the point a warning
dialog will pop up and tell you how
many images there are to analyze.
Write this in the excel document,
click ok and then record how many
images the program is going to
analyze (e.g., every 4th image).
f) Next click Choose ROIs (regions of
interest). There are four regions of
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g)
h)

i)

j)

interest, PMMA, Stain line 1, 2 and 3 (S1, S2 and S3). The PMMA is located on
the bone area, and when you select regions of interest for PMMA you want to
select an area that is unique for both points. For stain line 1, 2 and 3 select the
regions from left to right and make sure to get the full length of the stain line in
the box. An example is shown above of PMMA and stain line 2.
After you mark the regions of interest click Track ROIs and it will take about a
minute or so to track the regions on all the images.
After the tracking is done a graph will appear showing how far your regions
moved. To ensure your tracking worked use the scroll feature located right above
the Instron Restrict button to view your boxes across all the images.
After checking that the tracking worked click Text Output and save the file as
“32-XXX_PMMA-LR.roip” and change PMMA to S1, S2, or S3 depending
what stain line was tracked.
Lastly, copy the line from the MATLAB command window to excel

3. Apply_disp
a) This step allows us to apply the displacement of the PMMA to the first stain line
so that we can determine the tendon strain relative to bone. These markers should
not move a lot. A file is created, which is used in the following steps.
b) Type “apply_disp;” into the command line and a window will appear to choose a
file. Choose the file you created in step 2i) for the PMMA. Click open and then
another window will ask you to select another file and select the file from step 2i)
for S1.
c) A graph will appear and another window asking you to save the output file. Label
this output file: “32-XXX_S1SYN-LR_trk.txt”.
4. Trk2element
a) This step is going to compare the movement of S2 to S1SYN, S3 to S1SYN and
S3 to S2.
d) Type “trk2element;” into the command line and a window will appear to choose
a file. Choose the file you created in step 3c) called “32-XXX_S1SYNLR_trk.txt”. Click open and then another window will ask you to select another
file and select the file from step 2 called “32-XXX-S2-LR.roip”.
b) A graph will pop up showing how the two stain lines are moving relative to one
another. After a few seconds a box will appear asking if you want to save. Click
save and save as “32-XXX_S1SYN-S2_trk.txt”.
c) A few other graphs will appear after you save. Copy these graphs to the
Optikos_Figures excel spreadsheet
d) In the MATLAB console copy the mean angle and the three lines that have data
and start with 32-XXX_S…..txt to the respective excel pages.
e) Repeat steps b-d comparing the file 32-XXX_S1SYN-LR_trk.txt to 32-XXX-S3LR.roip for S3 to S1 and 32-XXX-S2-LR.roip to 32-XXX-S3-LR.roip for S3 to
S2.
5. El2d_stiffness
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a) Type “el2d_stiffness;” into the command line and a window will appear to
choose a file. Choose the …eld2D.txt file you created in step 4. Click open and
then another window will ask you to select another file and select the file from
step 1c called “Test1.steps.tracking_optikos_csv.txt”.
b) Once you load this a bubble will pop up called Image capture correction where
you can adjust the time your testing began. Usually it is 0.0 so click OK. It will
then ask you the primary loading direction. Since we stretched in the Y direction
click Y.
c) A graph will appear with Load against Optical Strain and a box with the image
number will appear. Each image is represented on the graph with the blue
diamond and black circle around it. The black line represents the best fit to these
images. In order to achieve the best fit, delete the images associated with the toe
region and try and get the line as fit as possible to the point. An example is shown
above. Specifically, choose the steepest region that best represents the curve.
Avoid any points that stack on top of each other. You can add/remove images by
using the Ctrl and Shift keys on your keyboard.

d) Click close on the image selector when your graph looks good and save the graph
as the default name. Copy the graphs to the Optikos_Figures excel spreadsheet
and copy the line in the MATLAB command window to excel.
6. Calib_image
Note: this step is not necessary if using
GetLength command for frequency sweep
analysis
a) Navigate to the folder on the
computer with the images for your
specimen. Open up the images
labeled calib~… and preview them to
make sure they look normal.
b) In the MATLAB console enter the
command “calib_image;”. Select one
of the normal images you previewed
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in step a.
c) A cursor will appear and select a region on the ruler (easy to do scales of 5 mm).
When clicking the cursor select to the left of the line and drag the cursor to the
left of another line to mark the range. An example image is shown to the right
with the line shown in yellow.
d) After you draw the line double click and a box will appear that says enter
calibration object length. Enter the length that your line spans and click enter.
e) In the MATLAB console copy the third number shown (L_cal (pix/mm)) into
the excel file
7. Calculations
a) Stiffness (optical) is calculated by converting the Optikos output Kopt in
N/pix to N/mm by multiplying by the conversion factor in pix/mm calculated
using GetLength or calib_image Matlab functions. Typically, however, we
report grip stiffness (Kgrip) instead.
b) Modulus (optical) is calculated by multiplying the Optikos output Kstrn in
N/% by 100% and dividing by the tendon cross-sectional area (2-4mm).
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Appendix 24: Supraspinatus Tendon MMP Activity Using Anaspec SensoLyte 520
Generic MMP Assay Kit
I.

II.

Tissue Homogenization
A. Mince tendon samples
1. Remove samples from -80ºC and immediately transfer to liquid
nitrogen.
2. Remove single sample from liquid nitrogen and place on black pad.
3. Use blade to mice tissue into small pieces.
4. Place samples back in tube and immediately place in liquid nitrogen.
5. Wipe down mat/forceps with ethanol between each sample.
6. Continue with remaining samples.
7. Store samples at -80ºC until ready to homogenize.
B. Tendon Homogenization
1. Remove minced samples from -80ºC and immediately transfer to
liquid nitrogen.
2. Remove sample from liquid nitrogen and sandwich between folded
aluminum foil.
3. Use large pestle to smash sample. Repeatedly return to liquid
nitrogen and smash until sample is in powder form.
4. Once pulverized, return sample to tube.
5. Add 150µl assay buff (provided in kit) with 0.1% Triton X-100.
6. Use micro-pestle to further homogenize sample.
7. Store samples on ice while working on remaining samples.
8. Centrifuge: 4ºC, 10000 rcf, 15 minutes
9.Transfer supernatant to new labeled tube
10. Take 28µl aliquot (transfer to new labeled tube) for BCA.
11. Store all samples at -80ºC.
Protein Quantification (BCA Assay)
A. Refer to BCA kit directions!
B. Make working reagent 50:1 from kit
C. Create standards:
Label µg/ml
Buffer (µl) BSA
Blank (0) All
none
H
125
60
60F
G
250
60
60D
F
375
30
90D
E
500
105
105B
D
750
30
90B
C
1000
130
130A
B
2000
none
All (full concentration)
A
D. To each 28 µl aliquot of homogenized tendon samples add 28 µl assay buffer
to get 1:1 dilution.
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E.
F.
G.
H.
I.

III.

Add 25 µl of each dilute sample and standard in duplicate to plate.
Add 200 µl working reagent to each well. Pipette up and down to mix.
Incubate 30 minutes at 37ºC .
Read on plate reader
For analysis:
1. Average each duplicate
2. Subtract average blank reading from each sample/standard averages
3. Create standard curve and plot best fit line with equation
4. Use equation to determine protein quantity from each sample
MMP Activity (SensoLyte 520 Generic MMP Assay Kit)
A. Refer to MMP activity kit directions!
B. Calculate the amount of sample and buffer to add for each sample to ensure
equal quantity of protein is placed in each well. For acute tendon I used 36µg
and chronic I used 39µg. Total volume of sample + assay buffer should be
49µl so that adding 1µl dilute component C (see below) will create 50µl total
volume.
C. For 1 plate:
1.Dilute 5µl Component C in 100 µl assay buffer
2.Dilute 45 µl substrate in 4455 µl assay buffer
D. Create standards using purified human MMP-13 (also include blank):
Label Quantity (ng) MMP-13 (µl) Assay Buffer (µl)
0.1
110H
110
I
0.2
165G
165
H
0.4
200D
200
G
0.5
110C
110
F
0.6
315D
105
E
0.8
294A
441
D
1.0
165A
165
C
1.5
165A
55
B
2.0
4.1
MMP-13
995.9
A
E. Plate all samples/blanks/standards in duplicate. Make sure to use 96-well
plates, black polystyrene, non-binding surface (CLS3991 from Sigma)
F. Activation: incubate 2 hours, 37ºC with dilute component C
G. Activity: incubate 45 minutes room temperature with MMP substrate
(50µl/well) covered with foil to block light
H. Stop solution: 50µl/well
I. Immediately read on plate reader
J. For analysis:
1. Average each duplicate
2. Subtract average blank reading form all other sample/standard
average
3.Create standard curve and plot best fit line with equation for the
human MMP-13 readings
4. Use equation to determine “normalized” MMP activity of each sample
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